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4Abstract
Schizophrenia is a devastating mental illness and a huge disease burden in
terms of cost. The individual is typically affected in early adulthood, thus
loosing the best years of their life. The stigma of mental illness and pattern of
downward social drift also results in families and society being adversely
affected.
With advances in neuroscience and neuroimaging, psychiatrists can advance
their understanding of schizophrenia as a disease of the brain using
biological models. This thesis investigates how volumetric magnetic
resonance imaging (MRI), structural MRI techniques such as magnetisation
transfer imaging (MTI), diffusion tensor imaging (DTI), and novel techniques
such as optical coherence tomography (OCT) and visual function testing may
be used to elucidate the neuropathology of schizophrenia in-vivo, in addition
to explaining the cognitive deficits that are commonly observed.
.
The following studies are included in this thesis:
1) A diffusion tensor imaging (DTI) study to explore white matter
abnormalities in first episode psychosis and correlations with cognitive
performance.
2) An exploratory study utilizing OCT to investigate whether retinal nerve
fibre layer thickness varies between patients with schizophrenia and
healthy controls.
3) A longitudinal study using MRI and MTI to examine structural brain
changes following first episode psychosis and correlating these
findings with cognitive performance.
4) An investigation of chromatic vision in schizophrenia spectrum
disorders and correlations between hue discrimination ability and
cognitive performance.
5) A cross-sectional comparison study of grey matter volume and
associations with oculomotor function in first episode patients and
healthy controls.
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1. AN OVERVIEW OF SCHIZOPHRENIA
1.1 Introduction
Schizophrenia is a word derived from Greek which literally translates as “split
mind”. As a diagnostic concept, “The Schizophrenias” were introduced by the
Swiss psychiatrist Eugen Bleuler in 1911. This was supposed to describe the
loss of coherent contact between different functions of the mind i.e. loosening
of associations (Bleuler, 1911). Schizophrenia gradually replaced the
Kraepelinian concept of Dementia Praecox, which described the symptoms
of patients who had catatonic or paranoid presentations thought to be the
result of a progressive brain disease with a poor prognosis (Kraepelin, 2009).
Today, schizophrenia remains a psychiatric disorder of major, global impact
with 1% prevalence, affecting all ethnic groups in any of the various social
strata. Contrary to popular belief, schizophrenia is equally common in men
and women, although women typically have a later illness onset and often a
less severe course of illness than men (Castle et al., 1998). One possible
explanation for the difference in illness severity is due to the gender
difference, with males and females being susceptible to what may be
different subtypes of schizophrenia, which have different ages of onset
(Murray et al., 1992).
Schizophrenia is a costly disease to both the affected individual and society
as a whole. Symptom onset is usually in early adulthood at a period in the
lifespan when humans are at their prime in terms of physical and intellectual
development. In the Western world, direct expenditure for treatment and
social care of patients with schizophrenia is estimated at 1 to 3% of the
national healthcare budget (Knapp et al., 2004). In economic terms,
schizophrenia cost an estimated total of £6.7 billion in the UK alone for
2004/5, with £2 billion spent on direct costs (i.e. treatment and social care)
and the remainder accrued through indirect costs to society (Mangalore and
Knapp, 2007). In the USA, the overall cost was estimated at $62.7 billion in
2002; with indirect costs estimated at $32.4 billion from days lost to
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unemployment, reduced workplace productivity, premature death by suicide
and family members providing care (Wu et al., 2005).
1.2 Clinical Diagnosis
A diagnosis of schizophrenia has historically been based on Schneider’s First
Rank Symptoms which describe a cluster of symptoms in four categories,
including auditory hallucinations, thought broadcast, delusions of control and
delusional perception (Schneider, 1959). Although a useful guideline, there is
controversy as first rank symptoms are not specific for schizophrenia
(Nordgaard et al., 2008), although they occur frequently in patients with
schizophrenia (Thorup et al., 2007). First rank symptoms have historically
contributed to the definition of schizophrenia in the two major classification
systems for psychiatric disorders, the International Classification of Diseases
(ICD) published by the World Health Organisation and the Diagnostic and
Statistical Manual (DSM) published by the American Psychiatric Association.
Both systems are under regular review and modification, and the suggestion
that first rank symptoms should be de-emphasised in future editions as
specificity for schizophrenia is poor (Nordgaard et al., 2008) has resulted in
changes to the DSM-5 (American Psychiatric Association, 2013) criteria,
which now states that it is characterized by delusions, hallucinations,
disorganised speech and behaviour, and other symptoms that cause social
or occupational dysfunction. For a diagnosis, at least two symptoms must
have been present for six months. The ICD-10 (World Health Organisation,
1992) specifies at least 1 month duration of symptoms and also classifies
different schizophrenia subtypes; instruments such as the Diagnostic
Interview for Psychoses (Jablensky, 2000) and the Schedules for Clinical
Assessment in Neuropsychiatry (Wing et al., 1990) have been developed
from this. These instruments have been primarily used to identify symptom
severity in those with an established diagnosis of schizophrenia but
increasing research interest is focused on the schizophrenia prodrome and
ways to identify the disease early.
Future aims include a more biologically based categorization of
schizophrenia using endophenotypes, once these have been firmly
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established (Tandon et al., 2009). As no medical test can confirm a diagnosis
of schizophrenia, it remains difficult to ascertain an early diagnosis and
predict disease progression or long-term prognosis. The search for biological
phenotypes is underway but diagnosis is still determined by clinical
observations. Schizophrenia remains an elusive illness as it encompasses a
wide range of symptoms with no clear disease biomarker that can be readily
measured or evaluated.
1.3 Epidemiological Findings
The incidence of schizophrenia is similar across different countries at a rate
of 0.16 to 0.42 per 1000 population (Jablensky et al., 1992). Some ethnic
groups are at increased risk of developing schizophrenia but reasons for this
remain unclear. Second generation, black African-Caribbean immigrants in
London are seven times more likely to develop schizophrenia than their
Caucasian neighbours. Conversely, the Hutterites of Manitoba and South
Dakota have low incidence rates compared to other white Caucasian,
immigrant settlers (Nimgaonkar et al., 2000). Socio-demographic studies
have found a particularly large cluster of schizophrenia cases in South
London, suggesting an association with social deprivation and social isolation
(Morgan et al., 2008).
Obstetric complications, poor social and occupational adjustment are all
linked to early illness onset (Murray et al., 1992). An excess of schizophrenia
patients are also found to have Winter-Spring births (Torrey et al., 1997).
Gender differences point to an effect of sex hormones and chronic oestrogen
applications have been shown to significantly shorten episodes of dopamine-
induced behaviour and reduce D2 receptor sensitivity in the brain, at least in
animal and post-mortem studies (Häfner et al., 1993). An X-linked
susceptibility locus determining age of onset has also been postulated
(DeLisi, 1992).
Perhaps the most controversial topic in schizophrenia research is the link
between cannabis use and onset of psychosis. In a longitudinal study of
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Swedish conscripts, it was found that those who smoked cannabis had
double the risk of developing schizophrenia during a 15 year period of follow-
up (Andréasson et al., 1987). Subsequent studies correlated the degree of
exposure to cannabis with the risk of developing schizophrenia (van Os et al.,
2002; Zammitt et al., 2002). A direct causal effect remains unfounded;
however there are serious public health implications that call for the
prevention of cannabis use (Macleod et al., 2006).
1.4 Chemical Neurotransmitters
Original treatments developed for schizophrenia were not based on scientific
evidence and often resulted in more harm than good e.g. inducing malaria
and insulin coma. While some have argued against the neurochemical model
of mental illness (Moncrieff, 2007), others have challenged the medical
model and concept of psychiatric illness itself (Laing, 1950).
In the 1950s, it was recognized that phenothiazines were useful antipsychotic
agents. This was a serendipitous finding considering chemists at the time
were attempting to develop an antihistamine. A similar tranquilizing effect
was also seen in the butyrophenones (another chance finding). Carlsson and
Lindquist demonstrated that both chlorpromazine and haloperidol increase
monoamine turnover and postulated that they might act on dopamine (DA)
receptors (Carlsson and Lindquist, 1963), thus providing a plausible
explanation for their mechanism of action, which gave rise to explanatory
theories of schizophrenia.
The dopamine hypothesis was subsequently born and confirmed by Positron
Emission Tomography (PET) studies (Creese et al., 1976). PET scanning
involves injecting a radio-active isotope which has been incorporated into a
biologically active molecule e.g. fluorodeoxyglucose (FDG), which is then
given time to accumulate in the tissue of interest. The scan is produced by
measuring the concentration of radio-active tracer as it decays over time. In
the case of antipsychotic drugs, it was shown that the degree of post-
synaptic dopamine receptor blockade correlated with potency of the drug
(Seeman et al., 1975). There are at least 5 dopamine receptor subtypes but
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functional imaging studies have found evidence of an increase in brain D2
receptor density in schizophrenia (Laruelle, 1998). It is now understood that
blockade of 60 to 70% of D2 receptors is required to optimize treatment of
psychotic symptoms.
Glutamate, an excitatory neurotransmitter has also been implicated in
schizophrenia. Blockade of NMDA glutamate receptors by agents such as
amphetamines or cocaine closely mimic psychosis as seen in schizophrenia
(Laruelle, 1998). Glutamate is also used to synthesise the inhibitory
neurotransmitter GABA but regulation of GABA neurotransmission is partly
due to its rate-limiting synthesizing enzyme glutamate decarboxylase (GAD).
Thompson and colleagues found a widespread deficit in GAD67 mRNA
expression throughout multiple areas of the brain in schizophrenia, with
significant reductions in the anterior cingulated cortex, superior temporal
gyrus, striatum and thalamus (Thompson et al., 2009).
Current developments are being made with LY404039 (a selective agonist for
metabotropic glutamate 2 and glutamate 3 receptors), with a promising
clinical trial using the oral pro-drug LY2140023. This treatment was safe and
well-tolerated by patients who showed statistically significant improvements
in both positive and negative symptoms of schizophrenia compared to a
placebo after 4 weeks (Patil et al., 2007). It has subsequently been
suggested that clinical antipsychotic action of a glutamate agonist may in fact
depend on its ability to interfere with DA neurotransmission by its DA partial
agonism (Seeman, 2009).
1.5 Neuropathology
For many decades, schizophrenia research produced no scientific
breakthroughs and was described as the “graveyard of neuropathologists”
(Plum, 1972) until 1976, when a seminal study by Eve Johnstone and
colleagues reported increased ventricular size on the first in-vivo, controlled,
comparison computerized tomography (CT) study of schizophrenia
(Johnstone et al., 1976). Although earlier studies had reported an increased
ventricular size in schizophrenia patients, they failed to attract much interest
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as they used invasive techniques such as pneumo-encephalography or
ventriculography on a small number of patients. Macroscopically, loss of
brain tissue appeared to result in ventricular enlargement of the third and
lateral ventricles, this is now a well-recognized feature of schizophrenia.
At a microscopic level, postmortem studies have suggested changes in the
brain at a cellular level, which points to schizophrenia being a
neurodevelopmental abnormality. An influential paper described abnormal
cytoarchitecture and lamination of the entorhinal cortex, with prominent
changes noted in lamina II of the entorhinal cortex (Jakob and Beckmann,
1986); however, a healthy control group was not used for comparison and
material was sampled based on external landmarks, resulting in a possible
sampling error (Harrison, 1999), hence the finding remains contentious.
Reduction in the number of dendritic spines and dendritic length have been
described in layer III of the dorsolateral prefrontal cortex (Glantz and Lewis,
2000), temporal and frontal association layers (Garey et al., 1998) and layer
V of the pre-frontal cortex (Black et al., 2004). Volume loss in the brain is
probably due to a reduction of neuropil (as proposed by the reduced neuropil
hypothesis) rather than a reduction in the actual number of neurons,
(Selemon and Goldman-Rakic, 1999). The main difficulty is in obtaining
sufficient numbers of post-mortem samples and fresh brain tissue as the
neuropathology studies quoted, each contained fewer than 25 brain tissue
samples from schizophrenia patients.
Oligodendrocytes responsible for optimizing nerve conduction by myelination
of the axons are also seen in reduced number (Uranova et al., 2004) and
expression of six myelin-related genes have subsequently been found to
have decreased expression in schizophrenia. The mouse model for
dysmyelination (the MAG knockout mouse) has also been found to have
changes in dendritic branching in layer III of the prefrontal cortex (Segal et
al., 2007).
There is no firm evidence for schizophrenia being a progressive
neurodegenerative disease (as initially postulated by Kraepelin himself).
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Although gliosis was reported in one post mortem study of schizophrenia
(Stevens, 1982) subsequent neuropathological investigations have revealed
mixed results and a more likely explanation is that schizophrenia brains are
more prone to cumulative damage resulting in gliosis (Harrison, 1999). Other
neurodegenerative hallmarks such as cortical thinning have been reported in
both post-mortem (Selemon et al., 1995) and in-vivo scanning studies
(Nesvag et al., 2008) but concurrent increased neuronal density suggests the
cortical thinning is probably due to a reduction in neuropil.
1.6 Models of schizophrenia
A neurodevelopmental explanation for schizophrenia seems plausible as
evidence suggests an association of the schizophrenia diagnosis with
obstetric complications such as prolonged labour or difficult births resulting in
cerebral anoxia (Geddes and Lawrie, 1995). Furthermore, the earlier the age
at onset of schizophrenia, the more likely the history of obstetric
complications (Verdoux et al., 1997) and low birth weight (<2500 g) with the
combination of low birth weight and short gestation (<37 weeks) more
common among adults with schizophrenia (Jones et al., 1998). These
suggest that schizophrenia may be an adverse outcome following perinatal
and/or fetal insults.
White matter tracts relay information between different cortical areas of the
brain and schizophrenia as a syndrome of disconnectivity has been
postulated (Friston and Frith, 1995). Disordered connectivity as a result of
disrupted white matter tract integrity has subsequently been evidenced by
scanning studies using diffusion tensor imaging (DTI) (Kubicki et al., 2005a;
Agartz et al., 2001). White matter tract integrity declines with chronicity of
illness (Carpenter et al., 2008) which may explain why studies including
patients at first episode of schizophrenia (Friedman et al., 2008) do not
always appear to support this hypothesis.
The large degree of variation in clinical presentation of schizophrenia
suggests that it is unlikely to be a single disease entity but ‘the
schizophrenias’ may form part of a disease spectrum as there is some
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symptom overlap between bipolar affective disorder and schizophrenia, with
schizoaffective disorder sitting between these two diagnoses. From imaging
studies, a generic association between genetic risk for both disorders and
white matter volume reduction in the left frontal and tempo-parietal regions
was consistent with left fronto-temporal disconnectivity as a genetically
controlled, structural brain abnormality common to both disorders (McDonald
et al., 2004). In another study comparing schizophrenia and bipolar disorder,
both groups showed reduced white matter density in the anterior limb of the
internal capsule (McIntosh et al., 2005). In a magnetic resonance
spectroscopy (SPECT) study, a similar decrease in N-acetyl-aspartate (a
breakdown product of the neurotransmitter acetylcholine) was found in the
prefrontal region in both schizophrenia and bipolar disorder, compared to
healthy controls (Molina et al., 2007). A meta-analysis of complete genome
scans for schizophrenia and bipolar disorder also found some overlap
between the two disorders, with the most promising regions for schizophrenia
at 8p24, 13q32 and 22q11, and for bipolar disorder at 13q32 and 22q11
(Badner and Gershon 2002). These studies all suggest that the
neuropathology of psychosis may arise from the same common root.
It is now evident that no single gene is responsible for causing schizophrenia.
Although some candidate genes have aroused interest e.g. NRG1
(Neuregulin) on chromosome 8p22, there appears to be ethnic variation. Han
Chinese schizophrenia populations were found to have at-risk haplotypes in
different regions on the NRG1 gene from Icelandic or Scottish populations (Li
et al., 2004). Studies on a large Scottish pedigree with schizophrenia have
led to findings of a balanced translocation affecting two genes on
chromosome 1, which have been named DISC (disrupted in schizophrenia) 1
and DISC2 but the mutation is probably unique to that pedigree alone (Millar
et al., 2000). Molecular genetic studies in schizophrenia have rarely
attempted to include environmental measures, assuming that if samples are
sufficiently large enough and the number of molecular markers sufficiently
numerous, genetic effects would be revealed even if underlying interaction
with environmental factors were present (van Os and Murray, 2008).
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1.7 Prodromal Schizophrenia
Before the first episode of psychosis, general decline in social and intellectual
functioning is often noted in the proceeding weeks and months. In a review of
the psychosis prodrome; Niendam and colleagues reported that individuals
who are clinically at higher risk of developing schizophrenia but not reaching
diagnostic criteria, had poorer psychosocial outcomes and worse cognitive
ability (Niendam et al., 2009). In a study using the Structured Interview for
Prodromal Syndromes, a large, multi-centred study found a 35% risk of
conversion to psychosis over a 2½ year follow-up period for a cohort at
clinically high risk of developing schizophrenia (Cannon et al., 2008). The
advent of operational criteria to identify individuals at ultra-high risk (UHR)
(Yung et al., 1998) has improved clinical ability for identifying those at high-
risk of developing schizophrenia. To be classified UHR the individual is
required to meet one of the following criteria: 1) Attenuated psychotic
symptoms up to several times a week with change in mental state between 1
week and 5 years, 2) brief limited intermittent psychotic symptoms (BLIPS) of
less than 1 week, 3) a first degree relative with psychotic disorder or an
individual with schizotypal personality disorder and significantly decreased
functioning between 1 and 12 months duration. Combined low dose
risperidone and CBT in UHR individuals have been shown to reduce the rate
of transition to psychosis (McGorry et al., 2002) and CBT alone may reduce
or at least delay transition to psychosis in this group (Morrison et al., 2002).
In recent years, setting up early intervention and first episode psychosis
services have been the vogue, yet clinical trials on prodromal psychosis have
produced mixed results. While Olanzapine (an atypical, second generation
antipsychotic) was useful in treating positive prodromal symptoms, it did not
significantly reduce rate of conversion to psychosis when compared with a
placebo (McGlashan et al., 2006). Other studies found that individuals with a
schizophrenia prodrome and randomized to olanzapine, improved to a
significantly greater degree over an 8-week period than patients randomized
to placebo, when positive and negative syndrome rating scales were used
(Woods et al., 2003).
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Those suffering from first episode psychosis tend not to seek immediate
medical attention and as a result, the duration of untreated psychosis (time
from onset of psychotic symptoms to the start of treatment) can be variable.
A large 2 year follow-up study, (Melle et al., 2008) found that first-episode
patients from an area with “early detection of psychosis services” had a
significantly lower duration of untreated psychosis, better clinical status, and
milder negative symptoms at the start of treatment compared to a healthcare
area without such a service. At 2-year follow-up, there was a significant
difference in negative symptoms and cognitive function between groups.
However; not all studies found a link between duration of untreated psychosis
and illness course, outcome, symptom improvement, or cognitive level.
Goldberg and colleagues found no association between longer duration of
untreated psychosis and worse cognition at baseline or less improvement in
cognitive function after 16 weeks of treatment with olanzapine or risperidone.
They argued that early intervention for treatment of psychiatric symptoms
may have little or no impact on cognitive function (Goldberg et al., 2009). A
review of early intervention studies found little evidence of benefit in long
term outcomes (Malla et al., 2005). With early intervention services, the
diversion of precious clinical resources and the unnecessary treatment of
false-positive patients are an issue of contention (Pelosi and Birchwood,
2003; Warner, 2005).
1.8 Treatment and Management
Apart from antipsychotic agents that primarily target dopamine receptors, no
pharmacological agents are available that specifically target treatment of
disabling negative symptoms, although new medications are currently in
development (as described in section 1.4).
Psychological intervention has gained increasing attention in the treatment of
schizophrenia. Randomized controlled trials have demonstrated the
effectiveness of cognitive behavioural therapy (CBT) as an adjunct to
“treatment as usual” in speeding recovery from acute symptoms in early
schizophrenia (Lewis et al., 2002) and reducing levels of distress caused by
auditory hallucinations in chronic, refractory illness (Wiersma et al., 2001).
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Clinical studies have also reported success in areas of cognitive remediation
training for improvement of social functioning (Combs et al., 2007) and
emotion recognition (Wolwer et al., 2005).
Current social interventions focus on care in the community and re-
integration into society, with Victorian asylums now institutions of a bygone
era. Between 1988 and 2005, the UK lost 58,000 psychiatric beds coinciding
with the growth of ‘Home Treatment’ and ‘Assertive Outreach’ mental health
teams, emphasizing treatment within the community. In 2001, only 14 out of
130 psychiatric hospitals functioning in 1975 in England and Wales were still
open (Leff, 2001). Sadly though, the stigma of mental illness means that in
reality, many patients with schizophrenia remain marginalized by society and
are shunned by fearful friends and family.
1.9 Oculomotor Movements and Visual Function
Abnormal smooth pursuit eye movements are known to occur in patients with
schizophrenia, this is unlikely to be an effect of medication as this
phenomenon has been observed in medication naïve, first episode patients
(Holzman, 1974). Various types of oculomotor deficits have been reported in
schizophrenia, including increased antisaccade latency (slower saccadic
movement towards a mirror image location following stimulus presentation)
and increased antisaccade error rate (erroneous saccades made towards a
peripheral stimulus despite instructions to look at a mirror image location)
(Turetsky et al., 2006). Abnormal eye movements are probably a trait rather
than a state phenomenon as they are also present in first-degree relatives of
patients with a level between that of healthy controls and schizophrenia
patients (Clementz et al., 1994). Abnormal smooth pursuit eye movements
are already present in children who have been diagnosed with schizophrenia,
whereas typically developing children have eye movements similar to adults,
suggesting development of this brain function is completed in early childhood
(Ross et al., 1998). Antisaccade errors in patients with schizophrenia appear
to be due to abnormal prefrontal cortical function and correlations have been
found with poor spatial working memory performance (Hutton et al., 2004).
Structural MRI studies have also demonstrated that smaller prefrontal lobe
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volumes in patients with schizophrenia are associated with increased
antisaccade latency (Schulze et al., 2006), while functional MRI data have
shown lack of prefrontal cortex activation in patients with schizophrenia
compared with healthy subjects performing an antisaccade task (McDowell et
al., 2002). There is a large body of research on oculomotor-function in
schizophrenia and it appears to be a promising genetic endophenotype but
has not provided the diagnostic breakthroughs that were originally envisaged.
There is a growing body of evidence suggesting that early visual processing
is impaired in schizophrenia. Butler et al. (2003) reported the effects of visual
backward masking (VBM), where a target stimulus is quickly followed by
another stimulus or “mask” that overlaps or surrounds the target stimulus
resulting in delayed response to visual stimuli in patients with schizophrenia.
Early visual processing impairment has also been demonstrated by
electrophysiological measurement of visual evoked potentials, which are
abnormal in patients with schizophrenia but unrelated to age, medication
status or chronicity of illness (Yeap et al., 2008). Chromatic vision also
appears to be adversely affected in schizophrenia and hue discrimination
ability is worse compared to healthy controls (Shuwairi et al., 2002).
Dopamine depletion is associated with deficits in blue-hue discrimination and
as antipsychotics act to block dopamine receptors in ‘hyperdopaminergic’
schizophrenia patients this has been explored (Haug et al., 1997).
Oculomotor function is further explored in chapter 9.
1.10 Cognitive Deficits
Cognitive function has been studied extensively in schizophrenia, the first
major meta-analysis reported clear deficits across the entire range of
neuropsychological tests (Heinrichs and Zakzanis, 1998) and it has been
generally accepted that there is decline in attention and memory. Structural
scanning has also shown a clear correlation between decreased white matter
FA (a measure of WM tract integrity) and impaired cognitive function in
patients with schizophrenia (Lim et al., 2006). It has now been suggested that
different subgroups of schizophrenia patients may show different profiles of
cognitive impairment. One study found that a high proportion of patients
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(40%) displayed a decline in IQ from estimated premorbid levels, while a
specific impairment of spatial working memory was present even in those
with high/average IQ (Joyce et al., 2005). Most researchers have reported
deficits in performance on executive tasks (which place demand on the
frontal lobes) in addition to memory and learning (temporal lobe tasks), of
these verbal memory seems disproportionately impaired in schizophrenia
(Heinrichs and Zakzanis, 1998). While entire assessment batteries such as
the Behavioural Assessment of Dysexecutive Syndrome (BADS) have been
shown to be valid within a population with schizophrenia (Katz et al., 2007); a
meta-analysis concluded that the digit symbol coding task (a subtest of the
WAIS) is a reliable measure of processing speed in schizophrenia but has
been overlooked by researchers (Dickinson et al., 2007). A description of the
cognitive battery utilized for studies described in this thesis is given in
chapter 4.
Subtle cognitive deficits are already present early on in the course of
schizophrenia. In a comparison of chronic and first-episode schizophrenia
patients, right-handed patients were noted to have better performance in
verbal tests and male patients showed more cognitive deterioration than
females (Bilder et al., 1992). A large proportion of children under 10 years of
age who subsequently developed schizophrenia in adulthood, displayed poor
social interaction and academic under-achievement compared to their
healthy peers (Sobin et al., 2001). Healthy subjects who are at high risk of
developing schizophrenia tend to perform at levels between those of
schizophrenia patients and healthy individuals on cognitive tasks, as well as
evidencing deficits in specific skills like visual memory. These cognitive
deficits are present and appear to exist independently of any prodromal
symptoms, supporting the hypothesis that a common pattern of cognitive
deficits exist for individuals at genetic risk of developing psychosis (Bertisch
et al., 2008).
1.11 Conclusions
Schizophrenia remains a complex disease to research and is probably an
entity of illnesses rather than a single diagnosis and possibly even part of a
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spectrum of psychiatric illness. Primarily, it is a syndrome identified by a
range of characteristic symptoms that manifest adverse effects on social
behaviour and cognitive function.
From epidemiological studies we know that certain factors such as birth
trauma, maternal influenza, cannabis use, social deprivation and ethnicity are
linked to an increased risk of developing schizophrenia. It seems likely that
genetic loading can increase the risk of schizophrenia and gene-environment
interactions may result in aberrant neurodevelopment. Schizophrenia clearly
affects brain tissue as evidenced by imaging studies and postmortem
neuropathology is demonstrated in the brains of affected adults.
Schizophrenia also has adverse effects on cognitive function in at least a
subgroup of patients but a decline in social and cognitive functioning is often
seen in a prodromal phase of illness, which may be years before the first
clinical episode of psychosis takes hold.
There now appears to be a range of possible schizophrenia endophenotypes
but research findings for any sample of patients are likely to be “watered-
down” by group heterogeneity. Perhaps the biggest hindrance is the absence
of a biological disease marker that can be used to accurately identify
schizophrenia and exclude those with other diagnoses who may also present
with psychosis and schizophrenia-like symptoms. Additionally, the
schizophrenia patient group is extremely difficult to follow-up as they often
disengage from psychiatric services and may lack illness insight. This feature
is unlike that of any other patient groups, for example in neurology, a
longitudinal 20 year follow-up study in multiple sclerosis (MS) retained 107 of
140 patients i.e. 76% of those originally enrolled (Fisniku et al., 2008).
Despite all the drawbacks, advances in technology are now able to provide
new means of exploring the brain that were unavailable just a few decades
ago. Through these means it will eventually be possible to identify the
biological mechanisms that lead to the development of schizophrenia and
methods to slow, halt or possibly even reverse the disease process can then
be developed.
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My thesis presents a collection of experiments that were designed to test the
neurodevelopmental and neurodegenerative models of schizophrenia that
attempt to explain the biological basis for the development of schizophrenia.
Hypotheses for each of my studies are described in further detail in chapter
4. Methods used included various neuroimaging modalities (see chapter 2)
which enabled me to look for differences in brain tissue structure and
neuropathological changes that develop over time in patients with psychosis
compared with healthy, unaffected individuals. By designing studies using a
first episode psychosis cohort, I was able to investigate a patient population
to explore changes that may occur early in the course of illness when there
has been minimal exposure to the confounding effects of medication and
other treatment interventions.
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2. AN INTRODUCTION TO THE PRINCIPLES OF MAGNETIC
RESONANCE IMAGING
2.1 Introduction
Magnetic Resonance Imaging (MRI) was developed by British physicist Peter
Mansfield and American chemist Paul Lauterbur in the 1970s. For their
achievements in the field of MRI, both scientists were awarded the Nobel
Prize for Medicine in 2003. With the advent of MRI scanning a non-invasive
technique that could allow direct visualisation of the brain in-vivo had at last
been found. Since then, advances in technology have led to improved
resolution of images and better visualisation of different tissue subtypes.
Without using harmful ionising radiation associated with other imaging
techniques such as Computerised Tomography (CT), MRI is now a
commonly performed medical investigation with scanners widely available in
many hospitals in the UK.
This chapter describes the basic physics principles behind MRI and structural
MRI methods of diffusion tensor imaging (DTI) and magnetisation transfer
imaging (MTI). These techniques have been used in the studies described in
subsequent chapters of my thesis and are described in further detail in the
methods of the relevant chapters. Analyses of brain tissue volumes obtained
from MRI data were made using Voxel Based Morphometry (VBM), while DTI
data were analysed using Tract Based Spatial Statistics (TBSS) to measure
white matter tract integrity (see section 2.7).
2.2 Basic principles of MRI
Magnetic resonance (MR) is based on the effect of a magnetic field on the
positively charged proton found in the nucleus of hydrogen (H) atoms
contained within a water molecule (H2O). The human body is composed of
approximately 60% water and with each water molecule containing 2 H
atoms; there are many protons available from which to measure the MR
signal.
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Bloch’s theory states that any charged particle i.e. an atomic nucleus with an
odd number of neutrons plus protons produces an electromagnetic field. A
hydrogen nucleus contains an unpaired proton and is therefore positively
charged as the MR active nucleus is constantly spinning around its own axis.
If a static, external, magnetic field (B0) is present, it aligns itself parallel or
anti-parallel to this field and produces a secondary spin called “precession”
which is best described by the Larmor equation.
Larmor Equation ω  = B0 γ 
Where:  ω is the frequency of precession (Radians per second) 
B0 is the strength of external magnetic field (Tesla)
  γ is the gyromagnetic ratio   
B0 is the magnetic field generated by the MRI scanner. Most protons will align
themselves parallel to this i.e. in the same direction as the magnetic field
because this is a low energy state. About 1 in a million protons will line up in
the opposite direction and are in a high energy state and anti-parallel, thus
producing a net magnetisation vector (NMV) resulting in macroscopic
magnetisation.
Figure 2.1 Precession of a proton about a hydrogen nucleus
The direction of spin can be manipulated by applying a radiofrequency (RF)
pulse which causes all the protons to spin in alignment about a common axis.
Spins correspond to the frequency of the RF pulse and nuclei return to
Magnetic
moment of
nucleus
Hydrogen nucleus
Precession of
protons
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equilibrium and realign in the B0 direction through two distinct relaxation
patterns, when the RF pulse ends.
Signal can only be detected when there is net magnetisation in a
comparative plane, hence the NMV must be flipped from the B0 direction to a
transverse plane by a RF pulse of magnitude given by the “flip angle”. The
transverse NMV produced induces an MR signal and a coil in the MRI
scanner detects the signal which is produced by a change in the frequency of
spins. Degree of decay in the MR signal indicates how much free water is
present.
Brain tissue is primarily compartmentalised into grey matter (GM), white
matter (WM) and cerebrospinal fluid (CSF). The main component of CSF is
free water, by contrast WM contains little free water, with the main
constituent being phospholipid bi-layers and intracellular organelles. GM lies
midway between these and contains more free water than WM but less free
water than CSF so these different brain tissues are clearly identifiable by the
difference in intensity with which they appear on an MRI scan.
T1 is the length of time required for 63% of the protons to achieve relaxation
(i.e. the time taken to return to their state of equilibrium and recovery of
longitudinal magnetisation to be achieved). 100% recovery is only achieved
when T1 is lengthened fivefold. Repetition time (TR) is the interval between
consecutive RF pulses. Fat has a short T1 compared with water because the
degree of signal will vary between different tissue subtypes depending on
their water content.
T2 is the length of time required for 63% of protons to loose their energy to
neighbouring structures and recover transverse magnetisation. The rate of
T2 decay is dependent on the extent of neighbouring macromolecules getting
in the way.
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Tissue Approx T1 times (ms) Approx T2 times (ms)
Cerebrospinal fluid 2000 300
Cerebral grey matter 520 100
Cerebral white matter 390 90
Table 2.1 Table Showing T1 and T2 Times of Different Brain Tissues
Adapted from the book MRI for Technologists (Woodward and Freimarck, 1995)
Tissues composed of large molecules with tightly bound proteins loose their
energy quickly because the spins diphase at a rapid rate, thus T2 relaxation
times are short. In comparison, tissues with high water content have more
“free” hydrogen protons and a longer T2. Repetition time (TR) is the interval
between consecutive RF pulses applied to the same slice. TR affects image
contrast characteristics by determining how much the longitudinal
magnetization can recover between pulses and is also a major factor in
determining total scan time.
2.3 Image Processing
To collect 3 dimensional data, spatial information is gathered from 3 gradient
coils each corresponding to the x, y or z axis in a three dimensional co-
ordinates system.
z
y
x
Figure 2.2 Diagram of the 3 Orthogonal Linear Magnetic Field Gradients
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The magnitude of B0 (external magnetic field) can be altered by the gradient
coils, therefore magnetic field strength can be predicted along the gradient
and precessional frequency of nuclei along the axis can be calculated.
Collating the data in 3 dimensions (3D) gives rise to an MRI scan which is
spatially encoded. Each pixel seen on a flat computer screen is in fact a
representation of a voxel (a 3D area of brain tissue). Analysis of brain MRI
data involves lengthy pre-processing steps so that individual variation in
shape and size can be standardised to the same space before a voxel by
voxel comparison can be made between different subjects. The three main
pre-processing steps of registration, segmentation and smoothing are
described below.
2.3.1 Registration
Because individuals each have heads of slightly different size and shape,
they need to be scaled to the same space and images need to be in the
same anatomical framework, so comparison of all component voxels can be
made. This is done by transformation of the original source image to a
reference or target image. Transforming the source to a reference image
requires mapping of each voxel from the source image to the target image.
Two different types of registration allow for different characteristics to be
preserved during this mapping process, these are “rigid transformation” or
“non-linear warping“. In rigid transformation, a single set of estimated
transformation parameters in 3D are applied to all voxels in the image. There
are six parameters – three translations and three rotations. Rigid affine
transformation preserves ratios and distances between the source and
reference image. In total there are twelve parameters in each of the three
dimensions: 3 translations, 3 rotations, 3 shears and 3 scaling factors. Non-
linear warping has the advantage of allowing for relative volume changes
between tissues to be accounted for, (this may be of clinical interest), this
model is used in the voxel-based morphometry (VBM) studies described in
chapters 7 and 9.
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2.3.2 Segmentation
In order to study each of the brain tissue compartments in more detail, it is
necessary to separate out grey matter, white matter and CSF from the skull
and from each other. Each voxel in an image is assigned a specific tissue
class based on intensity value and likely spatial distribution, this classification
is automated in SPM using Bayesian segmentation methods (Ashburner and
Friston, 2000). Additional methods such as use of the Brain Extraction Tool
(BET) www.fmrib.ox.ac.uk/fsl/bet2/index.html, allows for erosion of 1 or more
pixels around the periphery of the brain volume so there is increased
likelihood of sampling true cortical tissue and excluding any brain
parenchymal tissue that could masquerade as grey matter.
2.3.3 Smoothing
Images that have been segmented require smoothing to address registration
errors and inter-individual variance by increasing the signal to noise ratio.
When a smoothing filter is applied, neighbouring voxels are averaged to
make them more normally distributed. This is in keeping with the Central
Limit Theorem which states that the distribution of an average tends to be
normal, even when the distribution from which the average is computed is
not. The Gaussian filter size can be chosen and variable kernel sizes of full-
width-at half-maximum (FWHM) are available, for scanning studies of
schizophrenia patient populations, the kernel smoothing size selected is
usually between 6 and 12mm. Larger smoothing filters are used to detect
diffuse effects but are unsuitable for observing smaller variations within small
anatomical regions. The arbitrary choice of smoothing kernel size has been a
subject of much debate, with one study demonstrating that MRI results from
the same study population varied significantly depending on the kernel size
chosen (Jones et al., 2005). A meta-analysis by Honea and colleagues
found that studies using smaller smoothing kernels reported more volume
reductions in small structures (Honea et al., 2005).
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2.4 Voxel Based Morphometry: A method of comparing
group differences in structural MRI
Voxel Based Morphometry (VBM) is an automated approach for detecting
group differences in brain structure, it allows for analysis of the whole brain
without observer bias and the precise location of differences between groups
is automatically displayed. Statistical Parametric Mapping (SPM) is an
internationally recognised method of VBM style processing. The software is
freely available on-line (www.fil.ion.ucl.ac.uk/spm) and has been widely used
by many research groups around the world. It is frequently revised by the
authors and updated, although the basic pre-processing steps (which consist
primarily of registration, segmentation and smoothing) have remained as
described in the section above. MRI sequences can be taken either from an
individual subject at different time points or from groups of subjects for a
cross-sectional comparison. Images are initially segmented into three
different tissue classes GM, WM or CSF. The next step involves
normalisation of all MRI images to a template scan so they can be in the
same stereotactic space. The Montréal National Institute (MNI) have
produced several standard templates which are freely available and widely
used, these templates were created by averaging a large number of scans
from normal, healthy subjects; alternatively a custom template can be
created by averaging scans from subjects within the study. Scan are said to
be “normalised” once they have been registered to a template. The
normalised images are then smoothed, so neighbouring voxels are averaged
and the data will be more normally distributed thus increasing validity of
parametric statistics. Smoothing is applied to segmented images, with data
from an average value of neighbouring voxels, thus making it more normally
distributed.
The “optimised VBM” protocol (Good et al., 2001b), contains two additional
data processing concepts. Firstly, the normalised affine transformation is
warped by Jacobian modulation, this local volumetric expansion or
compression factor is stored in a three dimensional warping field so true
amounts of each tissue volume can be retrieved. Analysis of modulated data
tests for regional differences in GM volume, while analysis of unmodulated
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data tests for differences in GM concentration per unit volume. Secondly,
pre-processing steps are introduced to exclude non-brain voxels by
segmenting images in native space and normalising the extracted segmented
brain images. These normalisation parameters are then applied to original
whole brain images and segmented again, this time in standard space.
Statistical tests are performed using a general linear model (GLM), which in
effect allows linear regression to be performed on each voxel. Confounding
effects of age, gender or diagnosis can be added to the GLM matrix for
analysis. The outcome is a statistical parametric map (Friston, 1994), which
shows statistical significance of group differences at a given position and
assigns a p-value to the contrast.
Results of any experiment may contain a type I error (where a false positive
result is accepted) or a type II error (where a false negative result is
accepted). SPM analysis compares each voxel in all the slices that make up
a complete scan from one individual. Correction for multiple comparisons is
therefore applied to minimise the error rate. Taking into consideration that
each voxel comparison is not an independent observation due to high
correlation between neighbouring voxels, a family wise error (FWE) is
considered appropriate to use (Worsley et al., 1992). The FWE rate is the
probability of making one or more false discoveries of type I errors among all
the hypotheses when performing multiple paired tests.
The Bonferroni correction is considered highly conservative and is only
suitable for use in studies with small numbers of comparisons. Although able
to control for any false positives, it also leads to very low statistical power, in
other words reducing the ability of a statistical test to detect an effect where it
really exists.
The false discovery rate (FDR), controls for an expected proportion of false
positives among the suprathreshold voxels. Although a less conservative
method for comparison with greater power than the FWE correction, there is
an increased likelihood of obtaining type I errors.
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2.5 Diffusion Tensor Imaging
Diffusion of free water is isotropic in-vitro, this means water diffuses equally
in all directions. In-vivo, diffusion of water is anisotropic as it is hindered by
cell walls and organelles hence the net movement of water will be greater in
the direction with less restriction. Diffusion tensor imaging (DTI) is a
quantitative MRI technique that allows diffusion of water to be measured in-
vivo. Where there is no preferred direction for the diffusion of water
molecules, the probability of displacement of a water molecule at any given
time follows a Gaussian distribution. When diffusion of water molecules occur
in-vivo, it is anisotropic and follows a multivariate Gaussian distribution.
Mathematically this can be described by a diffusion-tensor matrix (D); a
square 3x3 matrix composed of 9 elements about the three (x, y, z) axes.
Only 6 of the 9 elements are independent as the matrix is symmetrical about
the diagonal (Wheeler-Kingshott et al., 2003).
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Figure 2.3 The Diffusion Tensor Matrix
If a magnetic field gradient is applied, diffusion accumulates different phase
shifts resulting in a loss of phase coherence and reduction in signal
amplitude. A pulsed field gradient (PFG) allows a phase shift for all spins,
with the second pulse reversing this shift and cancelling the phase shift for
static spins. For spins that have changed location due to molecular diffusion
during the time between first and second gradients, significant signal
attenuation occurs with incomplete refocusing by the second PFG and
reduced spin echo.
Signal change depends on the diffusion properties of a tissue and the
magnetic field gradients applied. The larger the amplitude and duration of the
magnetic field gradients, the stronger the diffusion weighting (b). If DT-MRI is
acquired without applying any diffusion weighting (b=0) and with diffusion
gradient (b
and the diffusion co
There are 3 main diagonal elements (λ
apparent diffusion co
eigenvectors (ε
molecular displacements are uncorrelated. The combination of eigenvectors
and eigenvalues is unique and indicates diffusion properties at each voxel.
Fractional
between 0 and 1, defined as a rotationally invariant parameter and can be
defined for each voxel by the following formula:
In brain tissue, DTI reflects tissue microstructure and orga
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axonal disruption
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Reduced WM FA can therefore be int
integrity; which has been demonstrated in schizophrenia
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DTI tractography enables investigation of white matter connectivity, an
example of the image obtained by this technique is shown in fig 2.4. Each
voxel has a principle eigenvector due to the net diffusion of water in one
particular direction. This is most
anisotropy occurs due to the cell walls restricting diffusion. Using this
assumption, FA and the principle eigenvector associated with the largest
,
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eigenvalue is utilized as the voxel of interest, FA of all the neighbouring
pixels are identified and possible projections are traced by propagating a
contiguous string of pixels along the estimated fibre orientations. Elimination
of voxels where angulation of turn exceeds a set threshold and enters an
area with FA lower than a certain threshold increases the likelihood that a
true fibre tract is identified. There are a number of possible tractography
algorithms that will allow fibre tract alignment to be estimated but the two
main classes are deterministic (which follow the main fiber directions as
revealed by the diffusion model and generate sequences of points that are
considered as fibers) and probabilistic (by repeating the deterministic
sequence and choosing the direction with highest probability of representing
true connectivity to generate a tract). A study comparing 10 tractography
methods found a high inter-method variability on visual comparison of the
estimated tract positions (Fillard et al., 2011).
Although tractography is able to show the most likely position of fibre tracts, it
is unable to calculate directionality hence the production of a colour map
which is essentially a map of FA with added colour coding using the
assumption that the principle eigenvector also indicates the dominant
orientation of the fibres running through each pixel. The colour map is
visualized using 3 colours; red, green and blue to represent the x,y and z
axes.
For tract reconstruction, two or more regions of interest (ROIs) must be
defined a-priori with a starting “seed point”. In addition a “through point” is
selected which the tracts must all run through, this adds further constraint.
This process creates three dimensional maps of white matter tracts based on
the probability of connectivity between adjacent voxels running through the
same ROIs. It is important to note that the lines creating the tracts do not
represent individual axonal fibres because resolution is not yet good enough
for this. Resolution of DTI acquisitions is usually between 3 mm³ and 15 mm³,
while the diameter of bundles of axons considered in fibre tractography are in
the order of 1mm and individual fibres are in the order of 1-30 µm (Mori and
van Zijl, 2002).
44
Each pixel visualized on an MRI scan is 2 to 3 mm therefore specific
connectivity of axons can not be identified. Where multiple fibre tracts cross
one another e.g. the junction between the corpus callosum and corona
radiata, caution must be taken. It is likely that in this area the pixels contain
axonal tracts in multiple directions so anisotropy appears low and the area
looks dark on a scan, when actually the area is rich in axons.
Figure 2.4 DTI Tractography of the Corpus Callosum
(Price et al., 2005)
2.7 Tract Based Spatial Statistics
Tract Based Spatial Statistics (TBSS) is used to examine white matter FA
values. TBSS identifies contiguous voxels that form the core of all white
matter tracts, where FA is likely to be higher than at the periphery and the
probability of measuring FA in voxels which lie in white matter areas is much
increased. Tract based Spatial Statistics (TBSS) is one method of DTI data
analysis, which obviates some of the confounding variables by including the
following processes:
1) Non-linear registration of all scans is to a “target” image. This means the
FA map has been averaged from all subjects within the study cohort. This
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corrects for misinterpretation of residual misalignment, which will be different
for each group.
2) Smoothing is not required, so the hazards and complications of arbitrary
selection of a variable smoothing kernel size is unnecessary.
3) A mean FA skeleton map of all white matter tracts is produced; to which
each subject’s scan can be compared, this allows comparison of all white
matter tracts as opposed to using a pre-selected, hand drawn regions of
interest.
2.8 Magnetisation transfer imaging
Magnetisation transfer imaging (MTI) allows measurement of the difference
in energy levels of water molecules found in brain tissue. Water may be
bound to large macromolecular structures, thought to be cell membrane
proteins and phospholipids in grey matter and myelin in white matter;
however, most water molecules exist in a free and unbound state.
In conventional MRI, the radio-frequency pulse must match the resonant
frequency of water to excite protons and make the MRI signal measurable.
An additional radio-frequency pulse can be used to saturate bound protons in
the semi-solid pool without affecting the free water proton pool because
restricted protons absorb energy at a frequency far from that of water. This
causes a reduction in longitudinal magnetization from the free proton pool,
reducing the apparent T1 relaxation time of water and decreasing signal
intensity by 50 to 60%. The reduced signal is expressed as a ratio known as
the magnetization transfer ratio (MTR) and is dependent on macromolecular
density.
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Figure 2.5 Water and Semi-solid Pool Absorption Rates Over a Range of
Radio-frequencies
MTI was first described by (Wolff and Balaban, 1989), it shows a map of
difference in saturation and is produced by a digital subtraction of saturated
(MT weighted) from unsaturated (un-weighted) MT images. Amount of signal
loss per voxel is therefore dependent on the degree of magnetization
transfer, which reflects capacity of molecules in the tissue to exchange
magnetization with surrounding free protons from water. In healthy brain
tissue, the magnetization transfer ratio (MTR) is highest in white matter (30 to
50%) because of the high lipid content and a smaller free water pool, less in
grey matter (20 to 40%) where there is a lower lipid content and lowest in
CSF (~0%) as this is mainly composed of free water.
MTR can be calculated by the following formula, where Mo is mean signal
intensity with signal on and Ms is mean signal intensity with signal off:
[Mo - Ms] / Mo x 100 = MTR in percentage units (pu)
MTR measurements are highly reproducible in healthy subjects rescanned at
various intervals (Barker et al., 1996). High intra and inter-rater reliability of
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MTR measurements have been reported in healthy controls (Sormani et al.,
2000). However; MTR varies according to pulse sequence and scanner used
so results from different centers are not always readily comparable.
A reduction of MTR indicates pathological change in the tissue under
investigation, presumably as more free water enters areas where the barrier
to diffusion is no longer intact. Animal studies of neuroinflammation have
shown that this can result in small MTR reductions (Stanisz et al., 2004).
Reduction in myelin and axonal density results in reduced MTR (Schmierer et
al., 2004), presumably because the semi-solid pool has a significant
phospholipid content. There is some degree of change in MTR associated
with the effects of ageing, particularly in white matter of the corpus callosum
(Silver et al., 1997), although others have concluded there are no significant
age-related variations (Rahul et al., 1995). Similarly, Hofman and colleagues
reported higher mean MTR in males than females (Hofman et al., 1999),
while others have reported no gender-related variation in MTR measures (Ge
et al., 2002). Because of ambiguity over whether age and gender affect MT
measures, they should always be incorporated as confounding factors in any
MTI study model. MT images can be processed using SPM in the same way
as for conventional volumetric MRI.
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3. STRUCTURAL IMAGING ABNORMALITIES IN
SCHIZOPHRENIA: A REVIEW OF MAGNETIC RESONANCE
IMAGING, DIFFUSION TENSOR IMAGING AND
MAGNETISATION TRANSFER IMAGING STUDIES
3.1 Structural MRI findings in longitudinal studies of
schizophrenia
The first structural MRI study of schizophrenia (Smith et al., 1984) concluded
that patients with chronic schizophrenia had enlarged ventricles. Although not
a novel finding, this confirmed the results of earlier studies reporting
ventricular enlargement using CT (Johnstone et al., 1976). The primary
advantage of MRI was it’s safety compared to other imaging techniques such
as CT (associated with ionizing radiation exposure risks) and the now
obsolete pneumo-encephalogram (with iatrogenically induced headache,
tachycardia and other medical sequelae). MRI has since been used
extensively to determine different brain tissue compartment volumes. Two
major papers in this area were a review (Shenton et al., 2001b) and a meta-
analysis (Wright et al., 2000) both concluded that differences in brain tissue
volumes between patients with schizophrenia and healthy individuals are
small, while ventricular volume differences are of a larger magnitude. In order
to identify when these structural brain changes might be occurring, the
importance of a longitudinal study design following the course of illness was
recognised.
The neurodevelopmental hypothesis for schizophrenia suggests that brain
abnormalities occur early in life and do not continue to progress throughout
adulthood. Evidence to support this hypothesis include abnormalities of early
motor and cognitive development that can be observed in those who
subsequently develop schizophrenia (Weinberger, 1987). Fetal growth
retardation and obstetric complications during pregnancy and delivery are all
associated with increased risk of developing schizophrenia later on in life
(Cannon et al., 2002); these are considered to be discreet mechanisms
predisposing to schizophrenia rather than progressive brain insults. This
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contrasts with the earliest proposals of Emil Kraepelin who after classifying
this mental illness in 1887 suggested a neurodegenerative hypothesis for
dementia praecox (Kraepelin, 2009). He believed destruction of neural tissue
was associated with psychosis; however, there is an absence of
neurodegenerative pathology in postmortem brain tissue from schizophrenia
patients, with no evidence of gliosis, no loss of cortical neurons and no
consistent evidence of neuronal degeneration (Harrison, 1999). The
neurodegenerative versus neurodevelopmental hypothesis of schizophrenia
has been fiercely debated in the past, as described in this extract taken from
DeLisi (2008), “In December of 1990, an all-day symposium conducted by L.
E. DeLisi and J. A. Lieberman as an ACNP (American College of
Neuropsychopharmacology) satellite brought together many of the
investigators in this field to debate the facts on neurodevelopment vs
neurodegeneration. The proceedings from this day were later published in a
special issue of Schizophrenia Research in 1991. During the conference,
Brian Woods (from McLean Hospital at that time) presented data showing an
extreme case of a patient with schizophrenia who had obvious visible
ventricular enlargement over time; but this was dismissed by many present
as a case of a degenerative neurological disease of unknown origin with
accompanying psychosis. Despite heated and at times emotional debate, no
consensus was reached at this meeting because carefully collected case and
control data were not yet available to confirm whether the structural brain
findings were stable over time or progressed.”
Longitudinal brain imaging studies have subsequently allowed investigators
to track morphometric changes as the disease progresses. The first, major
longitudinal imaging study (DeLisi et al., 1992) reported a two-year follow-up
of 30 first-episode schizophrenia patients and controls. Lateral ventricular
size at time of first-episode presentation generally correlated with outcome
and the larger the ventricles, the poorer the outcome. Although there were no
changes in mean ventricular or temporal lobe size over the two year follow-
up, ventricular enlargement was inversely correlated with the number of
hospitalizations and some patients showed individual changes greater than
20% in ventricular volume and 10% in temporal lobe volume.
50
A review of the earliest longitudinal imaging studies in schizophrenia
containing a mixture of CT and MRI data, mostly showed an increase in
ventricular volume over time in chronic schizophrenia patients but these
changes were less clear in longitudinal studies of first episode patients
(DeLisi, 1999). Since then, a large number of longitudinal MRI studies in
schizophrenia have been published. Articles in English language journals
listed on PubMed under the search terms “schizophrenia, MRI and
longitudinal follow-up” published since 2000 were retrieved (table 3.1) and
are discussed in further detail below (sections 3.1.1 to 3.1.6).
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Table 3.1 Longitudinal Magnetic Resonance Imaging Studies in
Schizophrenia
sz=schizophrenia, sa=schizoaffective disorder, sf=schizophreniform disorder, pt=patient,
ctrl=control, FE=first episode, GM=grey matter, WM=white matter, CSF=cerebrospinal
fluid, WB=whole brain, ICV=intra-cranial volume, ROI=region of interest
Study
Reference
(author and
year of
publication)
Description of
patient group(s)
Sample
Size
(Pt /Ctrl)
Method
(field strength,
time to follow-
up, regions of
analysis )
Summary of Main
Findings
(Gharaibeh
et al., 2000)
First episode of
non-affective
acute psychosis
55 / 22 1.5T, 33 to 64
months, 11
landmark
configuration and
shape analysis
Change in midline
brain morphology in
patients with
schizophrenia during
the subsequent 3–5
years consistent with
either a
neurodegenerative
disease process or
effect of treatment
with psychiatric drugs.
(Saijo et al.,
2001)
In-patients with
schizophrenia
15 / 12 0.2T, 4 and
10yrs, volume of
lateral ventricles
Progressive
ventricular
enlargement in
patients with
schizophrenia
continues even in the
chronic stage of
disease.
(Mathalon et
al., 2001)
Male in-patients
with
schizophrenia
24 / 25 1.5T, 4 years,
ICV and ROIs
lateral ventricles,
2 frontal and 2
temporal lobe
regions
Patients exhibited
accelerated fronto-
temporal GM decline
and cortical, sulcal
and lateral ventricular
expansion.
Greater clinical
severity associated
with faster rates of
fronto-temporal brain
volume changes.
(Lieberman
et al., 2001)
First episode
psychosis
107 / 20
baseline
51 / 13
follow-
up
1T, 18 months,
cortical regions
and white matter,
excluding
subcortical
structures
Poor outcome
schizophrenia is
associated with
increased ventricular
volume. No significant
reductions in cortical
and hippocampal
volumes over time.
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(Lang et al.,
2001)
First episode sz
treated with
risperidone (30),
pts chronically
treated with
typical
antipsychotics
(12)
30 / 12 /
23
baseline
- / 15 /
17
follow-
up
1.5T, 12 months,
basal ganglia
volume (caudate,
putamen and
globus pallidus)
Pts chronically treated
with typical
antipsychotics had
higher basal ganglia
volumes. Baseline
basal ganglia
volumes were similar
in FE and healthy
ctrls. No significant
changes in basal
ganglia volume after 1
year of risperidone in
FE pts.
(Puri et al.,
2001)
First presentation
to psychiatric
services with
schizophreniform
illness
24 / 12 1T, 8 months,
ventricular
volumes
No difference
between pts and ctrls
in ventricular volume
mean change but pts
had more variable
increases and
decreases in
ventricular volume
size than ctrls.
(Wood et al.,
2001)
First episode in-
pts (30) and
chronic
schizophrenia
>18 mth
continuous illness
in rehabilitation
unit (12)
30 / 12 /
26
1.5T,
hippocampus,
1.9yrs fu for fep
2.3yrs fu for sz
2.2yrs fu for ctrls
WB, temporal
lobe and ICV
Only WB volume loss
in both pt groups, rate
of volume loss similar
in FE psychosis for
chronic and first WH
injury. Hippocampal
and temporal lobes,
no volume change
reported.
(Tauscher-
Wisniewski
et al., 2002)
Schizophrenia
(11) &
schizoaffective (4)
pts
15 / 10 1.5T, 5yrs,
caudate nuclei
volume
Significant 9% age-
related decline in
caudate volume of pts
and ctrls
(Cahn et al.,
2002)
First episode
schizophrenia
(29) and
schizoaffective (5)
34 / 36
baseline
29 / 36
follow-
up
1.5T, 1yr, total
brain volume,
cerebral GM and
lateral ventricles
Decreased total brain
volume and GM
volume
Lateral ventricle
volume increase in
pts
Decrease in global
GM volume correlated
with outcome
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(Kasai et al.,
2003a)
First episode sz
(13),
first episode
affective
psychosis (15)
13 / 15 /
14
1.5T, 1.5yrs,
MRI volumes of
GM in superior
temporal gyrus
and amygdalae-
hippocampal
complex
Progressive decrease
in GM volume of left
STG in schizophrenia
(Ho et al.,
2003)
Recent onset
schizophrenia
73 / 23 1.5T, 3yrs, total
brain volume,
lateral ventricles,
cortical CSF,
tissue and CSF
for frontal,
temporal, parietal
and cerebellar
ROIs
Progressive reduction
in frontal lobe WM
with reciprocal
increase in frontal
lobe CSF volume
occurred more rapidly
in patients than
controls. Poor
outcome pts had
greater lateral
ventricle enlargement,
frontal lobe changes
associated with
functional impairment.
(Milev et al.,
2003)
Recent onset sz,
sa and sf disorder
123 / - 1.5T, 5yrs,
cerebral volume,
lateral ventricles,
brain tissue and
CSF volume of
frontal and
temporal lobes,
cerebellar volume
Temporal lobe volume
was predictive of
outcome with smaller
temporal GM volume
associated with
hallucinations.
(Kasai et al.,
2003b)
First episode sz
(13), first episode
affective
psychosis (15)
13 / 15 /
22
1.5T, 1.5yrs,
Heschl’s gyrus
and planum
temporale
volume
Significant decrease
in GM volume of left
Heschl’s gyrus and
planum temporale for
pts with first-episode
schizophrenia in
contrast to first-
episode affective
psychosis or ctrls.
(DeLisi et al.,
2004)
First episode sz 50 / 20
baseline
26 / 10
follow-
up
1.5T, 10yrs,
ventricles and
hemispheres
Significantly greater
ventricular
enlargement during
the last 5 yrs in pts.
Rate of ventricular
change in first 5 yrs
correlated with age at
first hospitalisation, in
yrs 5-10 correlated
with time spent in
hospital. Greater
ventricular change
correlated with better
outcome.
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(Bachmann
et al.,
2004)
First episode
psychosis
14 / 11 1.5T, 14mths,
frontal and
temporal lobes,
cerebellum and
CSF volumes
Significant volume
reductions in pt
group. Association of
symptom severity
with CSF volume and
structural volume
over time.
(Lieberman
et al.,
2005)
First episode
psychosis (sz/sa/sf)
263 / 58
baseline
161 / 58
follow-
up
1.5T, 12, 24, 52
and 104 weeks,
whole brain GM
and lateral
ventricle volume
No change in GM
volume in ctrls but
decreased GM in
some patients.
Haloperidol
associated with GM
loss but olanzapine
was not.
(DeLisi and
Hoff, 2005)
First hospitalisation
for psychosis (sf/sz)
27 / 10 1.5T, 5 and
10yrs, whole
temporal lobe
volume and STG
volume
No change over time
in these structures
when pts were
compared with ctrls.
(Garver et
al., 2005)
Schizophrenia 19 / 7 1.5T, 28 days,
cerebral cortical
GM
Volume increase of
cerebral cortical GM
with second
generation
antipsychotics but not
with first generation
haloperidol.
(Farrow et
al., 2005)
First episode
psychosis
(schizophrenia 25 &
bipolar 8)
33 / 22 1.5T, 2yrs, whole
brain GM and
WM
Sz pts had GM
deficits in lateral and
medial frontal regions
and bilateral posterior
temporal lobe regions
with losses over time
in lateral fronto-
temporal and left
anterior cingulate
gyrus. BPAD pts had
GM deficit in bilateral
inferior temporal gyri
with loss over time in
anterior cingulate
cortex.
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(Molina et
al., 2005)
Schizophrenia
(treatment naïve 17,
treatment resistant
12)
29 / 11 1.5T, 2yrs, GM
and WM volumes
in frontal, parietal,
occipital and
temporal lobes
Increase in GM and
decrease in WM
volume in parietal
and occipital regions
over time in pts.
Diffuse cortical GM
also increased in
chronic grp after
clozapine or
risperidone
treatment, most
marked GM gain in
occipital area.
(Molina et
al., 2006)
First episode
psychosis
(sz 22, no clinical
evidence for sz 15)
37 / 44 1.5T, 2yrs, ROIs
in DLPFC and
STG
Less GM in right
DLPFC and STG in
sz than ctrls or non-
sz psychosis.
(McCormick
et al., 2005)
Schizophrenia
neuroleptic naïve
31 / 18 1.5T, 3yrs,
anterior cingulate
cortex
Increased ACC
volume over time
with increased typical
neuroleptic exposure
but increased
atypical neuroleptic
exposure correlated
to decreased ACC
volume over time.
(Whitworth
et al., 2005)
First episode sz (21)
and chronic multi-
episode sz (30)
21 / 30
/ 32
baselin
e
- / 17 /
20
follow-
up
1.5T, 2 to 4yrs,
ROIs ventricles,
bilateral
hippocampus,
amygdala,
hippocampus-
amygdala
complexes and
hemispheres
Sz pts showed
ventricular
enlargement and
volume reduction of
hippocampus-
amygdala complexes
compared to ctrls at
baseline and follow-
up.
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(Whitford et
al., 2006)
First episode sz 41 / 47
baseline
25 / 26
follow-up
1.5T, 2 to 3yrs,
global GM volume
GM in frontal,
parietal, temporal
cortices and
cerebellum reduced
and occipital lobe
GM increased
compared to pts at
baseline.
Pts lost more GM
over time than ctrls,
especially in parietal
and temporal
cortices.
(Steen et
al., 2006)
52 cross-sectional
and 16 longitudinal
studies
Systema
tic
review
and
meta-
analysis
No significant
longitudinal change
in WM or cerebellum
but several studies
reported decrease in
brain volume, which
may be limited to GM
in schizophrenia.
(Price et
al., 2006)
First episode sz 16 / 12 1.5T, 3.7yrs,
whole brain
volume
WM volume loss in pt
group adjacent to
lateral ventricles in
both temporal lobes,
medial temporal
gyrus and in/around
right middle frontal
gyrus.
(Khorram et
al., 2006)
Chronic
schizophrenia
10 / 20 1.5T, 1yr, ICV and
whole thalamus
volumes
Gtr thalamic volumes
in sz subjects at
baseline. At follow-up
no difference btw
groups, +ve
correlation with
baseline thalamic
volume and typical
antipsychotic dose.
Higher baseline
doses correlated with
larger reductions in
volume.
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(van Haren
et al., 2007)
Schizophrenia 159 /
158
baseline
96 / 113
follow-
up
1.5T, 5yrs, whole
brain, GM and
WM volumes
Excessive decrease
in GM were found in
left superior frontal
and temporal gyri,
right caudate nucleus
and thalamus in pts.
Progression in left
frontal density loss
related to increased
number of psychotic
episodes.
(Salisbury
et al., 2007)
Within 1yr of first
hospitalization for
psychosis, sz (20),
BPAD (21)
20 / 21 /
32
baseline
11 / 13 /
13
follow-
up
1.5T, 1.5yrs,
Heschl’s gyrus
GM volume and
mismatch
negativity
First-hospitalised sz
subjects had reduced
Heschl gyrus GM
volume than ctrls and
BPAD subjects.
Progressive
reduction in volume
over time in sz but
not BPAD or ctrls.
(Whitford et
al., 2007a)
First episode
schizophrenia
19 / - 1.5T, 2-3yrs, GM
volume and EEG
recordings in
lobar ROIs
(frontal, temporal,
parietal and
occipital)
Pts lost a significant
amount of GM
volume in frontal,
parietal, temporal
and occipital lobes in
first 2 to 3 years of
schizophrenia onset.
(Panenka
et al., 2007)
Chronic
schizophrenia
10 / 20 1.5T, 1yr, ROIs
bilateral
hippocampi,
thalamus,
caudate nucleus,
putamen, globus
pallidus,
hippocampus
Pts had smaller
hippocampi volume
at baseline, left
smaller than right.
PANSS scores were
negatively correlated
with right
hippocampal volume.
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(Nakamura
et al., 2007)
First episode
psychosis in
schizophrenia (29)
& affective disorder
(34)
29 / 34 /
36
baseline
17 / 21 /
26
follow-
up
1.5T, 1.5yrs, ROIs
frontal, temporal
and parieto-
occipital
Smaller neocortical
GM volume and
enlarged sulcal CSF
in both pt groups
compared to ctrls at
baseline.
Progressive
reduction of GM vol
in sz (with bilateral
enlargement of
lateral ventricles and
supratentorial SCSF
enlargement). In
affective psychosis
pts had diffuse
increase of GM
volume.
(Whitford et
al., 2007b)
Schizophrenia 41 / 47
baseline
25 / 26
follow-
up
1.5T, 2 to 3yrs,
VBM at baseline
and longitudinal
tensor based
morphometry
Volumetric deficits in
WM of frontal and
temporal lobes at
baseline, with
increased WM in
fronto-parietal
junction bilaterally.
Pts lost more WM
over time than ctrls in
middle and inferior
temporal cortices
(Théberge
et al., 2007)
First episode sz,
never- treated (2
females, 14 males)
16 / 15
baseline
16 / 14
10mth
fu
16 / 16
34mth
fu
4T, 10 and
34mths fu, VBA of
whole brain GM
and spectroscopy
for glutamatergic
metabolites
At 10mths limited
grey matter loss and
widespread GM loss
by 30mths. Parietal
and temporal GM
loss correlated with
thalamic glutamine
loss.
(Borgwardt
et al., 2007)
Ultra high risk of sz 35 / 22 1.5T, 2yrs, VBM
whole brain
Hippocampal
abnormalities in UHR
group
59
(Wood et al.,
2008)
A review of
studies in
subjects at ultra
high risk for
psychosis
Review
article
Unclear cause for
progressive changes
but onset of psychosis
associated with
visuospatial and
executive dysfunction
that mirrors
progressive changes
identified on
neuroimaging.
(McClure et
al., 2008)
Chronic
schizophrenia
or
schizoaffective
disorder
10 / - 1.5T, 12 weeks
after re-starting
atypical
antipsychotic
medication,
ROIs caudate,
GM, WM and
sulcal CSF
No change in caudate
or grey matter volume
over time. No change
in volume of frontal or
temporal lobe GM or
WM, or lateral, third or
fourth ventricular CSF
volume.
(Zipparo et
al., 2008)
First episode
schizophrenia
52 / -
baseline
20 / -
follow-up
1.5T, 2-3yrs,
VBA GM, frontal
and temporal
lobes
Progressive GM
atrophy in whole brain
and frontal lobes
associated with mild
improvement in
overall cognitive
functioning.
(Reig et al.,
2009)
Adolescents
with first
episode
psychosis (5
females, 16
males)
23 / 34
baseline
21 / 34
follow-up
1.5T, 2yrs, VBA
whole brain GM
and CSF, ROIs
frontal, parietal,
temporal and
occipital,
Frontal lobe GM
volume loss higher in
male pts than ctrls.
Left frontal lobe CSF
volume increased
more than ctrls.
Clinical changes not
correlated with brain
changes over time.
(Rais et al.,
2008)
First episode
psychosis (sz
39, sa 1, sf 9,
nos 2)
all meeting
diagnosis of sz
(51) at follow-
up
51 / 31 1.5T, 5yrs, ICV,
total brain, GM,
WM, lateral and
third ventricle
volumes
Sz patients had larger
GM volume decrease
over time and larger
increases in lateral
and third ventricles.
More pronounced GM
loss in pts using
cannabis.
(Hulshoff Pol
and Kahn,
2008)
Review of 11
longitudinal
studies (9 MRI
and 2 CT) in
chronic
schizophrenia
Review of
studies
10 to
96pts / 5
to 113
ctrls
1 to 10 yr follow-
up
Continuous
progressive brain
tissue decreases and
lateral ventricle
volume increases in
chronic sz pts
continue for at least
the first 20yrs of
illness. Most
prominent GM loss in
fronto-temporal areas
and associated with
poor outcome and –ve
symptoms.
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(DeLisi,
2008)
Historical
perspective on
renewal of
Kraeplinian
concepts in brain
imaging in
schizophrenia
Review
article
GM and WM structure
change prior to illness
and before
medication, with active
and widespread
progression.
Ventricular
enlargement is a
consequence of
cortical change.
Genetic and
medication effects
remain speculative.
(van Haren
et al.,
2008a)
Comparison of
findings from
Utrecht sz study
group and other
results of other
studies
Review
article
Schizophrenia is a
progressive brain
disease with different
age-related
trajectories of brain
tissue loss. Genetic
and environmental
factors appear to play
a role.
(Brandt and
Bonelli,
2008)
MRI imaging
studies of the
basal ganglia in
schizophrenia
Review
article
Typical and atypical
neuroleptics may
produce different
effects on brain
morphology, these
changes are dynamic
and may be reversible.
(Koo et al.,
2008)
First episode
psychosis
schizophrenia
(39) affective
disorder (41)
39 / 41 /
40
baseline
17 / 18 /
18
follow-up
1.5T, 1.5yrs,
Cingulate gyrus
GM in 1
posterior and 3
anterior
subregions
(subgenual,
affective and
cognitive)
Progressive GM
volume decrease in
subgenual, affective,
cognitive and posterior
cingulate subregions
in sz pts, also smaller
left subgenual and
right cingulate gyrus
GM than ctrls.
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(Fornito et
al., 2008)
Ultra High Risk
subjects
(35 became
psychotic, 35
did not)
35 / 35 /
33
1.5T, 1 to 2 yrs,
ROI anterior
cingulate cortex
(ACC)
UHR psychotic
subjects have bilateral
thinning of rostral
paralimbic ACC region
that was negatively
correlated with –ve
symptoms. UHR
normal subjects had
relative thickening of
dorsal and rostral
limbic areas.
(Borgwardt et
al., 2008)
At Risk Mental
State (10
became
psychotic, 10
did not)
20 / 20 1.5T, 3yrs,
whole brain GM,
VBM
Volume decrease in
orbito-frontal, superior
frontal, inferior
temporal, medial and
superior parietal
cortices and
cerebellum only in pts
who developed
psychosis.
(Sun et al.,
2009b)
First episode
schizophrenia
(13 males, 3
females)
16 / 14 1.5T, 2yrs,
Cortical Pattern
Matching and
Structural Image
Evaluation using
Normalisation of
Atrophy (SIENA)
Brain surface
contraction in pts and
ctrls showed similar
anatomical patterns
although exaggerated
in magnitude across
entire brain.
Exaggerated,
progressive changes
seen in pts.
(Wang et al.,
2008)
Schizophrenia
(90 males, 49
females)
139 / 136
baseline
56 / 62
follow-up
1.5T, 2yrs,
Large
Deformation
High-
Dimensional
Brain Mapping
of deep brain
nuclei and
hippocampal-
amygdala
formation
Pattern of progressive
change in deep brain
nuclei and
hippocampal-
amygdala formation
variable. Thalamus,
caudate, nucleus
accumbens and
hippocampus showed
specific changes to sz
but amygdala and
putamen changes
similar in pt and ctrls.
(Brans et al.,
2008b)
Schizophrenia
(12 males, 4
females), same
gender siblings
(14 males, 4
females)
16 / 18 /
43
1.5T, 5yrs, ICV,
total brain, GM
and WM,
cerebellum,
lateral and third
ventricle
volumes
Whole brain and
cerebral GM volumes
decreased excessively
in pts compared to
their siblings and ctrls,
suggesting brain
tissue loss in
schizophrenia may be
related to the disease
process.
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(Brans et al.,
2008a)
92 participants
(9 monozygotic,
10 dizygotic
twin pairs
discordant for
sz and
14
monozygotic,
13 dizygotic
healthy ctrl twin
pairs)
18 / 20 /
28 / 26
1.5T, 5yrs, ICV,
total brain, GM,
WM, cerebellum,
lateral and third
ventricle
volumes and
lobar ROIs
(frontal, parietal,
temporal and
occipital)
Decrease in whole
brain, frontal and
temporal lobe volumes
in sz and their
unaffected twin
siblings compared to
ctrl twins over time.
Progressive volume
loss is at least partly
attributable to genetic
factors related to
schizophrenia.
(Cahn et al.,
2009)
First episode
psychosis
patients
sz(42), sa (5),
sf(1)
48 / - 1.5T, 5yrs, total
brain, GM, WM,
cerebellum,
lateral and third
ventricle
volumes
Assocation between
longer duration of
psychosis and larger
GM volume decrease
with ventricular
volume increase
(Sun et al.,
2009a)
Ultra High Risk
subjects
(12 developed
psychosis, 23
did not)
35 / -
baseline
12 / 23 / -
follow-up
1.5T, 1yr,
Cortical Pattern
Matching
Significantly greater
brain contraction in
right prefrontal region
in “converters”
compared to UHR
subjects who did not
develop psychosis.
Cortical volume loss is
associated with
psychosis onset.
(Takahashi
et al., 2009a)
First episode sz
(23), chronic sz
(11)
23 / 11 /
26
1.5T, 1 to 4yrs,
whole brain and
insular cortex
volumes
FEP patients showed
GM reduction of
insular cortex over
time compared to ctrls.
This GM loss
correlated with
severity of +ve and –
ve symptoms. No
difference in rate of
GM loss over time
between chronic sz
group and ctrls.
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(Wobrock et
al., 2009)
First episode
sz
Good outcome
(12) and poor
outcome (11)
sz
32 / -
baseline
12 / 11 / -
follow-up
1.5T, 1yr, ROIs
hippocampus,
lateral ventricle
and anterior
limb of internal
capsule (ALIC)
Reduced maximal
area of ALIC,
associated with poor
outcome in 1 year
(Navari and
Dazzan,
2009)
Antipsychotics
and brain
structure in 23
longitudinal
studies
Systematic
review
Antipsychotics act
regionally not globally
on the brain,
Volumetric changes
are of greater
magnitude in
association with
typicals increasing
basal ganglia volume
than atypicals.
(Takahashi
et al., 2009b)
Neuroleptic
naïve UHR (11
developed
psychosis and
20 did not)
31 / 20 1.5T, 1 to 4yrs,
ROIs insular
cortex
In pts who developed
psychosis, greater
reduction of insula
cortex GM volume
bilaterally than in ctrls
or non-psychotic UHR
subjects.
(Douaud et
al., 2009)
Adult onset
schizophrenia
(35) and
healthy ctrls
(35)
Adolescent
onset
schizophrenia
(25) and
healthy ctrls
(25)
35/35 and
25/25
follow-up
scan 12/12
adolescent
group only
1.5T, 2.5yrs,
whole brain GM
volumes and
TBSS of WM
tracts
Reduction of GM
density over time in
healthy adolescents
but increase of GM
density in sz pts.
Analysis of WM tracts
showed FA was
increasing in
adolescent onset sz
but roughly constant in
healthy ctrls.
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(Yoshida et
al., 2009)
Chronic
schizophrenia
all subjects
male
16 / 20 1.5T, 3.1yrs for
pts and 1.4yrs
for ctrls
Volumes of
STG, amygdale
and
hippocampal
complex
Smaller relative
volumes in
schizophrenia
compared with ctrls in
posterior STG and
AHC. No statistically
significant progression
of volume reduction in
either area. Volume
change in left anterior
AHC correlated with
PANSS negative
symptoms.
(Mitelman et
al., 2009a)
Good outcome
(23) and poor
outcome (26)
schizophrenia
23 / 26 / 16 1.5T, 4yrs,
Volumes of
caudate nucleus
and putamen
Poor outcome pts had
gtr decline in volume
of putamen than good
outcome pts. Caudate
volumes were lower at
baseline and follow-up
in pts compared to
ctrls but showed no
differential pattern of
progression between
groups.
(Deng et al.,
2009)
Newly
diagnosed and
anti-psychotic
naïve
schizophrenia
20 / 20 1.5T, 3 to 8
weeks, whole
brain cortical
GM volume
After 3 wks anti-
psychotic treatment,
GM volume increase in
right caudate, superior
and inferior frontal
gyrus, precentral gyrus
and left inferior parietal
lobe. After 8 wks
volume increase right
thalamus and bilateral
cerebellum. Meanwhile
progressive left medial
frontal gyrus GM
reduction.
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(Kasparek
et al.,
2009)
First episode
schizophrenia
23 / 18 all
subjects
male
1.5T, 1year,
Volumes of
superior temporal
gyrus and
amygdale
hippocampal
complex
FES subjects had
smaller GM volume in
left orbito-frontal and
fronto-polar cortex. GM
volume was reduced in
left prefrontal cortex of
pts with poor
functioning at 1yr
follow-up.
(Sun et al.,
2009b)
First episode
schizophrenia
(16)
16 / 14 1.5T, 2yrs, whole
brain cortical
surface mapping
Exaggerated
progressive changes in
sz but early changes
correspond to that
associated with normal
development in ctrls.
(Mané et
al., 2009)
First episode
schizophrenia or
schizophreniform
disorder, all
subjects
neuroleptic naïve
28 / 17
baseline
15 / 11
follow-up
1.5T, 4yrs, GM
change whole
brain VBM
GM decrease in
patients compared to
healthy individuals in
the left superior
temporal gyrus and
right orbitofrontal gyrus,
and increase in
bilateral lingual gyrus
and right cuneus. GM
changes in patients in
left lingual gyrus, right
insula and cerebellum,
inversely related to
functional outcome.
(Smieskov
a et al.,
2009)
6 cross-sectional
and 24
longitudinal
studies
investigating
effect of
antipsychotics on
brain volume
Systemati
c review
Sz pts tended to have
reduced GM volume,
particularly in frontal
and temporal lobes.
Typical antipsychotics
led to increased GM
volume in basal
ganglia, while atypical
antipsychotics reversed
this effect after
switching. Atypical
antipsychotics seem to
have no effect on basal
ganglia structure.
(Mitelman
et al.,
2009b)
Chronic
schizophrenia
good outcome
(23) and poor
outcome (26)
49 / 16
baseline
23 / 26 /
16 follow-
up
1.5T, 4yrs
Volume and FA
of corpus
callosum
Patients had more
pronounced decline in
absolute size of corpus
callosum, with poor-out
come patients
displaying more
pronounced decline in
size and good outcome
patients more decline
in anisotropy.
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(Hartz et
al., 2010)
Schizophrenia
(99) and
schizoaffective
disorder (11)
110 / - 1.5T, 3yrs
Frontal lobe
volume
Frontal lobe volume
loss related to G72
haplotype 1 and frontal
lobe WM loss related to
increased cerebral
cortical WM.
(Takahashi
et al.,
2010)
First episode sz
(18)
Schizotypal
disorder (13)
18 / 13 /
20
1.5T, 2.7yrs
Volume of STG
and subregions
(planum polare,
Heschl’s gyrus,
planum
temporale, rostral
and caudal STG)
At baseline pts had
smaller left planum
temporale and caudal
STG than controls.
Significant GM volume
reduction of STG over
time in schizophrenia
compared with
schizotypal pts or
controls.
(van Haren
et al.,
2010)
Sz smokers (54)
and sz non-
smokers (42)
Control smokers
(35) and ctrl non-
smokers (78)
96 / 113 1.5T, 5yr
Volumes from
total brain, GM,
WM, cerebellum,
third and lateral
ventricles
Cigarette smoking did
not explain GM volume
decreases seen in
patients and was not
associated with brain
volume change in
controls.
(Eack et
al., 2010)
Early course of
sz (35) or sa (18)
disorder,
symptomatically
stable but
cognitively
disabled out-pts
53 / 3T, 2yrs
Amygdala,
caudate,
cingulate gyrus,
DLPFC, fusiform
gyrus,
hippocampus,
parahippocampal
gyrus, putamen
and sup temporal
gyrus GM
Pts receiving cognitive
enhancement therapy
demonstrated greater
GM preservation in left
hippocampus,
parahippocampal gyrus
and fusiform gyrus.
(Mitelman
et al.,
2010)
Chronic sz
patients (49) with
poor outcome
(26) and good
outcome (23)
49 / 16 1.5T, 4yrs Expansion of lateral
ventricles appears to
have stabilised by time
of chronic phase of
illness. Posterior
cortical GM deficits and
occipital horns of lateral
ventricles expand in
poor-outcome pts.
(Kempton
et al.,
2010)
13 longitudinal
MRI studies on
sz patients
measuring lateral
ventricles
Meta-analysis Patients showed
progressive ventricular
enlargement after
illness onset. Chronic
sz patients also
showed progressive
ventricular
enlargement.
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(Bhojraj et
al., 2011)
Young adult non-
psychotic
offspring of sz
patients (56)
56 / 36 1.5T, 1yr
Auditory
association areas
in the STG
Left auditory
association surface
area showed decline
and cortical thinning in
the non-psychotic
offspring of sz patients.
(Takahashi
et al.,
2011)
First episode
psychosis (18)
and schizotypal
disorder (13)
18 / 13 /
20
1.5T, 2.7yrs
Pituitary volume
Pituitary volume larger
in sz patients than ctrls
at baseline. Over time
both pt groups had
significant pituitary
volume increase than
controls.
(Schaufelb
erger et al.,
2011)
First episode
psychosis
patients who
developed sz
39 / 52 1.5T, 2ys
Ventricle:brain
ratios
GM volume
No longitudinal
difference in
ventricle:brain ratios
between pts and ctrls.
Reversible GM vol
changes in sup
temporal cortex and
hippocampus in pts.
(McIntosh
et al.,
2011)
High genetic risk
of schizophrenia
(146) of whom 17
developed sz
146 / 36 1.5T, 2yr scan
intervals for up to
10yrs
WB volume,
lobar volumes
Pts at high genetic risk
of sz showed greater
whole brain, left and
right prefrontal and
temporal lobe volume
reductions over time
than controls.
(Ho et al.,
2011)
Schizophrenia
(192)
schizoaffective
(19) presenting
for treatment of
first psychotic
episode at
baseline
211 / - 1.5T, 3 scans in
7.2yrs
Total cerebral
tissue volume,
total GM and
WM, frontal,
parietal, temporal
lobes, caudate,
putamen and
cerebellum, CSF
Longer f/u correlated
with smaller brain
tissue and larger CSF
volumes. Smaller GM
volume associated with
more antipsychotic
medication and
progressive WM
volume decrement with
more antipsychotic
treatment
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(Olabi et
al., 2011)
27 studies
928
schizophrenia
patients and 32
different brain
ROIs
928 / 867 Meta-analysis
1 to 10yrs f/u
Volumes of WB,
GM, frontal GM,
frontal WM,
parietal and
temporal WM,
lateral ventricles
In pts brain volume
decreases over time in
whole brain, whole
brain GM, frontal grey
and WM, parietal WM
and temporal WM and
lateral ventricles
increase in volume.
(Prasad et
al., 2011)
Fiest episode sz
antipsychotic
naive (26)
26 / 38 1.5T, 1yr
Brodmann’s
areas 8, 9, 32
GM loss in posterior
cingulate gyrus in
HSV1 seropositive sz
subjects over time. No
change in prefrontal
GM volumes.
(Andrease
n et al.,
2011)
First episode sz 202 / 125 1.5T, 2yrs then
every 3 to 4 yrs
for up to 15 yrs
Whole brain
Decrease in GM and
WM with corresponding
CSF increase was most
severe in early years
after sz onset,
occurring at severe
levels only in a subset
of patients.
(Takahash
i et al.,
2011)
First episode sz
(18) and
schizotypal
disorder (13)
18 / 13 /
20
1.5T, 2.7yrs
GM volume of
fusiform, middle
temporal and
inferior temporal
gyri
Smaller fusiform gyri
bilaterally in patients at
both time points with
significant reduction of
fusiform gyrus volume
in sz patients over time.
(Boonstra
et al.,
2011)
Schizophrenia
(57)
57 / 56 1.5T, 5yrs
Brain volume
change
No evidence for
relationship between
duration of untreated
illness and brain
volume change in sz.
(van
Haren et
al., 2011)
Schizophrenia
(92) and
schizoaffective
(4)
154 / 156
baseline
96 / 113
follow-up
1.5T, 5yrs
Cortical
thickness and
change in
cortical thickness
Widespread
progressive cortical
thinning over time in
patients but higher
cumulative intake of
atypical antipsychotic
medication was
associated with less
cortical thinning. Frontal
and temporal cortices
were thinner while
parietal and occipital
cortices were thicker in
patients than controls at
baseline.
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(Asami et
al., 2011)
First episode sz
(33)
33 / 36
baseline
21 / 23
follow-up
1.5T, 1.5yrs
VBM analysis of
whole brain GM
with manual
ROI comparison
GM volume reduction in
left STG, frontal,
parietal and limbic
regions including the
cingulate gyrus. Worse
cognitive function was
linked to volume
reduction in frontal,
temporal and parietal
regions.
(Kong et
al., 2012)
First-episode
schizophrenia
(20)
20 / 20
baseline
20 / -
follow-up
1.5T, 1yr
GM changes
At follow-up patients
had significantly
decreased neurological
soft signs. Localised
changes in left frontal
lobe, cerebellum and
cingulate gyrus in those
who improved while
GM reductions of sub-
lobar claustrum,
cingulate gyrus,
cerebellum, frontal lobe
and middle frontal
gyrus in those who
worsened.
(Li et al.,
2012)
First-episode
drug naïve
schizophrenia
(66)
66 / 23
baseline
42 / 23
follow-up
3T, 6 weeks
Volume of
putamen
Increased grey matter
volume in right
putamen of patients
after 6 weeks
treatment. Volume
increase correlated with
improved
psychopathology
(reduced positive
symptoms)
(Collin et
al., 2012)
Schizophrenia
and related
spectrum
disorders (105)
105 / 100 1.5T, 5yrs
Global brain
volume
Sz patients with higher
levels of
disorganization exhibit
more progressive
decrease of brain
volume and have lower
IQs.
(Roiz-
Santiáñez
et al.,
2012)
First episode
schizophrenia
spectrum pts (59
males and 34
females)
93 / 70 1.5T, 1 yr
Straight gyrus
morphometry
Straight gyrus volume
change over 1 yr was
similar to healthy
controls and not
associated with clinical
variables.
70
(Takahashi
et al., 2012)
Chronic sz (17)
from in-pt and
out-pt clinics with
at least 3yrs
illness duration
17 / 17 1.5T, pituitary
volume
No significant change in
pituitary volume over
time, patients had a
larger pituitary volume
than ctrls at both time
points.
(Cobia et
al., 2012)
Schizophrenia
(20)
20 / 20 1.5T, 2yrs
Cortical GM
thickness,
volume and
surface area
Cortical thinning of
middle frontal, superior
and middle temporal
gyri in patients
(Treszniak
et al., 2012)
FE psychosis
patients with sz
(62), mood
disorders (46)
and other
psychosis (14)
and ctrls (94)
122 / 94
baseline
80 / 52
follow-up
1.5T, 13 months
Length of
adhesion
interthalamica
and cavum
septum
pellucidum
Significant reduction in
AI length in sz FE
patients at baseline.
Cavum septum
pellucidum length more
prominent increase in
the psychosis than
controls over time.
(Nesvag et
al., 2012)
Long-term
treated
schizophrenia
(52) and healthy
subjects (63)
52 / 63 1.5T, 5yrs
Cortical
thickness and
subcortical
volumes
Regional differences in
cortical thickness and
volume between
patients and controls
are stable across 5 yrs.
Right lateral ventricle
volume increases more
in patients. Some
progression in
subcortical structures
may be present in pts
with poor outcome.
(Mamah et
al., 2012)
FE patients from
14 international
centres receiving
haloperidol or
olanzapine
134 / 51 104 weeks
follow-up
Hippocampal
volume and
shape metrics
No change in
hippocampal volume
over time but surface
deformation was
variable with
olanzapine having less
longitudinal effect on
hippocampal surface
deformation than
haloperidol.
(Walter et
al., 2012)
Antipsychotic
naïve at- risk
mental state
patients (18)
8 transitioned to
psychosis and
10 did not
8 / 10 1.5T, 988 days
hippocampal
volume
Significant decrease in
hippocampal volume
over time seen in both
groups and
independent of clinical
outcome.
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(Vita et al.,
2012)
19 studies
comparing
longitudinal GM
changes in
patients with sz
and controls
Meta-
analysis
813 / 718
Higher volume loss of
total cortical GM in
patients, especially in
left hemisphere. FE
patients showed more
significant progressive
loss.
(Welch et
al., 2012)
Increased risk of
sz
Exposed to
cannabis (23) and
not exposed to
cannabis (32)
23 / 32 3T, 2 yrs, GM
volume, tensor
based
morphometry
Cannabis exposure
was associated with
significantly greater
loss of right anterior
hippocampal and left
superior frontal lobe
GM.
3.1.1 Discussion of Methods Used
Only two papers included a preliminary power calculation to ensure
recruitment of sufficient numbers of subjects for an 80% or greater probability
of detecting structural differences that were being sought between groups
(Kanaan et al., 2009b). Insufficiently powered studies are likely to have
increased error rates and some studies had so few subjects e.g. 10 patients
(McClure et al., 2008) and 8 patients (Walter et al., 2012) it is questionable
how much weight these findings can add to our current knowledge base.
Difficulty with recruitment and retention of patients is perhaps the most
obvious problem faced by any clinical researcher, especially in longitudinal
studies with high dropout rates. A longitudinal study by van Haren and
colleagues (van Haren et al., 2007) only managed to scan 96 of 159 patients
at 5 years follow-up with “refusal to participate” and “too unwell” being the
most commonly cited reasons for a 40% drop out. A further 14 patient scans
were not useable because of poor image quality probably due to movement
artefacts. Lieberman and colleagues fared even worse with a dropout rate of
over 50%, with only 51 out of 107 patients returning for a follow-up scan after
18 months (van Haren et al., 2007; Lieberman et al., 2001). Imaging studies
often suffer additional sample attrition due to claustrophobia and discomfort
from the noise produced by the MRI scanner leading to patients being unable
to tolerate scanning.
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Duration of follow-up is also problematic, with most studies following patients
for intervals between 18 months to 3 years, usually commencing from an
early stage of illness. Range and duration of follow-up was highly variable
between studies, this variation in length of follow-up makes comparisons
between studies difficult, one paper reported a 2 to 4 year follow-up interval
(Whitworth et al., 2005) while another reported a range of 33 to 64 months
follow-up interval (Gharaibeh et al., 2000). The longest follow-up study
appeared to span 10 years, (DeLisi et al., 2004) but there were so few 10
year follow-up studies published, valid comparisons could not be made.
DeLisi and colleagues reported that ventricular enlargement during the latter
5 years in schizophrenia patients correlated with time spent in hospital
(DeLisi et al., 2004); while another 10 year follow-up study reported that
lateral ventricular volume continues to increase even in chronic stages of
disease between 4 and 10 years after schizophrenia has been initially
diagnosed (Saijo et al., 2001); this study used a 0.2T MRI scanner but almost
all other studies used 1.5T or 3T scanners, hence limitations of low resolution
may have affected results. The ability to maintain scanner stability over a 10
year period is also questionable. With the above limitations in mind, a review
of 11 longitudinal schizophrenia imaging studies (Hulshoff Pol and Kahn,
2008) concluded that there is progressive loss of cortical grey matter in
fronto-temporal areas, with volume increase in the lateral ventricles.
When comparing imaging studies, techniques for MRI data analysis are
variable; although automated voxel based morphometry (VBM) is commonly
used. VBM is useful in studies looking at whole brain measures and different
tissue volumes i.e. grey, white and CSF with comparisons made between
subjects of interest and controls. Where a strong apriori hypothesis exists, a
region of interest analysis may be more appropriate, for example a study
specifically investigating volumes of Heschl’s gyrus and planum temporale in
schizophrenia patients with auditory hallucinations (Kasai et al., 2003b), as
both these structures form part of the auditory cortex. One continuing
criticism of ROI studies has been the accuracy of hand-drawn areas, which
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are both time consuming and open to operator error. Other groups have used
cortical surface mapping (Sun et al., 2009a) and further combined this with
other techniques to compare the rate of cortical surface contraction between
patients and controls (Sun et al., 2009b) utilizing programmes such as
“Structural Image Evaluation, using Normalisation of Atrophy” (SIENA).
3.1.2 First Episode Studies
Many studies have recruited patients at their first episode of psychosis, with
the rationale of recruiting patients at illness onset in an attempt to visualise
the earliest structural changes in schizophrenia and avoid chronicity related
confounders such as medication or institutionalisation. The definition of this
group; however, has clear overlap with studies recruiting “recent onset
schizophrenia patients” (Ho et al., 2003; Milev et al., 2003) which
encompassed a wide time range for untreated psychosis. Similarly, some
patient groups were described as being “at first hospitalization for psychosis”
(Deng et al., 2009; Dickey et al., 2004; Salisbury et al., 2007) within this
group some patients were acutely unwell in their first episode of psychosis
while others had been chronically unwell in the community prior to their first
admission. If we are to truly understand the effect of schizophrenia on
various brain structures, we need to carry out imaging at time of disease
onset; internationally recognised and standardised terminology would enable
this to happen through improved study design.
3.1.3 Ultra High Risk Studies
By the time of onset of first episode psychosis, pre-morbid decline in social
and cognitive function has typically occurred. In recent years, research
interest has turned to Ultra High Risk (UHR) subjects, who are not formally
diagnosed with a schizophrenia spectrum disorder but are at high risk
through one or more of the following: 1) attenuated psychotic symptoms; 2)
brief, limited intermittent psychotic symptoms with spontaneous resolution; 3)
family history of psychosis accompanied by a decline in general functioning
over the previous 12 months. Fornito and colleagues (2008) reported that
UHR subjects who subsequently converted to frank psychosis had bilateral
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thinning of rostral paralimbic ACC regions (an effect mainly driven by those
who developed a schizophrenia spectrum psychosis). Hippocampal
abnormalities in UHR subjects have also been reported (Phillips et al., 2002)
and those who converted to frank psychosis after 1 year were found to have
loss of right, prefrontal cortex compared to those who remained non-
psychotic (Sun et al., 2009a), suggesting that significant changes to brain
structure occur around the time of first episode psychosis.
3.1.4 Childhood Onset Schizophrenia
In children and adolescents the course of schizophrenia appears to be
different to that of adults. A different neuropathological course of disease has
been described in adolescent onset schizophrenia, which typically manifests
with severe psychotic symptoms. A greater grey matter involvement is seen
compared to adult onset schizophrenia, including Heschl’s gyrus, parietal
operculum, sensory, primary and supplementary motor areas (Douaud et al.,
2007). In healthy adolescence, synaptic pruning usually results in grey matter
volume loss but this process appears to “fail to occur” in those with
schizophrenia (Douaud et al., 2009). Rates of subsequent brain volume
reduction were significantly higher for patients with childhood-onset
schizophrenia than for healthy comparison subjects. In childhood-onset
schizophrenia, the rate of grey matter volume reduction was related to
baseline severity of clinical symptoms and premorbid impairment in cognitive
and social development but not to gender, ethnicity, or age at onset (Sporn et
al., 2003).
3.1.5 Medication Effects
Medication effects may account for at least some of the structural changes
observed in longitudinal imaging studies and the potential confounding
effects of medication have been considered in detail. This medication effect
was initially described by Lang et al. (2001), who found larger basal ganglia
volumes in patients treated with typical antipsychotics but no significant
volume changes after using the atypical antipsychotic risperidone. In studies
measuring whole brain GM volume the picture has been variable; a large
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study with 161 patients who completed 2 years follow-up by Lieberman and
colleagues (2005), found that the typical antipsychotic haloperidol was
associated with whole brain GM loss but the atypical antipsychotic
olanzapine was not. Conversely, Garver et al. (2005) described cortical GM
volume increase with atypical antipsychotics risperidone and ziprasidone but
not with the typical antipsychotic haloperidol; however, this study only
sampled 19 patients who were scanned after a very short 28 day interval.
Diffuse, cortical GM increase has also been described in parietal and
occipital regions after treatment with risperidone or clozapine (Molina et al.,
2005) and in the anterior cingulate cortex following exposure to typical
antipsychotics (McCormick et al., 2005).
Khorram et al. (2006) described thalamic volume decrease in patients who
were switched from typical antipsychotics to the atypical olanzapine. Within 1
year, patients had thalamic volumes similar to the control group. The authors
argued that following a medication switch, reversal of brain abnormalities can
occur, even in patients with chronic schizophrenia.
Antipsychotic naïve patients recruited in one study (Deng et al., 2009) were
scanned at 3 and 8 weeks after starting antipsychotic medication. GM
volume was found to have increased in some areas (right caudate, frontal
gyrus, precentral gyrus and left inferior parietal lobe) during this short follow-
up period, but decreased in other areas (left medial frontal gyrus). This
finding suggests that medication effects on GM volume are already apparent
within a short period of time. In another study, decreased hippocampal
volume was seen in the hippocampi of medication naïve first episode
psychosis patients regardless of whether or not they transitioned to develop
schizophrenia (Walter et al., 2012). The authors concluded that it was not
possible to determine whether hippocampal volume reduction was due to
psychosis as antipsychotic medication might mask this effect by protecting
against further volume loss. In a large longitudinal study, Ho et al. (2011)
described widespread GM volume reduction associated with the use of
antipsychotic medications. Elsewhere it is reported that there may be
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differences in action between typical and atypical antipsychotics on GM
volume (Borgwardt et al., 2008). A literature review concluded that while
typical antipsychotics increased GM volume of the basal ganglia, atypical
antipsychotics reversed this effect after a medication switch and had no
effect on basal ganglia structure (Smieskova et al., 2009).
The prescription of cannabinoid drugs has been controversial in the medical
profession and an association between use of cannabis and development of
psychotic illness has been hotly debated in recent years (Arsenault et al.,
2004). Whether cannabis is a causal factor for schizophrenia remains
unanswered but there is good evidence that the risk of developing psychotic
illness is increased by frequency of exposure to cannabis (Moore et al.,
2007). Rate of GM loss is also influenced by cannabis, with one longitudinal
imaging study showing more pronounced GM loss after five years in
schizophrenia patients using cannabis regularly compared to patients not
using cannabis (Rais et al., 2008). Another study of cannabis exposure
described hippocampal volume loss, regardless of whether a first episode
patient transitioned to schizophrenia or not (Walter et al., 2012).
Two reviews concluded that schizophrenia patients tend to have reduced GM
volume but while typical antipsychotic medication led to increased basal
ganglia volume, atypical antipsychotics had no effect on basal ganglia
volume. Atypicals did however appear to reduce basal ganglia volumes down
to normal again following a medication switch (Smieskova et al., 2009; Navari
and Dazzan, 2009).
3.1.6 Region of Interest Studies
Many studies examine specific regions of interest (ROIs) in schizophrenia but
one of the continuing criticisms of ROI studies is the lack of a uniform,
standardised methodology. Regions are usually hand drawn, hence time
consuming and studies often contain small subject numbers, therefore they
lack statistical power and reproducibility of results is limited.
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The superior temporal gyrus (STG) has been investigated in several
longitudinal schizophrenia studies. Abnormalities of this structure are already
well-documented in cross-sectional imaging studies of schizophrenia, as
described by Honea (Honea et al., 2005) and Shenton (Shenton et al.,
2001b). The STG contains primary and secondary auditory and language-
related areas. There appears to be convincing evidence that STG cortical
volume is already reduced in patients at first episode of schizophrenia
compared to healthy controls but it continues to decrease with disease
progression (Milev et al., 2003; Kasai et al., 2003a; Molina et al., 2006). In
chronic schizophrenia, the picture has been more confusing, Yoshida et al.
(2009) did not find progressive reduction in STG volume in patients with
chronic schizophrenia at 3 year follow-up but van Haren et al. (2007) found
STG volume loss at 5 year follow-up in a large patient cohort. This suggests
that volume loss in the STG may occur more rapidly early on in the course of
illness or it may evolve differently, depending on age at illness onset. More
specific regions of interest within the STG have been Heschl’s gyrus and the
planum temporale, where significant volume reductions over time have been
described (Kasai et al., 2003b).
3.2 Cortical and deep grey matter
Cortical GM loss has been described in numerous studies comparing brains
of healthy individuals with those of adult onset schizophrenia, with the fronto-
temporal regions being particularly affected (Ho et al., 2003; Mathalon et al.,
2001; Smieskova et al., 2009), although more widespread GM loss has been
documented by others (Whitford et al., 2007a; Théberge et al., 2007). In a
study comparing schizophrenia patients and their unaffected siblings with a
healthy control group Brandt and Bonelli (2008) found that whole brain and
cerebral GM volumes of patients decreased excessively compared to their
siblings and healthy controls, suggesting that brain tissue loss in
schizophrenia is related to the disease and is not a genetically pre-
determined trait. Zipparo (2008) described an association between
progressive GM atrophy and mild improvement in overall cognitive
functioning. One possible reason for this surprising finding would be that
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patients at follow-up were no longer psychotic and therefore found it easier to
complete the cognitive tests while an alternative explanation is due to
practice effects. Other studies have found GM loss to be associated with
poor outcome and negative symptoms (Hulshoff Pol and Kahn, 2008).
Some studies additionally identified deep GM structures changing in volume
in response to trials of antipsychotic medications (Smieskova et al., 2009).
These include use of typical antipsychotics leading to increased GM volume
in the basal ganglia, an effect that was reversible by an atypical antipsychotic
medication switch. Similarly caudate and putamen volumes were lower in
patients than controls or poor outcome patients; who would have been on
larger doses of antipsychotic medications compared with good outcome
patients (Mitelman et al., 2009a).
Surface area and cortical thickness measures have seen a recent surge of
interest in schizophrenia as foci of investigations (Bhoraj et al., 2011; Cobia
et al., 2012; Nesvag et al., 2012; van Haren et al., 2011). Findings
demonstrate that cortical morphology is clearly different from that of healthy
controls and include cortical thinning and misfolding. These suggest an
abnormality in the columnar microstructure of cortical cell layers and support
a neurodevelopmental explanation for schizophrenia.
3.3 CSF and the Ventricles
Most studies concluded that ventricular enlargement was occurring
regardless of whether the patient was at first episode of psychosis (Cahn et
al., 2002); or suffering from chronic schizophrenia (Saijo et al., 2001). Only
one study reported no difference in ventricular volume change between
patients and controls but the mean time to follow-up was only 8 months and
patients were noted to have more variable increases and decreases in
ventricular volume than controls (Puri et al., 2001). A Dutch study showed an
association of ventricular enlargement with cannabis use (Rais et al., 2008),
suggesting that specific environmental factors may increase the rate of
ventricular enlargement. Changes to adjacent white matter may also
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influence rate of ventricular enlargement (Christensen et al., 2004). An earlier
study from my research group (Price et al., 2006) reported volume loss in
white matter areas adjacent to the lateral ventricles in the right and left
temporal lobes of patients, a finding which has subsequently been reported
by others as well (Hulshoff Pol and Kahn, 2008).
3.4 Diffusion Tensor Imaging Studies in schizophrenia
Since 1998, an increasing number of publications have emerged in
schizophrenia research reporting findings from diffusion tensor imaging (DTI)
studies. DTI is useful in structural imaging of white matter tracts, as a tool for
pre-operative planning in neurosurgery and has been extensively used to
study brain injury.
Literature searches for studies in schizophrenia on Psych Info and Ovid
Medline databases were used to identify the publications listed in table 3.2.
This is not intended as an exhaustive list of all published DTI literature
available, but summarizes articles published in English language journals
describing DTI findings in schizophrenia, the cohort(s) used, the methodology
and main findings. From the studies reviewed, it is observed that methods
have continued to be refined in order to improve the quality of results
obtained. Cardiac gating and methods of dealing with image artefacts were
not mentioned in any literature predating 2005, yet personal experience
shows that approximately 10% of DTI data obtained is unsuitable for
inclusion to studies, most commonly due to movement artefacts. Head
stabilization is not included as part of the methodology in a number of
studies, which is surprising given that movements are a common
extrapyramidal side-effect of anti-psychotic medication.
80
Table 3.2 Diffusion Tensor Imaging Studies in Schizophrenia
ROI = Region of interest, ROI-T = Region of interest with tractography, LSDI = Line scan
diffusion imaging, EPI = Echo planar imaging
Author and
Year
Patient group Sample
Size
(Pt /
Ctrl)
Method (field
strength,
sequence,
analysis type,
slice no. and
thickness)
Results
(patients
compared to
controls)
(Buchsbaum et
al., 1998)
Schizophrenia
out-pt and in-pt
sample
5 / 6 1.5T, LSDI, WB
Unspecified slice
number, 1.8mm
thick
Lower average
anisotropy in
white matter of
PFC, internal
capsule and
temporal lobes
(Lim et al.,
1999)
Schizophrenia,
armed forces
veterans
10 / 10 1.5T, EPI, ROI
18 axial oblique
slices, 5mm thick
Widespread
decrease in FA
from frontal to
occipital regions
(Foong et al.,
2000b)
Chronic in-pt
schizophrenia
20 / 20 1.5T, EPI, ROI
12 axial slices,
5mm thick
Increased MD
and decreased
FA in splenium
but not genu of
the CC
(Agartz et al.,
2001)
Chronic
schizophrenia
20 / 24 1.5T, EPI, WB
22 axial oblique
slices, 4mm thick
Decreased FA in
splenium of CC
and occipital WM
(forceps major)
bilaterally
(Steel et al.,
2001)
Chronic
schizophrenia
10 / 10 2T, EPI, ROI
10 axial slices,
6mm thick
No difference in
diffusion
anisotropy in pre-
frontal white
matter ROI
(Foong et al.,
2002)
Chronic
schizophrenia
14 / 19 1.5T, EPI, WB
12 axial slices,
5mm thick
No difference in
whole brain VBM
analysis
(Kubicki et al.,
2002)
Schizophrenia,
out-pt, in-pt, day
treatment and
foster care
15 / 18 1.5T, LSDI, ROI
31 to 35 coronal
slices, 4mm thick
FA similar in both
groups but
patients lacked
asymmetry seen
in controls (L>R)
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(Hoptman et al.,
2002)
Schizophrenia
COMT genotype
14 / - 1.5T, EPI, ROI
21 axial slices,
2.5mm thick
No control group
but lower FA in
inferior frontal
WM associated
with impulsivity
and aggression in
patients
(Kubicki et al.,
2003)
Schizophrenia,
Out-pt, in-pt, day
treatment and
foster care
16 / 18 1.5T, LSDI, ROI
31 to 35 coronal
slices, 4mm thick
Decreased FA
and smaller area
in cingulum
bundle
(Sun et al.,
2003)
Schizophrenia 30 / 19 1.5T, EPI, ROI
unspecified slice
number, 5mm thick
Decreased FA in
anterior cingulum
only
(Minami et al.,
2003)
Schizophrenia 12 / 11 1.5T, EPI, ROI
4 axial slices, 6mm
thick
FA decreased in
all regions of WM
bilaterally
(Burns and
Job, 2003)
Schizophrenia 30 / 30 1.5T, EPI, ROI
31 axial slices,
5mm thick
Decreased FA in
left uncinate and
arcuate fasciculi
(Wang et al.,
2003)
Schizophrenia 29 / 30 1.5T, EPI, ROI
12 slices, 3mm
thick
No FA difference
in superior or
middle cerebellar
peduncles
(Wolkin et al.,
2003)
Schizophrenia in
and out pt
10 / - 1.5T, EPI, ROI
5 axial slices, 5mm
thick
Decreased FA in
inferior frontal
WM, which is
correlated with
severity of
negative
symptoms
(Begre et al.,
2003)
First episode
schizophrenia
7 / 7 1.5T, EPI, ROI
12 axial slices,
5mm thick
No difference in
hippocampal FA
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(Ardekani et al.,
2003)
Schizophrenia
(7) and
schizoaffective
(7) disorder
14 / 14 1.5T, EPI, WB
20 axial slices,
5mm thick
Reduced FA in the
corpus callosum, left
STG, MTG, IPG,
parahippocampal
gyri, medial occipital
lobe and deep
frontal perigenual
region
(Wang et al.,
2004)
Schizophrenia 21 / 20 1.5T, EPI, ROI
12 axial slices,
3mm thick
Reduced FA both
sides of anterior
cingulum bundle and
less L>R FA
asymmetry
(Kalus et al.,
2004)
Schizophrenia
paranoid subtype
15 / 15 1.5T, EPI, ROI
13 slices parallel
to long
hippocampal
axis, 2.5mm
thick
Decreased
intervoxel coherence
in posterior
hippocampus and
reversed coherence
asymmetry with
anterior
hippocampus in
schizophrenia
(Okugawa et
al., 2004)
Schizophrenia,
paranoid (15),
disorganized (8)
and catatonic (2)
25 / 21 1.5T, EPI, ROI
unspecified slice
number, 6mm
thick
Reduced FA in
middle cerebellar
peduncles
(Kumra et al.,
2004)
Young people
with Early Onset
Schizophrenia
12 / 9 1.5T, EPI, ROI
18 slices, 5mm
thick
Reduced FA in
frontal WM
bilaterally and right
occipital WM
(Hubl et al.,
2004)
Acute
Schizophrenia
with auditory
hallucinations
(13) & without
(13)
13 / 13 /
13
1.5T, LSDI, WB
12 axial slices,
5mm thick
Reduced FA in all
brain WM regions
Increased FA in
parts of arcuate
fasciculus and
corpus callosum
(Kalus et al.,
2004)
Schizophrenia 14 / 14 1.5T, EPI, ROI
13 slices, 2.5mm
thick
Inter-voxel
coherence reduced
bilaterally in the
hippocampus
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(Hoptman et
al., 2004)
Schizophrenia or
schizoaffective
disorder
25 / - 1.5T, EPI, WB
20 axial slices,
5mm thick
Negative
correlations between
FA and impulsivity in
inferior frontal WM,
anterior cingulate,
caudate, insula and
inferior parietal lobe
(Hoptman et
al., 2004)
Schizophrenia or
schizoaffective
disorder
25 / - 1.5T, EPI, WB
20 axial slices,
5mm thick
Negative
correlations between
FA and impulsivity in
inferior frontal WM,
anterior cingulate,
caudate, insula and
inferior parietal lobe
(Park et al.,
2004)
Schizophrenia
out-pt, in-pt, day
treatment and
foster care
23 / 32 1.5T, LSDI, WB
31 to 35 coronal
slices, 4mm thick
FA asymmetry lower
in cingulum and
anterior CC, absent
in anterior limb of
internal capsule,
uncinate fasciculus
and superior
cerebellar peduncle
(Nestor et al.,
2004)
Schizophrenia 41 / 46 1.5T, LSDI, ROI
31 to 35 coronal
slices, 4mm thick
Lower levels of
declarative-episodic
verbal memory
correlated with
reduced left uncinate
and executive
function errors link to
left cingulum
(Price et al.,
2005)
First episode
schizophrenia
20 / 29 1.5T, EPI, ROI
21 axial slices,
5mm thick
No differences in FA
or diffusivity in the
splenium or genu of
the corpus callosum
(Kitamura et
al., 2005)
Schizophrenia 6 / 6 3T, EPI, ROI
5 axial slices,
5mm thick
Frontal FA reduced
(Kalus et al.,
2005)
Paranoid
schizophrenia
14 / 14 1.5T, EPI, ROI
13 slices, 2.5mm
thick
Decreased inter-
voxel coherence in
the amygdala
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(Szeszko et al.,
2005)
First episode
schizophrenia
and
schizoaffective
disorder
10 / 10 1.5T, EPI, WB
18 axial slices,
5mm thick
Reduced FA in left
internal capsule, left
middle frontal gyrus
and posterior
superior temporal
gyrus
(Kubicki et al.,
2005a)
Schizophrenia
out-pt, in-pt, day
treatment and
foster care
21 / 26 1.5T, LSDI, WB
31-35 coronal
slices, 4mm thick
Decreased diffusion
anisotropy in the
fornix, corpus
callosum and
bilaterally in the
cingulum bundle,
superior occipito-
frontal fasciculus,
internal capsule,
right inferior occipito-
frontal fasciculuc
and left arcuate
fasciculus
(Okugawa et
al., 2005)
Schizophrenia,
paranoid (15),
disorganized (8)
& catatonic (2)
25 / 21 1.5T, EPI, ROI
axial slices
parallel to AC-
PC line,
6mm thick
Reduced FA in
middle cerebellar
peduncle in patients
with schizophrenia
(Kumra et al.,
2005)
Schizophrenia
(17),
schizoaffective
(8)
schizophreniform
(1)
26 / 34 1.5T, EPI, WB
23 slices,
thickness
unspecified
Reduced FA in the
left anterior cingulate
(Jones et al.,
2006)
Schizophrenia
in-pt and out-pt
14 / 14 1.5T, EPI, ROI
Unspecified slice
number or
thickness
FA lower in patients
in the superior
longitudinal
fasciculus but this
may be due to
correlation with age
(Kuroki et al.,
2006)
Schizophrenia
out-pt, in-pt, day
treatment and
foster care
24 / 31 1.5T, LSDI, ROI
31-35 coronal
slices, 4mm thick
Reduced FA in
fornix and mean
diffusivity increase
seen in bilateral
hippocampi
(Kanaan et al.,
2006)
Schizophrenia in
remission
39 / 43 Field strength
unspecified, EPI,
ROI
>60 near-axial
slices, 2.5mm
thick
No difference in FA
in genu of corpus
callosum using
conventional ROI
method but reduced
FA when
tractographic ROI
method used
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(Shin et al.,
2006)
Schizophrenia
in-pt and out-pt
19 / 21 1.5T, EPI, WB
40 axial slices,
4mm thick
Increased apparent
diffusion co-
efficient in bilateral
fronto-temporal
areas.
(Okugawa et
al., 2006)
Schizophrenia
(14 paranoid, 4
disorganised, 3
catatonic)
21 / 21 1.5T, EPI, ROI
Unspecified slice
number, 6mm thick
Lower FA in
superior cerebellar
peduncles
(Mitleman et al.,
2006)
Schizophrenia,
in-pt and out-pt
104 /
41
1.5T, EPI, WB
14 axial slices,
7.5mm thick
Lower FA in
widespread
temporoparietal
and prefrontal
white matter
regions and
associated with
lower regional GM
volumes
(Rose et al.,
2006)
Schizophrenia 12 / 12 1.5T, EPI, WB
45 axial slices,
2.5mm thick
Increased mean
diffusivity in
temporal, parietal
and prefrontal
cortical regions,
also thalamus
(dorsal medial and
anterior nucleus)
including caudate
(Federspiel et
al., 2006)
Schizophrenia 12 / 12 1.5T, EPI, WB
12 axial slices,
5mm thick
Intervoxel
coherence higher
in 3 clusters and
lower in 11 clusters
(Buchsbaum et
al., 2006a)
Schizophrenia,
in-pt, out-pt, day
treatment and
vocational rehab
63 / 55 3T, EPI, WB
28 slices, 3mm
thick
Reduced FA in the
frontal white
matter, corpus
callosum, cingulate
gyrus and superior
longitudinal
fasciculus
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(Buchsbaum et
al., 2006b)
Schizophrenia,
in-pt, out-pt, day
treatment and
vocational rehab
103 /
41
T not mentioned,
EPI, ROI
14 axial slices,
7.5mm thick
Manual
tractography found
that anterior
thalamic radiations
from internal
capsule to
prefrontal WM was
shorter in length
and FA lower
(Caan et al.,
2006)
Recent onset
schizophrenia or
related DSM IV
disorder
34 / 24 1.5T, EPI, WB
Unspecified slice
number and
thickness
Decreased FA in
genu of corpus
callosum and
increased FA in
posterior limb of
internal capsule
and uncinate
fasciculus
(DeLisi et al.,
2006)
High risk of
schizophrenia
15 / 25 1.5T, EPI, WB
19 slices, 5mm
thick
ADC was reduced
in four regions of
the left brain:
parahippocampal
gyrus, lingual
gyrus, superior
frontal gyrus and
middle frontal gyrus
(Lim et al.,
2006)
Schizophrenia or
schizoaffective
disorder
25 / - 1.5T, EPI, WB
20 slices, 5mm
thick
Better performance
in verbal memory,
attention and
executive function
correlates with
higher FA in task
relevant WM
regions.
(Butler et al.,
2006a)
Schizophrenia
(15) and
schizoaffective
(2)
17 / 21 1.5T, EPI, ROI
20 slices, 5mm
thick
Optic radiations
show reduced FA
bilaterally
(Schlösser et
al., 2006)
Schizophrenia 18 / 18 1.5T, EPI, WB
19 axial slices,
3mm thick
Reduced FA in
right medial
temporal lobe and
right frontal lobe
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(White et al.,
2007)
Children and
adolescents with
schizophrenia
(14) and
schizoaffective
disorder (1)
15 / 15 3T, EPI, WB
Unspecified slice
number, 2mm thick
Decreased FA in
left posterior
hippocampus and
posterior limbic
regions with
concurrent
increase in average
diffusivity
(Nestor et al.,
2007b)
Chronic
schizophrenia
18 / 30 1.5T, LSDI, ROI
Coronal oblique
unspecified
number, 4mm thick
Left cingulum
bundle FA
correlated with
orienting of
attention
(Mori et al.,
2007)
Chronic
schizophrenia
42 / 42 1.5T, EPI, WB and
ROI
20 axial slices,
5mm thick
Reduced FA in
bilateral frontal and
temporal lobes,
uncinate fascicule,
cingulum bundles
and corpus
callosum, age
related reduction in
FA more prominent
in patients
(Mitelman et al.,
2007)
Schizophrenia
poor outcome
(53) & good
outcome (51)
104 /
41
1.5T, EPI, ROI
14 axial slices,
7.5mm thick
Reduced FA in left
cingulum, anterior
thalamic radiation,
fronto-occipital and
inferior longitudinal
fasciculus, corpus
callosum, internal
capsule, superior
longitudinal
fasciculus, optic
radiation and
fronto-temporal
extra-fascicular
white matter.
(Nestor et al.,
2007a)
Schizophrenia 21 / 25 1.5T, LSDI, ROI
Coronal oblique
unspecified
number, 4mm thick
Reduced FA of
fornix correlated
with reduced
executive
functioning
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(Leitman et al.,
2007)
Schizophrenia
(17)
schizoaffective
disorder (2)
19 / 19 1.5T, EPI, WB
20 slices, 5mm
thick
Lower FA
correlates with
impaired voice
emotion
identificationin
auditory pathways,
orbitofrontal cortex,
corpus callosum
and peri-amygdala
white matter
(Seok et al.,
2007)
Schizophrenia,
hallucinating (15)
and
non-hallucinating
(15)
15 / 15
/ 22
1.5T, EPI, ROI
About 45 axial
slices, 2mm thick
FA significantly
decreased in the
left superior
longitudinal
fasciculus and
increased in the left
inferior longitudinal
fasciculus
(Shergill et al.,
2007)
Schizophrenia,
from hospital
wards and
out-pt clinics (33)
33 / 40 1.5T, EPI, WB
Over 60 near-axial
slices, 2.5mm thick
Reduced FA in
superior
longitudinal
fascicule bilaterally
and genu of corpus
callosum
(Miyata et al.,
2007)
Schizophrenia,
out-pt (42) and
in-pt (3)
40 / 36 3T, EPI, ROI
40 axial slices,
3mm thick
Smaller
anterior/total
corpus callosum
area and length
(Karlsgodt et
al., 2007)
Schizophrenia,
young adults
with adolescent
onset
12 / 17 1.5T, EPI, ROI
75 AC-PC aligned
slices, 2mm thick
Lower FA in
superior
longitudinal
fasciculus
bilaterally,
correlations with
performance on
verbal working
memory in left but
not right SLF
(Andreone et
al., 2007)
Schizophrenia 68 / 64 1.5T, EPI, ROI
20 axial slices,
5mm thick
Greater apparent
diffusion co-
efficient in frontal,
temporal and
occipital white
matter
(Fujiwara et al.,
2007)
Schizophrenia 42 / 24 3T, EPI, ROI
40 axial slices,
3mm thick
Reduced FA in
anterior and
posterior cingulum
bundles
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(Manoach et al.,
2007a)
Chronic
schizophrenia
out-pt
17 / 19 3T, EPI, ROI
64 axial oblique
slices, 2mm thick
Reduced FA in
right cingulate
(Tang et al.,
2007)
Schizophrenia
in-pt, out-pt, day
treatment and
vocational rehab
42 / 40 3T, EPI, ROI
28 slices, 3mm
thick
Reduced FA in
bilateral medial
temporal lobes
(Kyriakopoulos
et al., 2008)
Early onset
schizophrenia
19 / 20 1.5T, EPI, WB
60 slices, 2.5mm
thick
Lower FA in
parietal association
cortex bilaterally
and in left middle
cerebellar
pedcuncle
(Szeszko et al.,
2008)
Recent onset
schizophrenia
33 / 30 1.5T, EPI, WB
23 axial slices,
5mm thick
Lower FA in the
temporal lobe white
matter, uncinate
fasciculus , left
inferior fronto-
occipital fasciculus
and left superior
longitudinal
fasciculus
(Maniega et al.,
2008)
Schizophrenia
(31), high risk of
schizophrenia
(22) and controls
31 / 22
/ 51
1.5T, EPI, ROI
48 axial slices,
2.8mm thick
FA reduced in left
arcuate fasciculus,
bilateral uncinate
fascicule and
anterior limb of
internal capsules.
High risk subjects
had reduced FA in
anterior limb of
internal capsules
only.
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(Peters et al.,
2008)
Schizophrenia
(10), ultra-high
risk of psychosis
(10)
10 / 10
/ 10
3T, EPI, ROI
Para-transversal,
tilted to coronal
No difference in
corpus callosum FA
between healthy
controls and either
patient groups
(McIntosh et
al., 2008b)
No patients,
healthy control
subjects
genotyped for
NRG1
polymorphism
(risk allele for
schizophrenia)
- / 43 1.5T, EPI, ROI
48 axial slices,
2.8mm thick
FA at anterior limb
of internal capsule
was lowest in
homozygous TT,
highest in
homozygous CC
and midway for
heterozygous CT
(Carpenter et
al., 2008)
Schizophrenia in-
pt, out-pt, day
treatment and
vocational rehab
76 / 77 3T, EPI, ROI
28 slices, 3mm
thick
Lower FA in genu
but not splenium of
corpus callosum.
Correlation of lower
FA with increasing
age and duration of
illness
(Mandl et al.,
2008)
Schizophrenia 40 / 40 1.5T, EPI, ROI
60 slices, 2.5mm
thick
Decreased FA in
left uncinate
fasciculus
significantly
correlated with age
in patients but not
controls
(Rowland et al.,
2008)
Deficit
schizophrenia
with primary
enduring –ve
symptoms (10),
non-deficit
schizophrenia
(10)
10 / 10
/ 11
3T, EPI, ROI
60 slices, slice
thickness
unspecified
Reduced FA in
right SLF and
frontal white matter
in deficit patients
(Kunimatsu et
al., 2008)
Schizophrenia 19 / 20 1.5T, EPI, ROI
30 slices, 5mm
thick
FA lower and ADC
higher in superior
occipito-frontal
fasciculus
(Kubicki et al.,
2008)
Chronic
schizophrenia
32 / 42 1.5T, LSDI, ROI
5 sagittal oblique
slices, 4mm thick
FA decreased in
corpus callosal
fibres connecting
frontal regions
(McIntosh et
al., 2008a)
Schizophrenia
(25), bipolar (40)
and controls
25 / 40
/ 49
1.5T, EPI, ROI
48 axial slices,
2.8mm thick
FA reduced in
uncinate and
anterior thalamic
radiations
bilaterally in both
groups
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(Hoptman et
al., 2008)
Schizophrenia
(23), high
genetic risk of sz
(22) and controls
23 / 22
/ 37
1.5T, EPI, WB
Unspecified slice
number, 5mm thick
High genetic risk
group had reduced
FA in the cingulate
and angular gyri
bilaterally.
(Narr et al.,
2009)
Adult onset
schizophrenia
(26), unaffected
first degree
relatives (36),
controls (20) and
control relatives
(32)
26 / 36
/ 20 /
32
1.5T, EPI, WB
50 axial slices,
3mm thick
Mean diffusivity
increases in bilateral
temporal regions in
schizophrenia
compared with
unrelated control
probands
(Fitzsimmons
et al., 2009)
Chronic
schizophrenia
36 / 35 1.5T, LSDI, ROI
Coronal oblique
slices aligned to
AC-PC line, 4mm
thick
FA decreased in
fornix bilaterally and
higher fornix FA
correlated with
combined visual
memory, verbal
memory, recall and
recognition in
controls only.
(Kawashima et
al., 2009)
Psychosis in-pts
with
schizophrenia
(15) & affective
psychosis (15)
15 / 15
/ 15
1.5T, LSDI, ROI
31-35 coronal
slices, 4mm thick
FA reduced
bilaterally in
uncinate fasciculus
in schizophrenia,
affective psychosis
FA intermediate
between between sz
and ctrl groups
(Lee et al.,
2009)
Schizophrenia 22/ 22 1.5T, LSDI, WB
Coronal slices,
4mm thick
Mean diffusivity
increased but no
differences in FA
(Ellison-Wright
and Bullmore,
2009)
Meta-analysis of
15 DTI studies
in schizophrenia
407 /
383
Meta-analysis FA reductions seen
in left frontal and
temporal deep white
matter with no FA
increases seen
(Kubicki et al.,
2009)
Schizophrenia
in-pt, out-pt, day
treatment, foster
care
18 / 18 1.5T, EPI, ROI
32-35 coronal
oblique slices,
4mm thick
Decreased FA in
bilateral cingulum
bundles which
correlated with
reaction times and
Stroop effect in pt
group only.
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(Kanaan et al.,
2009b)
Schizophrenia
in-pt and out-pt
33 / 33 1.5T, EPI, ROI
60 slices, 2.5mm
thick
FA lower in WM
tracts of the
cerebellum but no
difference in mean
diffusivity
(Hao et al.,
2009)
Schizophrenia
pts (34) and
healthy siblings
(34)
34 / 34
/ 32
1.5T, EPI, WB
30 axial slices,
4mm thick
FA values in
prefrontal cortex,
hippocampus and
anterior cingulate
cortex, lower in pts.
Similar decreased
FA in prefrontal
cortex and
hippocampus in
siblings.
(Kyriakopoulos
et al., 2009)
Adolescent onset
schizophrenia
(17) and adult
onset
schizophrenia
(17)
17 / 17 1.5T, EPI, WB
60 slices, 2.5mm
thick
Adolescent onset sz
showed decreased
FA in parietal areas
but adult onset sz
showed decreased
FA in frontal,
temporal and
cerebellar areas.
(Bai et al.,
2009)
Schizophrenia
with tardive
dyskinesia (TD),
schizophrenia
without TD and
controls
20 / 20
/ 20
1.5T, EPI, WB
70 axial slices,
2.2mm thick
Patients with TD had
more widespread
decreased FA than
patients without TD,
especially cortico-
basal ganglion
circuit.
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(Wang et al.,
2009)
Schizophrenia 31 /
36
1.5T, EPI, WB
Unspecified slice
number, 3mm
thick
FA reduced in
anterior cingulum
with group by
genotype interaction
lowest in
homozygous TT,
highest in
homozygous CC
and midway for
heterozygous CT
(Gasparotti et
al., 2009)
Schizophrenia,
first contact,
drug-naïve (21)
21 /
21
1.5T, EPI, ROI
29 slices, 5mm
thick
Lower FA in
splenium but not
genu of corpus
callosum.
(Phillips et al.,
2009)
Schizophrenia 23 / 22 1.5T, EPI, ROI
55 slices oblique
to AC-PC line,
2.5mm thick
Reduced FA in
arcuate fasciculi and
inferior longitudinal
fasciculi
(Camchong et
al., 2009)
Study 1: Healthy
monozygotic
twins (18 pairs)
Study2: First
degree relatives
of schizophrenia
pts (22)
Study
1:
36 / -
Study
2:
22 / 30
3T, EPI, ROI
55 axial slices,
2.5mm thick
Study 1: FA values
more strongly
correlated between
MZ twins than
randomly generated
pairs in genu of
corpus callosum,
anterior cingulum
and forceps minor.
Study 2: Lower FA
in right genu of
corpus callosum in
relatives
(Sussmann et
al., 2009)
Familial
schizophrenia
(28), familial
bipolar disorder
(42) and controls
28 / 42
/ 38
1.5T, EPI, ROI
48 axial slices,
2.8mm thick
Reduced FA in
anterior limb of
internal capsule,
anterior thalamic
radiation and
uncinate fasciculus
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(Cheung, 2009) Never medicated
first episode
schizophrenia
25 / 24 - FA reduced in the
right posterior limb of
internal capsule and
substantia nigra, left
middle temporal
gyrus, cerebral
peduncle and
splenium of corpus
callosum
(Peters et al.,
2009)
Ultra high risk for
psychosis (10)
and recent onset
schizophrenia (8)
or schizoaffective
disorder (2)
and controls
10 / 10
/ 10
3T, EPI, WB
48 slices, 2.2mm
thick
FA reduced in the
UHR group in right
superior frontal lobe
and left middle
frontal lobe
In sz group FA
reduced in parietal
lobes, left frontal and
superior temporal
lobe, right temporal
lobe and insula
(Voineskos et
al., 2009)
Schizophrenia 10 / 10 1.5T, EPI, ROI
57-62 axial slices,
2.6mm thick
Between group FA
differences not
calculated in this
physics methods
paper
(Kanaan et al.,
2009a)
Schizophrenia in-
pt and out-pt
76 / 76 1.5T, EPI, WB
Over 60 near-axial
slices, 2.5mm
thick
Lower whole brain
FA with widespread
FA decreases
throughout multiple
WM structures
(Bai et al.,
2009)
Schizophrenia
with tardive
dyskinesia (TD),
schizophrenia
without TD and
controls
20 / 20
/ 20
1.5T, EPI, WB
70 axial slices,
2.2mm thick
Patients with TD had
more widespread
decreased FA than
patients without TD,
especially cortico-
basal ganglion
circuit.
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(Herbsman and
Ziad, 2010)
Schizophrenia 13 / 16 3T, EPI, WB
30 slices, 3mm
thick
Decreased diffusivity
in right prefrontal
cortex, left superior
longitudinal
fasciculus,
cerebellum and
increased FA in
occipital projections
of the corpus
callosum
(Moriya et al.,
2010)
Early stage of
first episode
schizophrenia
19 / 19 3T, EPI, WB
Unspecified slice
number, 4mm
thick
Increased mean
diffusivity in left
parahippocampal
gyrus, left insula and
right anterior
cingulate gyrus
(Nestor et al.,
2010)
Schizophrenia 16 /
12
1.5T, LSDI, ROI
31 to 35 coronal
slices, 4mm thick
Right cingulum
bundle FA positively
correlated with IQ
(Pérez-Iglesias
et al., 2010)
First episode
schizophrenia
62 /
54
1.5T, EPI, WB
27 axial slices,
5mm thick
Mean FA values
lower in frontal and
temporal poles and
corpus callosum
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The first study to investigate schizophrenia using DTI was published in 1998
(Buchsbaum et al., 1998). Subsequent findings have varied, although there
has been a trend for studies to find lower fractional anisoptropy (FA) in
patients with schizophrenia compared to healthy controls, despite variation in
methodology. Kubicki’s research group used line scan diffusion imaging
(LSDI) which collects scan data in coronal slices and is supposedly prone to
less movement artefacts but most studies used conventional echo planar
imaging (EPI), which collects data in axial slices. Although high field MRI
scanners are available, they are not suitable for clinical use and most of the
published data reported findings from 1.5T scanners. Analysis of data used
either of two main methods; whole brain voxel-wise analysis or tract specific
comparison between groups. Although VBM is useful where no apriori
hypothesis exists and a global search is required, there is more room for type
I errors due to multiple comparisons on a larger scale than for a tract specific
analysis. Registration has also been raised as a potential problem but using
technology such as Spatial Parametric Mapping (SPM), processing can be
automated, hence more accurate than calculating FA in a hand drawn ROI.
Despite differences in methodology the commonest reported finding appears
to be lower FA in patients than controls (although some studies report no
difference in FA between the groups). The only study to report higher FA in
patients than controls (Hubl et al., 2004) was specifically testing the
hypothesis that schizophrenia patients with auditory hallucinations might
have increased FA in the middle and superior temporal gyri. The rationale for
this hypothesis being that the auditory processing pathway extends through
these brain regions and may be “over-developed” hence predisposed to
hyperactivity and give rise to auditory hallucinations.
Many DTI studies have reported decreased FA in the corpus callosum but
the specific regions have been variable; being the largest white matter tract in
the brain, the margins of this structure are clearly visible on MRI. In a ROI
study, Foong et al. (2000b) found decreased FA in the splenium of the
corpus callosum of patients but no difference in FA of the corpus callosum in
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a subsequent study using a whole brain voxel-based analysis (Foong et al.,
2002), which suggests that whole brain voxel-based studies may be less
sensitive to discrete FA changes. Two later studies by Caan et al. (2006) and
Carpenter et al. (2008) reported decreased FA in the genu but not the
splenium of the corpus callosum using a voxel based analysis. One
explanation for this may be that patients were clinically worse affected by
schizophrenia; conversely, FA of first episode schizophrenia patients was
similar to healthy controls in ROIs of the genu and splenium of the corpus
callosum (Price et al., 2005).
It has been suggested that white matter changes are progressive and may
vary with illness duration but in some first episode psychosis studies (Foong
et al., 2000b; Pérez-Iglesias et al., 2010), patients already had reduced WM
FA compared to healthy controls, suggesting onset of WM microstructural
changes have already started by the time of symptom onset. This finding has
also been replicated in medication naïve subjects, suggesting FA variation is
unlikely to be due to any effects of medication (Cheung, 2009). Some first
episode studies reported no difference in WM FA compared to healthy
controls (Price et al., 2005; Begre et al., 2003) but this apparent
inconsistency may be due to the limited effect size as any group differences
are likely to be very subtle.
A review of 18 DTI studies by Kubicki et al. (2007) concluded that the
evidence for FA differences between schizophrenia patients and healthy
controls were controversial. The authors pointed out that low spatial
resolution and high signal to noise ratio probably contributed to the
discrepancies found between studies. A more comprehensive review (Konrad
and Winterer, 2008) including structural MRI, DTI, magnetic resonance
spectroscopy (MRS) and post-mortem schizophrenia studies concluded that
there is increasing evidence from multiple imaging modalities that structural
connectivity might be pathologically altered in schizophrenia, giving rise to
two models of WM disconnectivity for schizophrenia; global and macro-
circuit. Global theory suggests that WM reductions occur uniformly
98
throughout the brain, possibly as a result of genetic abnormalities in the
protein pathways controlling myelination; macro-circuit theory proposes that
specific WM tracts connecting GM regions are disrupted either as a cause or
a consequence of schizophrenia.
A subsequent meta-analysis of 15 DTI studies (Ellison-Wright and Bullmore,
2009); concluded that most studies enrolled chronic schizophrenia patients
where white matter FA reduction is probably more widespread. Overall FA
was significantly reduced in two regions, the left frontal and left temporal
deep white matter. “The first region, in the left frontal lobe, is traversed by
white matter tracts interconnecting the frontal lobe, thalamus and cingulate
gyrus. The second region, in the temporal lobe, is traversed by white matter
tracts interconnecting the frontal lobe, insula, hippocampus–amygdala,
temporal and occipital lobe. This suggests that two networks of white matter
tracts may be affected in schizophrenia, with the potential for ‘disconnection’
of the grey matter regions which they link”.
Most DTI studies support the notion that white matter integrity is impaired in
schizophrenia but findings need to be interpreted with caution for several
reasons. FA measures are believed to reflect directionality and position of the
white matter tract; however, anisotropy is highly variable in different white
matter regions depending on the degree of coherence of fibre tract directions.
In regions where WM tracts branch and axons cross, the fibre pattern is less
coherent so diffusion anisotropy is significantly reduced (Pierpaoli and
Basser, 1996). A further difficulty lies with sampling of patients, illness
severity does not necessarily correlate with duration of illness and while
some studies recruited chronic out-patients, others recruited from in-patient
wards where patients would be more acutely unwell. Chronic patients are
also likely to be older than first episode patients and there are clear age-
related differences in brain maturation (Jones et al., 2006). Future studies
should aim to improve methodology by introducing more stringent recruitment
criteria, better correction of movement artefacts and increase uniformity in
MRI processing.
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3.4.1 Tractography Studies of Schizophrenia
In recent years there have been an increasing number of studies published
investigating the integrity of WM tracts in schizophrenia (table 3.3). The WM
tracts reconstructed using tractography can give an idea of the overall
position and directionality of WM tracts in-vivo; hence the degree of
connectivity between different brain regions can be estimated using
quantitative measures of anisotropy or diffusivity obtained by this type of
analysis of diffusion tensor imaging (DTI) data.
Table 3.3 summarizes DTI studies of schizophrenia found on literature
search using PubMed that have been published in English language journals.
While earlier studies tended to look at the number of seed tracts passing
between two ROIs to determine strength of connectivity between two areas
(Jones et al., 2006) there has been much variation in subsequent
methodology. Where diffuse regions of change are sought, multiple regions
of interest can be used; for example to demonstrate decreased FA in multiple
projections of the DLPFC in schizophrenia (Oh et al., 2009) or in multiple
cerebellar tracts (Kanaan et al., 2009b). Other studies have used novel
techniques for analyzing DTI data, for example “Guided Tensor Restore
Anatomical Connectivity Tractography” (Magnotta and Cheng, 2005) which is
a two pass approach generating an approximation to the fibre tracts followed
by guided tracking in regions of low FA or large curvature, which simulates
the natural branching of fibre bundles. With the majority of studies using ROI
rather than a whole brain analysis approach, tractography findings have been
diverse; although FA is generally lower in patients with schizophrenia and FA
changes are already apparent at first episode of psychosis (Gasparotti et al.,
2009; Luck et al., 2010; Price et al., 2007; Price et al., 2008).
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Table 3.3 Tractography Studies in Schizophrenia
Sz = schizophrenia, FA = fractional anisotropy, ILF = inferior longitudinal fasciculus, MD = mean
diffusivity, UF = uncinate fasciculus, CB = cingulate bundle, DLPFC = dorsolateral prefrontal cortex,
MROI = multiple regions of interest, PICo = probabilistic index of connectivity, ROI = Region of interest,
WM = white matter
Author
and Year
Patient
group
Sample
Size
(Pt/Ctrl)
Field strength and
methodology
Results (patients
compared to
controls)
(Jones et
al., 2006)
Right-
handed
males
with sz
14 / 14 1.5T Fibres between 2
ROIs sought using
algorithm of 0.5mm tracking
step and FA threshold 0.15
Youngest pts had
lower diffusion
anisotropy than age-
matched ctrls but
difference diminished
with increasing age.
This may be due to
age related
differences in brain
maturation.
(Price et
al., 2007)
FE sz
spectrum
disorders
18 / 21 1.5T Probabilistic index of
connectivity (PICo)
tractography algorithm with
seed regions in genu and
splenium
FA was reduced in
tracts crossing the
genu and splenium
in pts but tract
volumes were similar
to controls.
(Ashtari et
al., 2007)
Adolesce
nts
11–18yrs
sz/sa
23 / 21 1.5T Fibre assignment by
continuous tracking
(FACT), threshold FA 0.2
and turning angle < 41º to
extract ILF.
Reduced FA in L
inferior temporal and
occipital regions.
Reduced FA and
increased radial
diffusivity in left ILF
of pts.
(Miyata et
al., 2007)
Sz 40 / 36 3T Continuous tracking
method between 2 ROIs
with termination criteria FA
< 0.2 of turning angle > 50º
Pts showed small
anterior/total corpus
callosum length and
area suggesting
interfrontal
hypoconnectivity in
sz. Lower FA and
higher MD anteriorly.
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(Price et
al., 2008)
FE
psychosis
19 / 23 1.5T Probabilistic
tractography algorithm
used to map uncinate
fasciculus
Number of voxels
with high FA values
reduced in the core
of the left UF
suggesting changes
in fibre alignment
and tract coherence
in pts.
(Zhou et
al., 2008)
Paranoid
sz
in-pts
17 / 14 1.5T Fibre assignment by
continuous tracking (FACT)
used with FA threshold of
0.15 and angle > 10º
performed in conjunction
with fMRI.
Mean FA in the
fornix was reduced in
pts
(Nestor et
al., 2008)
Sz 25 / 28 1.5T Fibre tractography
from reconstructed entire
WM fibre bundles
(cingulate and uncinate)
using stopping criteria FA
0.15 and angle 20º per
1mm.
Bilateral reductions
of UF correlated with
deficits in memory
while bilateral
reductions of CB
correlated with
deficits in executive
functioning.
(Kim et al.,
2008)
Sz 30 / 22 1.5T Probabilistic
thalamocortical pathways
were calculated from the
thalamus to 4 parceled
cortical masks with 5000
iterations per thalamic seed
voxel
Decreased
anisotropy and
increased
longitudinal and
transverse diffusivity
in pts within
pathways from
mediodorsal nucleus
and pulvinar to
orbitofrontal and
parietal-occipital-
temporal lobes.
(Rosenberg
er et al.,
2008)
Sz 27 / 34 Reconstruction of cingulum,
uncinate and inf occipito-
frontal fasciculi using whole
brain fiber tractography
threshold FA < 0.15 &
angle of curvature > 20º per
1mm. 2 ROIs per tract were
selected for purposes of
tractography.
Significant decline in
FA with age in
cingulum and
uncinate of pts but
not inf occipito-frontal
fasciculi.
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(Takei et
al., 2008)
Sz 31 / 32 1.5T Seed point with
0.66 mm fixed steps along
the principal axis. The
diffusion tensor at the next
location was determined
from adjacent voxels by
trilinear filtering, and its
principal axis was
subsequently estimated.
Tracking lines were
automatically traced in this
way and were propagated
in the anterograde and
retrograde threshold FA >
0.2.
Reduced FA and
increased MD in
fornix of pts.
Increased MD in left
fornix correlated with
lower verbal learning
while increased MD
in right fornix showed
association with
poorer semantic
memory in patients.
(Magnotta
et al., 2008)
Sz male
pts
12 / 10 1.5T Novel fibre tracking
algorithm “Guided Tensor
Restore Anatomical
Connectivity Tractography”
tracking threshold 0.26,
curvature 45º
Reduced FA in pts
between cerebellar
WM and thalamus
connections with
reduced anisotropy
in the region of the
sup cerebellar
peduncles projecting
towards red nucleus.
(Carpenter
et al., 2008)
Age range
18-78 sz
18-82 ctrls
76 / 77 3T multiple region brute-
force fibre tracking method
threshold for FA 0.1 &
angle change 45º
Decline in FA
correlated with
duration of illness in
genu & splenium of
corpus callosum but
not the pyramidal
tracts. Progressive
loss of WM integrity
in pts beyond that
accounted for by
ageing.
(Kubicki et
al., 2008)
Chronic
sz
32 / 42 1.5T Novel method for
computation of probabilistic
subdivision of the corpus
callosum into 4 segments
Decreased FA within
parts of corpus
callosum
interconnecting
frontal regions in sz.
No sig changes for
callosal fibres
interconnecting
parietal and temporo-
occipital regions.
(McIntosh
et al., 2008)
Sz, bp
and ctrl
groups
with 2 or
more
affected
family
members
25 / 40 /
49
1.5T Probabilistic
tractography for
segmentation of tract of
interest. TBSS used to
create reference tracts
typifying general trajectory
of fasciculus.
Reduced FA in the
uncinate fasciculus
and ant thalamic
radiation of sz and
bp as a feature
common to both
disorders
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(Kunimatsu
et al., 2008)
Male pts
with sz
19 / 20 1.5T Knowledge-based , 2
ROI method
Threshold of line-tracking
at FA > 0.18
Mean FA reduced &
apparent diffusion
coefficient increased
in sup occipitofrontal
fasciculus of pts
(Phillips et
al., 2009)
Sz 22 / 23 1.5T Fibre Assignment by
Continuous Tracking
algorithm used for MROI
approach. 3D tract
reconstruction with FA
threshold of 0.2 and turning
angle threshold of 41º
Reduced FA in
arcuate fascicule and
inf longitudinal
fasciculi in pts
(Fitzsimmo
ns et al.,
2009)
Male pts
with
chronic sz
36 / 35 1.5T Multiple ROI method
used with 5 ROIs identified
Bilateral decrease in
fornix FA in sz.
Higher fornix FA
correlated with visual
memory, verbal
memory, recall and
recognition in
controls.
(Gasparotti
et al.,
2009)
First
contact,
antipsych
otic drug-
naϊve sz 
21 / 21 1.5T ROIs placed on
splenium (40mm³) and
genu (30mm3) on
unregistered directionally
encoded colour maps.
FA lower in splenium
but not in genu of pts
more pronounced in
males
(Voineskos
et al.,
2009)
Sz 10 / 10 1.5T Whole brain
tractography using
deterministic (streamline)
approach with comparison
of clustering and MROI
approaches.
Excellent interrater
reliability of
clustering and MROI
methods,
quantitatively and
spatially.
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(Kito, Jung
&
Kobayashi,
2009)
Sz 20 / 20 1.5T Streamlines Tracking
Technique used with step
width 0.5mm, fiber
trajectories terminated
when FA < 0.25 or angle >
45º
Pts showed
reduction in cross-
sectional area of L
ant thalamic
peduncle, no
differences for mean
FA but increased
standard deviation of
FA.
(Takei,
Yamasue &
Osamu,
2009)
Sz in-pts
and out-
pts
31 / 31 1.5T A “seed” was defined
as the location for the
initiation of tracking
algorithm, which moved
0.66 mm along the principal
axis. The diffusion tensor at
the next location was
determined from adjacent
voxels by trilinear filtering,
and its principal axis was
subsequently estimated.
Tracking lines were
automatically traced in this
way and were propagated
in the antegrade and
retrograde directions until
FA fell below 0.18.
Bilaterally decreased
FA in the pregenual
CB and dorsal CB,
and a bilaterally
increased MD in the
dorsal CB of pts,
which showed
significant
correlations with a
longer color–word
incongruent and
neutral reaction time
in the Stroop task in
patients
(Oh et al.
2009)
Chronic
sz
18 / 21 1.5T LSDI Whole brain
seeding tractography
followed by multiple ROI
selection technique
Decreased FA and
increased MD in the
DLPFC projections,
decreased FA &
unchanged MD in
ACC projections,
increased MD &
unchanged FA
frontal pole,
orbitofrontal, inferior-
prefrontal projections
(Kanaan,
R.A. et al.,
2009)
Sz pts 33 / 33 1.5T Tractography to
dissect 4 WM cerebellar
tracts & measure FA and
mean diffusivity in these
ROIs
FA was lower in sz
group compared with
controls. MD did not
differ between
groups.
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(Savadjiev,
P. et al.,
2010)
Sz pts 23 / 20 3T Novel indices of
computed WM dispersion
and curving, a proof of
concept paper
SZ group having
higher index values
in the UF, and lower
values in the corona
radiate
(Voineskos
et al., 2010)
Younger
sz pts
< 56yrs &
older sz
pts
> 55yrs
(both grps
matched
with ctrls)
25 / 25 /
25 / 25
1.5T Whole brain
deterministic tractography
(Runge-Kutta order 2
tractography 0.5mm fixed
steps) with manual
extraction of specific tracts
of interest
L uncinate fasciculus
and R cingulum
bundle are disrupted
in younger chronic
patients with sz.
Older groups did not
differ
(Luck,
2010)
FE sz 32 / 25 1.5T, reconstruction of
fornices by Fiber
Assistance by Continuous
Tracking (FACT) Seeding
voxels with FA>0.15,
constraining angle <45º
Significant FA
reduction in the
fornix of patients
(Whitford,
2010)
Sz 19 / 19 3T, automated fiber
clustering parcelled into 6
segments, FA & mode
calculated for each
segment
Corpus callosum
showed a variety of
diffusion
abnormalities related
to psychotic
symptoms
(Pomarol-
Clotet et
al., 2010)
Sz 32 / 32 1.5T, 4 ROIs as seed
regions for optimized
tractography algorithm
(Tractography was one of
three imaging techniques
used in this study)
WM abnormalities
predominated in the
anterior corpus
callosum, implicating
fibres projecting to
the medial frontal
cortex with
convergent
abnormality in the
DLPFC.
There are still no standardized criteria for tractography studies and although
there is a wide degree of variation in methodology amongst the studies
reviewed in this chapter, the principal approaches are to measure FA in a
specific region or to measure mean FA along a continuous WM tract. FA in a
specific WM region can be measured by one of two approaches; entire WM
fibre bundles are parcellated out and the FA of WM fibre tracts passing
through at specific points is calculated or a specified ROI is drawn on a whole
brain volume and FA is measured at this site. Tractography is an extension of
the above technique and measures the degree of anisotropy between
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neighbouring voxels in order to predict position of a tract. This technique
relies on automated stepwise progression algorithms calculated by the
degree of angulation between neighbouring voxels and strength of
anisotropy. If there is a sharp turning angle or FA drops below a certain
threshold, it is anatomically unlikely that fibres would continue in that
particular direction and tracking is terminated but the threshold for turning
angles varied between studies, from 50º (Miyata et al., 2007) to 10º (Zhou et
al., 2008). Furthermore, consecutive fixed steps for track extension varied
between 1mm (Nestor et al., 2008) and 0.5mm (Voineskos et al., 2010), with
FA threshold varying between 0.26 (Magnotta et al., 2008) and 0.1
(Carpenter et al., 2008). Limitations of tractography arise when there are
areas of crossing fibres or a high degree of branching, which cannot be
effectively modelled using current techniques, leading to reduced confidence
in the results obtained.
3.4.2 Tract Based Spatial Statistics Studies in Schizophrenia
Tract Based Spatial Statistics (TBSS) builds on the concept of tractography
by comparing FA within a WM skeleton of the whole brain. The skeleton is
formed of the core of WM tracts, where there is much higher probability of
WM being present. There have been fewer studies using TBSS to investigate
schizophrenia as this method of investigating FA in WM tracts has only been
available since 2006 and was originally developed as a method of improved
registration to avoid distortion by better alignment of FA images from multiple
subjects (Smith et al., 2006).
The first TBSS study to be published in schizophrenia (Seal et al., 2007)
reported lower FA in the external capsule, internal capsule and thalamus of
patients with established schizophrenia compared to healthy controls. This
was accompanied by higher radial diffusivity in the external capsule with no
change in axial diffusivity. These components of diffusion can indicate
pathology, with increased radial diffusivity suggesting increased movement of
water in the horizontal direction as a result of more porous cell walls. There
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was however, no indication of the chronicity or severity of illness in patients
recruited to this study and subject numbers were small, with only 14 in each
group.
Karlsgodt and colleagues published two studies (2008, 2009) using TBSS in
a ROI study by using a mask for parcellating out the superior longitudinal
fasciculus (SLF) for further analysis after processing of the whole brain WM
skeleton was completed. In the first study, FA differences in 12 patients with
schizophrenia and 17 healthy controls were investigated and FA of the left
SLF correlated with verbal working memory as measured by the Modified
Sternberg Item Recognition Task (Karlsgodt et al., 2008). In the second
study, six ROIs had been defined apriori and these were parcellated out after
analysis was run on the whole brain WM skeleton of each subject. The
patient group consisted of 36 Ultra-High Risk for Psychosis (UHR) individuals
who were clinically followed up at 6 and 15 months compared with 25 healthy
controls. Main findings were a lower baseline FA in the UHR group in the
SLF, an increased hippocampal FA with age in healthy subjects and at 15
month follow-up, lower FA in the hippocampus and inferior longitudinal
fasciculus predicted decline in social function and a decrease in hippocampal
volume in the UHR group (Karlsgodt et al., 2009).
Miyata et al. (2009) combined a whole brain FA analysis using TBSS with
whole brain VBM analysis of grey matter, in a study which demonstrated
direct association between two regional areas of FA reduction and multiple
cortical and subcortical reductions in schizophrenia. However; it was difficult
to ascertain which tracts were responsible for decreased FA in each TBSS
cluster because of coarse DTI resolution.
A two part study by Camchong et al. (2009) used TBSS to investigate
differences in white matter FA between monozygotic twin pairs, unaffected
first-degree relatives of a schizophrenia cohort and healthy controls. FA
values were more strongly correlated between MZ twin pairs than between
randomly generated pairs in genu of corpus callosum, anterior cingulum and
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forceps minor. In unaffected relatives, reduced FA in medial frontal white
matter was demonstrated, suggesting that anatomical connectivity in medial
prefrontal cortex is significantly heritable within MZ twin pairs, an important
criterion in the development of an endophenotype. In addition, altered medial
frontal white matter integrity found in relatives of schizophrenia patients
suggests that reduced white matter integrity in medial frontal regions of the
brain might be associated with the genetic liability to schizophrenia. In
adolescent onset schizophrenia, which often follows a more severe course of
illness than adult onset schizophrenia, TBSS analysis has shown that white
matter FA increases around the time of illness onset but remains stable in
healthy adolescents (Douaud et al., 2009). This pattern of white matter
disease progression is clearly different from adults, which showed that white
matter FA is reduced or unchanged at first episode of psychosis in adult
onset schizophrenia.
3.5 Magnetisation Transfer Imaging Studies in schizophrenia
Few studies have used magnetization transfer imaging (MTI) to investigate
schizophrenia. MTI should be able to reveal more subtle effects of
schizophrenia on brain tissue, with MTI abnormalities explained by changes
to the neuropil which consist primarily of dendrites, axons and synapses
(Glantz and Lewis, 2000; Selemon and Goldman-Rakic, 1999). It is thought
that the magnetization saturation capacity of brain tissue decreases in
disease states, hence the magnetization transfer ratio (MTR) will decrease.
MTR is not a quantitative value and does not reflect the absolute degree of
saturation with a pulsed gradient in the tissue. A more detailed description of
the basic principles of MTI have already been described in chapter 2.
The first published findings of MTI in schizophrenia by Foong et al. (2000a),
reported reduced MTR in temporal lobe white matter of 25 chronic
schizophrenia patients, compared with 30 healthy controls. When this
analysis was repeated using whole brain VBM on the same group, MTR
reductions were found predominantly in the fronto-temporal regions of the
cortex extending into white matter only in the temporal lobes (Foong et al.,
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2001). In a study of 30 first episode psychosis patients and controls, a VBM
whole brain analysis showed reduced MTR bilaterally in the medial prefrontal
cortex, insula and white matter incorporating the uncinate fasciculus in the
patients in the absence of any volumetric differences between groups
(Bagary et al., 2003). An earlier study using the thalamus as a region of
interest revealed no volumetric or MTR differences between patients and
controls (Bagary et al., 2002).
A small study investigating the hippocampus as a ROI and consisting of 14
schizophrenia patients and 14 controls (Kiefer et al., 2004) found no group
differences in MTR or volume. Kubicki et al. (2005a) found widespread
reduction in MTR of the corpus callosum, fornix, right internal capsule, and
the superior occipito-frontal fasciculus bilaterally in a whole brain analysis of
21 patients with schizophrenia and 26 controls. Concurrent DTI scanning
revealed that FA was also reduced in some of these tracts, suggesting that
schizophrenia may cause abnormal coherence of fibre tracts and these
abnormalities may be attributed to coincide with myelin/axonal disruption.
Another study (Kalus et al., 2005) looked at the amygdala as a ROI and used
DTI and MTI in addition to volumetric MRI. Although no difference in
amygdala volumes were identified between 14 schizophrenia patients and
controls, diffusion anisotropy and quantitative MTI parameters were reduced
in the patient group although there was no significant difference in MTR
between groups.
Using a higher resolution 3T scanner to perform whole brain MTI, no
differences in MTR were found between 20 schizophrenia patients and 23
healthy controls (Anostik-Biernacka et al., 2006). Although there were trends
for reduced MTR in the left superior temporal gyrus, right occipital cortex, and
left periventricular white matter in patients, these were lost after correction for
multiple comparisons.
A more recent study compared whole brain MTR and volume in a VBM
analysis of 48 first episode psychosis patients and 47 healthy controls (Price
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et al., 2010). In patients, MTR was reduced in right entorhinal cortex,
fusiform, dentate and superior frontal gyri and in left superior frontal and
inferior/rostral cingulate gyri, with volumetric differences between groups in
fronto-temporal areas only. This suggests neuroaxonal and myelin changes
are more extensive in patients than can be detected using conventional
volumetric MRI.
Although findings from MTI studies of schizophrenia have varied, it appears
that investigations of smaller, well defined ROIs did not find differences
between patient and control groups, while studies comparing whole brain
volumes generally found reduced MTR in patients. As no longitudinal MTR
studies have been published, it is difficult to ascertain if MTR changes
indicative of neuropathology accumulate over time with disease progression.
3.6 Imaging studies linking bipolar affective disorder and
schizophrenia
Both bipolar affective disorder (BPAD) and schizophrenia have overlapping
psychopathology and it is increasingly apparent that they share common
genetic and neurochemical abnormalities (Lin and Mitchell, 2008). Some
imaging studies have directly compared these two conditions to seek
similarities in neuropathology which would support the hypothesis of
psychosis being on a continuum with affective disorder.
Patients with first episode psychosis showed differences in GM volume at
baseline and in their pattern of disease progression depending on whether
they were found to have schizophrenia or affective disorder at follow-up.
Initial differences and progressive changes in patients with affective disorder
were confined to the subgenual cingulate, whereas patients with
schizophrenia initially had widespread but progressively smaller volume
changes (Koo et al., 2008). Progressive GM loss has also been described in
the hippocampus, fusiform gyri and cerebellum of bipolar disorder patients in
a longitudinal study (Moorhead et al., 2007). Just as medication effects of
111
clozapine and risperidone have been linked with increased cortical GM
volume, patients treated with lithium have been shown to have increased GM
volume, compared to bipolar patients on valproate and unmedicated controls
who did not show GM volume changes over time (Lyoo et al., 2010). In a
similar manner to schizophrenia, reduction in temporal lobe GM of bipolar
patients correlated with intellectual function decline and number of relapses
(Moorhead et al., 2007), with duration of illness demonstrated as being
inversely correlated with total GM volume (Frey et al., 2008).
Decreased FA as a marker of compromised white matter integrity has been
described, with the distribution of affected white matter tracts in BPAD over-
lapping with those affected in schizophrenia. McIntosh and colleagues found
that both bipolar and schizophrenia patients showed reduced FA in the
uncinate fasciculus and anterior thalamic radiation in a whole brain VBM
study (McIntosh et al., 2008a). Meanwhile, a region of interest analysis
published several years earlier by the same group, found that both
schizophrenia and bipolar disorder patients had reduced white matter density
in the anterior limb of the internal capsule compared to their unaffected
relatives (McIntosh et al., 2005). In a longitudinal study comparing change in
bipolar and schizophrenia brain volumes, GM deficits were observed in
lateral and medial frontal regions and bilateral posterior temporal lobe
regions, with extensive losses over time in lateral fronto-temporal regions and
left anterior cingulate gyrus in patients with schizophrenia. GM deficit in
bipolar patients was however localized to bilateral inferior temporal gyri with
additional loss over time observed only in the anterior cingulate cortex
(Farrow et al., 2005). Therefore, GM volume differences probably predate the
onset of symptoms and neurodegenerative GM volume loss is diagnosis-
related. Research findings may be restricted because studies are diagnosis
orientated rather than covering the broader remit of psychosis, which would
include the affective disorders spectrum. Some structural differences include
more pronounced global and regional volumetric deficits in schizophrenia,
particularly in the thalamus, hippocampus, STG and volume increase in the
third ventricle (Emsell and McDonald, 2009).
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In a review of brain imaging studies in psychosis (Gur et al., 2007), the
authors observed that studies rarely provided direct comparisons between
different psychotic disorders using integrated investigation methods and
there is a need to implement sufficiently powered studies if psychosis is to
ever be deconstructed. With this in mind, future studies should be designed
to include patients with various diagnoses in order to compare psychosis as a
common symptom arising from different disease models.
3.7 Conclusions
The MRI studies reviewed in this chapter showed changes in brain volumes
in patients with varying illness duration at various stages of disease and
lend support to hypotheses of progressive neuropathology (Gur et al., 1998;
Lieberman et al., 2001; Mathalon et al., 2001). As Weinberger and McClure
(2002) commented, the 2% annual rate of GM volume loss and similarly the
ventricular enlargement rate of 13% per year as reported by the latter study,
is similar to the degree of change reported in Alzheimer’s Disease but post-
mortem brains of schizophrenia patients clearly do not show the same
gross neuropathology. With a model of cumulative loss you would expect no
brain tissue to be left in older schizophrenia patients if atrophy continued at
such an alarming rate. This would suggest that there is an initial insult in
early development that predisposes to schizophrenia but time of onset is
variable. In summary, the neuropathological changes evidenced in the
current literature include:
1. Ventricular enlargement
2. Cortical and deep GM volume loss
3. Loss of WM integrity
The longitudinal imaging studies that have been reviewed in this chapter
demonstrate that schizophrenia is not purely a neurodevelopmental disorder
but may be due to an accumulation of neuropathological changes. Similarly,
the evidence for neurodegeneration is limited and not supported by post-
mortem studies. More conceivable perhaps is a hypothesis of neurotoxicity,
which suggests that processing of stimuli is different in a brain affected by
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schizophrenia and due to cortical plasticity unique adaptations are made
dependent on environmental exposure. Neuropathological changes therefore
accumulate in a non-linear fashion and lead to variation between individuals.
This may also explain why imaging studies of schizophrenia have shown
such diverse findings and why the course of this disease is so
heterogeneous.
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4. METHODS AND STUDIES PERFORMED
4.1 Introduction
The five studies that comprise this thesis, investigate neurobiological
abnormalities in patients with first episode psychosis and schizophrenia
spectrum disorders. Using structural imaging techniques sensitive to subtle
neuropathological changes, magnetic resonance imaging (MRI),
magnetisation transfer imaging (MTI) and diffusion tensor imaging (DTI) were
used to investigate brain tissue compartments. Optical coherence
tomography (OCT) was used to study thickness of the unmyelinated retinal
nerve fibre layer (RNFL) and I also investigated hue discrimination ability in
schizophrenia as a possible screening tool for the disease. These findings
were correlated with clinical and cognitive parameters to examine their
possible utility in predicting severity of the condition and functional outcome.
Experiments were primarily designed to examine whether differences
between patient and control groups might provide evidence to support either
a neurodevelopmental or neurodegenerative explanation of schizophrenia. A
first episode psychosis patient cohort was used in a cross-sectional study to
look for the earliest signs of disease affecting white matter integrity which
might provide evidence of a neurodevelopmental abnormality affecting
myelination (chapter 5). A longitudinal study (chapter 7) was designed to
track patients from first episode of psychosis, to look for structural brain
changes occurring early on in the course of disease. It was predicted that
grey matter volume loss suggesting neurodegeneration might be seen over
time, whilst MTI would reflect more subtle structural changes occurring. The
cross sectional study of oculomotor function and grey matter volume (chapter
9) also utilised a first episode patient cohort to investigate whether grey
matter volume loss suggestive of neurodegeneration, has already occurred
early in the disease. In a cross-sectional study involving patients with
established schizophrenia or schizoaffective disorder (chapter 6), a novel
method of imaging in schizophrenia was used to measure RNFL thickness
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and neurodegeneration by directly visualising this structure. The cross-
sectional study on hue discrimination and cognition (chapter 8) was designed
to investigate the visual system at a functional level in patients with
established schizophrenia or schizoaffective disorder. Comorbid hue
discrimination and cognitive deficits in patients might suggest a
neurodevelopmental abnormality along a common pathway.
The remainder of this chapter details the patient and control samples
common to all studies and provides a hypothesis for the studies with a brief
introduction to the methods used, in addition to a short description of the five
studies I carried out. Each study is individually discussed in greater detail
within chapters 5 to 9.
4.2 Study Subjects
Patients were recruited from the West London Mental Health Trust and the
South West London and St George’s Mental Health Trust. Permission to
conduct all parts of the study were obtained from Merton, Sutton and
Wandsworth, Riverside and Ealing, and The National Hospital for Neurology
and Neurosurgery & Institute of Neurology Joint Research Ethics
Committees. Consultant psychiatrists in all local CMHTs were requested to
refer patients between the ages of 16 and 60 years of age, who were
presenting to psychiatric services for the first time with psychosis and
interested in research participation. Two clinical research nurses additionally
visited in-patient wards on a regular basis to identify potential patients for
inclusion to the study. All patients were recruited within 12 weeks of first
episode psychosis onset.
Patients in all of the studies discussed in my thesis formed part of the larger
West London First Episode Psychosis Longitudinal Study cohort. This cohort
consisted of over 200 first episode psychosis patients with baseline
structured clinical interview, neuropsychometry and oculomotor function
testing, follow-up of clinical outcomes and neuropsychometry were continued
over the next 5 year period. Studies have already been published from this
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dataset describing the cognitive trajectory (Leeson et al., 2011) and social
function outcomes (Barnes et al., 2008).
All subjects included in the studies described in my thesis had expressed an
interest in participating in the neuroimaging part of the study. I contacted
them by telephone to explain the scanning process and to discuss my study
before booking them an appointment at the UCL Institute of Neurology,
London. At the appointment, I explained the MRI process before taking
written informed consent for the study. In addition I carried out a safety
checklist screening tool, assessed handedness using the Annett scale
(Annett, 1970) and performed a routine clinical neurological examination. All
subjects were seen by me at both baseline and approximately 18 months
later at follow-up, when visual function testing and optical coherence
tomography (OCT) scanning were offered. Although there was some overlap
between patients and controls used for the different studies, all collected
material was from new data.
Controls from the West and South West London areas were recruited from a
variety of sources including via advertisements on a website
(www.gumtree.com), job centres, bus depots and a college of further
education, some control subjects also became involved in the study via word
of mouth. The main inclusion criteria were good physical and mental health;
all suitable controls were offered neuroimaging, neuropsychometry and
oculomotor function testing with repeat testing at follow-up after a mean of 18
months. Control participants were also offered visual function testing and
optical coherence tomography (OCT) scanning as part of the follow-up
appointment.
All participants had to meet the following exclusion criteria: previous head
injury resulting in loss of consciousness, previous episode of psychiatric
illness requiring treatment by a psychiatrist and drug or alcohol dependency.
All participants gave written, informed consent and received an honorarium.
117
4.3 Clinical Diagnosis
All prospective patients were interviewed by a qualified psychiatric, clinical
research nurse, trained in gathering information on medication, using a
battery of rating scales and finding out detailed information about each
patient’s course of illness at baseline and at follow-up. Eligible patients were
screened using the WHO Psychosis Screen (Jablensky et al., 1992) and
excluded if disease criteria for the schizophrenia spectrum were unmet.
Diagnosis was ascertained using a structured interview, the diagnostic
module of the Diagnostic Interview for Psychosis (DIP-DM) (Jablensky,
2000), including items from the Operational Criteria Checklist for Psychosis
(OPCRIT) (McGuffin et al., 1991) and the World Health Organization
Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (Wing et al.,
1990). A computerized algorithm generated diagnoses under DSM IIIR and
ICD 10 classification systems and the DSM IIIR diagnoses were
subsequently checked against DSM IV criteria by entering data into OPCRIT
for Windows (http://sgdp.iop.kcl.ac.uk/opcrit/). Patients were reviewed and
their case notes assessed by two experienced consultant psychiatrists at one
year after inclusion into the study to confirm the clinical diagnosis.
4.4 Symptom Ratings and Clinical Assessments
Symptoms experienced by patients were assessed using the Scales for
Assessment of Positive Symptoms (Andreasen, 1983) and Negative
Symptoms (Andreasen, 1981), a clinician administered tool which consists of
a semi-structured interview. Affective symptoms were measured with the
Hamilton depression rating scale (HamD), an administered questionnaire
consisting of 21 items, with a closed rating score of 1 to 5 for each item
(Hamilton, 1960) and the Young Mania Rating Scale (Young et al., 1978), an
11 item questionnaire with a similar closed scoring system. Age of onset,
duration of untreated psychosis and duration of illness were established
using the Symptom Onset in Schizophrenia Inventory (Perkins et al., 2000).
Handedness was assessed using the Annett scale (Annett, 1970) and criteria
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for substance abuse and dependence established, using the Alcohol and
Drug Use Scales (Drake et al., 1990).
4.5 Magnetic Resonance Imaging
In brief, all study participants underwent a series of magnetic resonance
imaging (MRI) brain scans following completion of a standard MRI safety
checklist. Volumetric MRI, magnetization transfer imaging (MTI) and diffusion
tensor imaging (DTI) data were collected at baseline using a 1.5 Tesler
scanner (GE, Milwaukee). The scanning process lasted approximately 60
minutes, with a short break while the head coil was changed over for the DTI
sequence and pulsed cardiac gating applied. At the follow-up appointment
approximately 18 months later, scanning sequences were repeated with
exception of the DTI, in order to reduce the scanning time. Detailed MRI
methodology and statistical analysis of the data obtained are described in the
following chapters.
4.6 Neuropsychometry
A large, neuropsychometric test battery was administered to all participants
at baseline, one year and three year follow-up by the research psychologists.
Data relevant to studies described in later chapters of this thesis included
measures of current and premorbid IQ, working memory, verbal learning and
processing speed. Correlations between cognitive function and brain
structure were sought.
Current full scale IQ was measured using the Weschler Adult Intelligence
Scale (WAIS) composed of 14 sub-units, of which there are 7 performance
IQ and 7 verbal IQ measures (Wechsler, 1997). An abbreviated form of the
WAIS- III comprising subtests of information, arithmetic, block design and
digit symbol has been validated for use in schizophrenia (Blyler et al., 2000)
and was used in this study.
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Estimated premorbid IQ was obtained using the National Adult Reading
Test (NART), a reading list of 50 irregularly spelt words in the English
language, with accuracy of pronunciation scored to give an estimate of
premorbid IQ in native English speakers (Nelson and Willison, 1991).
Spatial working memory was measured using the computerised Cambridge
Neuropsychological Test Automated Batteries (CANTAB), with subjects
required to find a token by searching only once in each of a number of boxes
without returning to the same box (Fray et al., 1996). Total errors were used
as an index of working memory manipulation.
Verbal learning was measured using the Rey Auditory Verbal Learning Task
(Rey, 1964), which required 15 nouns to be read aloud in five consecutive
recall trials, an interference list was then presented and effects on immediate
recall measured. A score was derived from the maximum number of words
recalled from the list in the best of five trials.
Processing speed was measured using the digit symbol subtest of the
WAIS. In this pen and paper task, participants were required to match as
many digit-symbol pairs as possible within 90 seconds.
4.7 Visual Function Testing and Optical Coherence
Tomography (OCT)
The visual testing battery consisted of measurements of visual acuity, visual
fields, colour hue discrimination and optical coherence tomography (OCT).
All tests were performed on both right and left eyes.
 Visual acuity testing required subjects to sit at a distance of 4m from
a light box and read aloud progressively smaller and fainter letters
from Sloan letter charts to measure contrast visual acuity.
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 Visual field testing was performed using the automated Humphrey
field analyzer HFA 2i, (Carl Zeiss, Meditec Inc. USA).
 Colour vision was assessed using the Farnsworth-Munsell 100 Hue
test.
 OCT scanning was carried out by a neurologist trained to use the
Stratus OCT3, (Carl Zeiss, Meditec Inc. USA) to measure retinal nerve
fibre layer (RNFL) thickness and macula volume in both eyes.
4.8 Oculomotor Function
A more detailed description of the collection and analysis of oculomotor
function is provided in chapter 6. In brief, eye tracking data were collected at
baseline by a research psychologist trained in measuring eye movements
with an Eyelink I eye tracker (SR-Research, Osgoode, Ontario). The right eye
was sampled at 250Hz in all subjects.
4.9 Description of the Five Studies in this Thesis
1. Diffusion Tensor Imaging and Cognitive Correlations
This study examined differences in white matter (WM) tract integrity by using
DTI to measure fractional anisotropy (FA) in first episode psychosis patients
and matched healthy controls. A comparison of between-group FA was made
using tract based spatial statistics (TBSS). Cognitive performance measures
were compared between groups and their correlations with WM FA were
investigated. The hypothesis that first episode schizophrenia patients have a
lower FA than controls and worse cognitive performance in patients would be
correlated to lower FA was tested.
2. Imaging of the Retinal Nerve Fibre Layer Thickness
This study investigated axonal integrity in schizophrenia using optical
coherence tomography (OCT) to measure retinal nerve fibre layer (RNFL)
thickness. Comparisons were made between patients with established
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diagnoses of schizophrenia or schizoaffective disorder and healthy controls.
The hypothesis that patients have a thinner RNFL than healthy controls due
to disrupted axonal structure was tested.
3. A Follow-up Imaging Study Using MRI and MTI
Structural changes were investigated in this longitudinal imaging study, with
patients recruited at first episode of psychosis and matched to a healthy
control group. MRI and MTI were carried out at baseline and a mean of 18
months later. Changes in GM, WM and CSF volume were sought, in addition
to GM and WM MTR changes. Changes in cognitive performance measures
over this time frame were also investigated and correlated with imaging
variables. The hypothesis was tested that in schizophrenia patients, GM
volume loss would be accompanied by CSF volume increase, while GM and
WM MTR would become increased over time.
4. Colour Hue Discrimination
The Farnsworth Munsell 100 Hue Colour Test was used to compare colour
hue discrimination ability between patients with schizophrenia and healthy
controls. The hypothesis that patients would perform worse than controls in
colour hue discrimination was tested and correlations with measures of
cognitive function were sought.
5. Oculomotor Function and Correlations with Grey Matter Volume
Oculomotor function was measured using an infra-red eye tracking device to
look at smooth pursuit, antisaccade error rate and prosaccade latency. GM
volume was measured using voxel-based morphometry in a first episode
schizophrenia cohort and associations with oculomotor function measured.
The hypothesis that oculomotor function is impaired in first episode
schizophrenia and associated with reduced GM volume was tested.
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5. AN INVESTIGATION OF WHITE MATTER TRACT
INTEGRITY AND COGNITIVE CORRELATIONS USING TRACT
BASED SPATIAL STATISTICS
5.1 Introduction
The notion that schizophrenia may be due to “anatomical disruption of
association fibre tracts” was initially suggested by Carl Wernicke. This
hypothesis has since been reiterated with a biological model of schizophrenia
describing a syndrome of disconnectivity, affecting white matter connections
between cerebral cortical areas (Friston and Frith, 1995).
Neurological diseases that typically affect white matter development, appear
to be associated with higher rates of schizophrenia-like psychosis, including
metachromatic leukodystrophy (Merriam and Hegarty, 1993) and Niemann-
Pick disease (Josephs et al., 2003) where psychosis occurs in 25 to 40% of
cases. By contrast, multiple sclerosis is a disease of demyelination (where
normally formed myelin is lost) and rates of psychosis are much lower, only
occurring in up to 5% of cases (Feinstein et al., 1992). A review by
Walterfang et al. (2005) concluded that diseases disrupting myelin formation
appeared to be associated with higher risk of developing psychosis
compared to diseases disrupting mature myelinated structures. Additionally,
diffuse rather than discrete lesions affecting fronto-temporal areas, were
more strongly associated with schizophrenia-like psychosis.
Imaging studies have consistently reported reduced cortical grey matter
volume in patients with schizophrenia (Hazlett et al., 2008; Hulshoff Pol et al.,
2002; van Haren et al., 2007) but white matter volume loss appears to be
more subtle and has been less frequently reported (Bose et al., 2009;
Okugawa et al., 2002; Price et al., 2006). There is certainly a lack of
evidence for gross neurodegeneration from neuropathology studies
(Weinberger and McClure, 2002). Gene expression studies investigating the
dorsolateral prefrontal cortex (DLPFC) in schizophrenia describe a significant
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decrease in the expression of myelin-related genes in oligodendrocytes,
which supports the hypothesis for an underlying pathology of myelination
occurring in schizophrenia (Hakak et al., 2001).
Diffusion tensor imaging (DTI) reflects tissue integrity and microstructure by
quantifying the diffusion of water in a scalar value known as fractional
anisotropy (FA) (Basser and Jones, 2002). Reduced FA reflects the degree
of disruption of white matter integrity. If barriers to water molecules diffusing
between parallel axons in white matter tracts are decreased as a result of
pathology, FA decreases as the water molecules are less restricted and can
move more freely in a perpendicular plane. (A detailed explanation of FA has
been provided in chapter 2, section 2.5). With DTI data, maps can be
constructed to reveal white matter FA of the whole brain and allows
voxelwise comparisons of FA to be made between subjects. In
schizophrenia, reduced FA has been reported even in the absence of any
volume decrease (Lim et al., 1999); this is now a well-replicated finding
(Kubicki et al., 2005a; Kubicki et al., 2007; Minami et al., 2003; Okugawa et
al., 2005; Wang et al., 2003) and suggests that the neuropathology of
schizophrenia may lie in a disorder of the myelin sheath.
DTI data can be analysed using tractography, which allows three dimensional
reconstruction of white matter tracts by estimating the orientation of greatest
diffusion between neighbouring voxels and predicting pathways between two
or more seed points. Although not always anatomically correct, the most
likely path of white matter tracts can be mapped using this method.
Tractography appears to have greater sensitivity for detecting reduced FA in
the corpus callosum compared to conventional FA mapping in the same
region of interest (ROI), in schizophrenia (Kanaan et al., 2006). A
tractography study of first episode psychosis (Price et al., 2007), described
reduced FA in the genu and splenium of the corpus callosum, some of those
study subjects overlap with the cohort described in this chapter.
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When an apriori hypothesis is present, a specific region-of-interest can be
investigated but problems arise with placement of seed points along with
issues relating to the size, shape and number of ROIs selected (Kanaan et
al., 2005). In schizophrenia there is diffuse and subtle white matter
pathology, hence a global searching strategy using voxel-based approaches
applied to DTI may be more appropriate. Tract Based Spatial Statistics
(TBSS) (Smith et al., 2006) allows a fully automated comparison across
whole brain white matter tracts in contrast to investigation of isolated tract
reconstruction which is much slower and can be subject to operator error.
TBSS registers all scans to a non-linear model to correct misinterpretation of
residual alignments. A skeleton map consisting of the core of all white matter
tracts is obtained; against which the study group’s FA data are projected, the
resulting “mean FA skeleton” is then subjected to voxel-wise cross-subject
comparison.
TBSS has been used to investigate white matter pathology in neurological
conditions such as motor neurone disease (Ciccarelli et al., 2009) and can
identify localized abnormalities in preterm infants, even in the absence of
focal lesions detectable using conventional MRI (Anjari et al., 2007). In
schizophrenia, reduced white matter FA has been consistently reported by
studies employing various techniques to analyse DTI data as described in
reviews by Kanaan et al. (2005) and Kubicki et al. (2007). TBSS has already
been used to demonstrate widespread WM FA reductions in chronic
schizophrenia, particularly in fronto-temporal areas (Seal et al., 2007).
Severe microstructural deficits in childhood onset schizophrenia have also
been described, using TBSS to evidence reduced FA in multiple areas,
including corticospinal/corticopontine tracts, superior thalamic radiations, left
optic radiation, arcuate fasciculus, corpus callosum and brainstem (Douaud
et al., 2007).
At onset of schizophrenia cognitive heterogeneity is reported, with a high
proportion of patients already having undergone general cognitive decline
(Joyce et al., 2005). Patients with established schizophrenia and cognitive
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deficits have reduced white matter volume and larger lateral ventricles
(Wexler et al., 2009). One DTI study (Lim et al., 2006) reported an
association between higher FA and better verbal memory, attention and
executive function in task relevant regions. Using TBSS in a ROI analysis, a
positive correlation between working memory and FA in the left superior
longitudinal fasciculus was reported (Karlsgodt et al., 2008). It would
therefore appear reasonable to surmise that WM microstructural changes
may be reflected by the cognitive deficits commonly seen in schizophrenia.
White matter maturation is the final stage of neurodevelopment and
continues well into the third decade, WM tissue might therefore be more
vulnerable in a psychotic illness where onset typically occurs in early
adulthood. If TBSS was able to demonstrate subtle differences in WM
between first episode psychosis (FE) patients and healthy controls, this
would provide evidence of disruption in the final stage of neurodevelopment
and loss of WM integrity occurring early in the course of illness. Objectives of
this study were primarily to compare FA differences in white matter tracts of
FE patients and healthy controls. Secondly, cognitive performance
(processing speed, verbal learning, spatial working memory, current and
premorbid IQ) and their associations with white matter FA were sought. It
was therefore hypothesised that:
1. FE patients would have lower FA compared to controls.
2. FE patients would perform worse than controls on cognitive
measures which would correlate with reduced FA.
5.2 Methods
5.2.1 Subjects
All patients recruited to this study formed part of the West London First
Episode Psychosis Study cohort as described in chapter 4.
Thirty-two, right-handed FE patients (25 males, 7 females) and mean age
28.3 (range 16-49) years, participated in this study. Neuroimaging was
performed within 12 weeks of first presentation to psychiatric services,
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average duration of treatment with medication at time of imaging was 13
(range 0-27) weeks; with some patients prescribed medication by their
primary care physicians prior to psychiatric referral. 26 patients were
diagnosed with schizophrenia (SZ), 5 schizoaffective (SA) and 1
schizophreniform (SF) disorder. Diagnoses were subsequently confirmed 1
year later by patient interview and review of clinical notes by two consultant
psychiatrists. The study was naturalistic with no restrictions on prescribed
medication; at the time of scanning 31 patients had been prescribed second
generation antipsychotics, 8 were additionally prescribed antidepressants
and 1 a mood stabiliser.
Thirty-two, right-handed healthy subjects (17 males and 15 females), mean
age 24.8 (range 16-35) years, were recruited as controls. Those with a
previous psychiatric history or family history of psychiatric illness in first-
degree relatives were excluded.
Exclusion criteria for all subjects were: a) history of neurological disease, b)
previous head injury with loss of consciousness and c) a history of drug or
alcohol dependence. This study was approved by the local Ethics
Committees. All participants gave written informed consent obtained
according to the Declaration of Helsinki and received an honorarium.
5.2.2 Clinical Assessment
In patients; positive, negative and disorganisation syndrome scores were
calculated using the SAPS and SANS assessment tools (Andreasen, 1981;
Andreasen, 1983). Inter-rater agreement (linearly weighted kappa) was
assessed using a standard set of videotaped interviews. Using global
subscale items, linearly weighted kappas of 0.76 for SAPS and 0.74 for
SANS were achieved (Andreasen, 1990). Factor scores for positive, negative
and disorganization symptoms were derived from these results.
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5.2.3 Cognitive Assessment
Premorbid IQ was estimated using the Revised National Adult Reading Test
(NART) (Nelson and Willison, 1991), shown to be valid in schizophrenia
(Crawford et al., 1992; O'Carroll et al., 1992). Current IQ was measured
using a short form of the WAIS III (Wechsler, 1997) validated for use in
schizophrenia (Blyler et al., 2000), comprising of the Information, Arithmetic,
Block Design and Digit Symbol subtests. The scaled digit symbol test scores
were analyzed independently as a measure of information processing speed.
In this pen and paper task, participants have to match as many digit-symbol
pairs as possible within 90 seconds. A measure of working memory
manipulation was obtained by the spatial working memory task (SWM) from
the computerized CANTAB battery (Sahakian and Owen, 1992). This is a
self-ordered search task measuring the ability to remember the location of
previously found ‘tokens’ while searching for new tokens. An error occurs
when a participant returns to the location where a token has already been
found. The total errors score was used as an index of working memory
manipulation. Verbal memory was assessed using the Rey Auditory Verbal
Learning Test (RAVLT) (Lezak, 1995), a score was derived from the
maximum number of words recalled from a list of 15 nouns in the best of five
trials.
5.2.4 Magnetic Resonance Imaging Data Acquisition
MRI imaging was performed on a GE Signa 1.5T MRI scanner (General
Electric, Milwaukee, WI, USA). Diffusion tensor imaging (DTI) for each
subject was acquired with an 8-channel RF head coil and a single-shot echo
planar imaging sequence. (TE=81.3ms, matrix=96x96, FoV=220x220mm,
60x2.3mm contiguous slices). Diffusion sensitizing gradients (b=1200s/mm-2)
were applied in 61 non-collinear directions (Cook et al., 2006), and seven
images were acquired with no diffusion-weighting. Images were interpolated
to a 128x128 matrix during reconstruction, yielding a final in-plane resolution
of 1.72mm. To improve data quality, the acquisition was cardiac gated by
pulse oximetry and head motion minimized with foam padding.
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5.2.5 Image Processing
The diffusion weighted volumes were spatially aligned with a 12 parameter
model to correct for subject motion and eddy current effects (Jenkinson et al.,
2002). The diffusion tensors (Basser and Jones, 2002) were estimated using
‘robust estimation of tensors by outlier rejection’ (RESTORE) (Chang et al.,
2005), which includes an algorithm for outlier rejection and is implemented in
the Camino software package www.cs.ucl.ac.uk/research/medic/camino
(Cook et al., 2006). Subjects whose images contained excessive motion or
spike artifacts were rejected from the study; a rejection criterion of 5 or more
artifacts per slice (>6.7%) was chosen in keeping with published reports
(Chang et al., 2005). Spike artifacts were manually labeled as outliers to
assist the RESTORE algorithm (Jackson et al., 2008). FA maps (Pierpaoli
and Basser, 1996) were computed from the diffusion tensor using Camino.
FA maps were prepared for voxel-wise statistical analysis following the tract-
based spatial statistics (TBSS) methodology (Smith et al., 2006) as described
on the TBSS home page (www.fmrib.ox.ac.uk/fsl/tbss/index.html), using
version 4.0.2 of the FSL software (www.fmrib.ox.ac.uk/fsl/). 1) Skull-stripped
FA maps of all subjects were aligned to a template image using nonlinear
registration (Rueckert 1999, www.doc.ic.ac.uk/~dr/software). 2) The aligned
images were averaged and thinned to yield a group ‘mean FA skeleton’, then
further thresholded at an FA value of 0.2 to represent the core of all white
matter tracts common to the group. 3) Voxel values of each subject’s FA map
were projected onto the skeleton by searching for the local maxima along the
perpendicular direction of the skeleton. 4) Voxel-wise statistical analysis was
performed across the entire skeleton (see below). 5) White matter clusters of
interest were anatomically located by overlaying the JHU (John Hopkins
University) DTI-based white-matter atlas (http://cmrm.med.jhmi.edu)
contained within the TBSS program.
5.2.6 Statistical Analysis
Chi-squared and independent samples t-tests were used to compare age,
gender, cognitive measures and clinical ratings in patient and control groups.
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Using the Randomise tool (www.fmrib.ox.ac.uk/fsl/randomise/index.html), a
general linear model was applied to compute voxel-wise statistics and
significant FA differences between patient and control groups were sought.
Confound regressors of age and gender, were included in all analyses. The
general linear model was also used to explore associations in regional FA
variation and cognitive measures between groups. The resulting t-statistic
maps were thresholded at t=3, with a cluster-wise significance level of p<0.05
as recommended on the TBSS homepage
(www.fmrib.ox.ac.uk/fsl/tbss/index.html) and corrected at cluster level for
multiple comparisons using permutation-based nonparametric inference
(Hayasaka and Nichols, 2003).
5.3 Results
Patient and control groups were matched for age (t= -1.31, p=0.20) and
gender (χ²=3.39, p=0.07). Mean duration of untreated psychosis was 11.3 
(sd 17.5) weeks but total duration of illness was an average of 30 (sd 39.3)
weeks. Positive symptoms 0.67 (sd 0.26) were more prominent than negative
0.29 (sd 0.24) or disorganized symptoms 0.26 (sd 0.22).
5.3.1 Cognitive Measures
Cognitive data were available for 22 SZ patients, 4 SZ patients did not
complete the test battery. SZ patients and controls had similar estimated
premorbid IQ but SZ patients performed significantly worse in tasks
measuring current IQ, processing speed, working memory and verbal
learning (table 5.1).
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SZ (n=22) Ctrl (n=32) Comparison
Estimated premorbid IQ 100.3 (11.7) 105.7 (11.9) t=1.85, df=62,
p=0.07
Current IQ 94.8 (19.6) 110.6 (15.1) t=3.62, df=62,
p=0.001
Processing speed 6.4 (2.8) 10.2 (2.9) t=5.31, df=62,
p<0.001
Working memory 32.8 (15.2) 15.3 (16.1) t=-4.47, df=62,
p<0.001
Verbal learning 10.3 (2.1) 12.7 (2.2) t=4.55, df=62
p<0.001
Table 5.1 Table of Cognitive Measures Comparing Schizophrenia
Patients and Controls
Results displayed = mean (sd)
5.3.2 Mean FA differences
FE patients had significantly lower FA than controls. A lower FA was also
seen in SZ patients but not in SA/SF patients compared to controls but as
there were only 6 SA/SF subjects, no further analyses were run on this
subgroup (table 5.2).
Groups Mean FA (sd) FA difference between pt and
ctrls (95% CI)
FE patients (n=32) 5749.0 (374.7) 272.9 (84.7- 461.1); p<0.001
SZ (n=26) 5703.2 (373.1) 318.70 (119.8 – 517.6); p=0.02
SA/SF (n=6) 5947.4 (341.4) 74.53 (-262.6 – 411.6); p=0.64
Controls (n=32) 6021.93 (378.55)
Table 5.2 Comparison of FA in Patients & Controls
Using TBSS, specific regions of reduced FA were identified corresponding to
the right (t>3, p=0.04) and left (t>3, p=0.03) posterior thalamic radiations in
FE patients (fig 5.1). When the TBSS analysis was repeated excluding the
SA/SF patients, no regional FA differences were identified between SZ
patients and controls.
Figure
First Episode Psychosis
(A=anterior, P=posterior, R=right, L=left, S=superior, I=inferior)
5.3.3
W
positive correlation between mean FA and estimated premorbid IQ (
df 55, p=0.04) but no significant correlation between mean FA and current IQ
(r
learning (
When SZ patients and controls were considered together, no correlations
were found between mean FA and cognitive measures of estimated
premorbid IQ (r=
hen FE patien
<-0.01, df 55, p=0.09), working memory (
5.
Cognitive measures and FA correlations
1 Regions of Posterior Thalamic Radiation with Reduced FA
r=0.06, df 55, p=0.68) or processing speed (
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working memory (r=0.24, df 50, p=0.09), verbal learning (r=-0.11, df 50,
p=0.43) or processing speed (r=-0.18, df 50, p=0.20).
Correlations between cognitive measures and mean FA in patients, showed
premorbid IQ correlated with mean FA in FE patients (table 5.3). Mean FA in
the SZ subgroup did not correlate with any cognitive measures.
FE (r, df, p) SZ (r, df, p)
Premorbid IQ 0.44, 24, 0.02 0.36, 18, 0.12
Current IQ -0.19, 24, 0.36 0.18, 18, 0.44
Processing speed 0.13, 24, 0.54 0.49, 18, 0.84
Working memory -0.63, 24, 0.76 0.04, 18, 0.88
Verbal learning 0.04, 24, 0.84 -0.03, 18, 0.91
Table 5.3 Correlations Between Mean FA & Cognitive
Performance in Patients
FE=first episode, SZ=schizophrenia: results displayed=r, df, p value
Using TBSS, regional FA values did not correlate with cognitive measures of
premorbid IQ (t>3, p=0.75), current IQ (t>3, p=0.79), WM (t>3, p=0.93),
verbal learning (t>3, p=0.61) or processing speed (t>3, p=0.75) across both
patient and control groups combined. Comparison between controls and FE
patients showed group differences at a trend level (t>3, p=0.06), in the
strength of association between FA and processing speed (fig 5.2) in an area
of the left superior longitudinal fasciculus (SLF). No differences were seen
between controls and FE patients for premorbid IQ (t>3, p=0.42), current IQ
(t>3, p=0.79), working memory (t>3, p=0.49) or verbal learning (t>3, p=0.69).
When TBSS analysis was repeated excluding SA/SF patients, a significant
difference between SZ patients and controls was seen in the strength of
association between FA and processing speed (fig 5.3) in the left SLF (t>3,
p=0.04) and right posterior thalamic radiation (PTR) (t>3, p=0.03). No
significant group differences were found in the strength of association
between FA and estimated premorbid IQ (t>3, p=0.91), current IQ (t>3,
p=0.42), working memory (t>3, p=0.87) or verbal learning (t>3, p=0.27).
Figure
with Processing Speed
(A=anterior, P=posterior, R=right, L=left, S=superior, I=inferior)
5.2 FA in the Left Superior Longitudinal Fasciculus is Associated
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Figure
with Processing Speed
(A=anterior, P=posterior, R=right, L=left, S=superior, I=inferior)
5.3.4
To further investigate the regional FA differences associated with processing
speed, a white matter mask of the 4 regions of interest (ROIs) were taken
from the JHU atlas and used to extract mean FA values from the SLF and TR
bilaterally in each subject.
5.
Post hoc analysis
3 FA in the Right Posterior Thalamic Radiation is Associated
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SLF FA mean (sd) PTR FA mean (sd)
Diagnosis Left Right Left Right
Controls
n=32
4780.24
(270.49)
4820.25
(270.72)
4909.18
(380.86)
5537.33
(467.30)
Schizophrenia
n=26
5737.00
(504.79)
4839.47
(257.60)
5040.24
(438.79)
5504.43
(447.27)
Table 5.4 Comparison of FA in Patients and Controls from Regions of
Interest in Superior Longitudinal Fasciculi & Posterior Thalamic
Radiations
SLF=superior longitudinal fasciculus, PTR=posterior thalamic radiation
FA in the left SLF of SZ patients was higher than that of controls (t=-8.12,
df=-0.26, p<0.001) while FA in the right SLF and bilateral PTR were similar.
FA values obtained from the 4 ROIs of each participant were correlated with
WAIS digit-symbol scores (as a measure of processing speed), while
controlling for effects of age and gender. Processing speed and FA in the 4
ROIs were confirmed as normally distributed using the Kolmogorov-Smirnov
test.
In controls, a positive correlation was found between FA in the right SLF and
processing speed (r=0.37, p=0.04), suggesting faster processing speed
corresponds to higher FA values. Correlations between FA and processing
speed were seen at a trend level of significance in the left SLF (r=0.34,
p=0.06) and right PTR (r=0.32, p=0.08).
In FE patients, there was a significant correlation between FA and working
memory in the right SLF (table 5.5).
In SZ patients, a significant correlation was found between working memory
and FA in the right SLF, suggesting that worse performance in the working
memory task corresponded with lower FA. No other correlations were
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observed between regional FA and cognitive measures in SZ patients (table
5.6).
SLF PTR
Cognitive variable Left Right Left Right
Premorbid IQ 0.34, 0.09 0.22, 0.28 0.08, 0.70 0.11, 0.58
Current IQ 0.03, 0.87 0.19, 0.38 -0.01, 0.95 0.04, 0.83
Processing speed 0.29, 0.16 0.17, 0.41 0.12, 0.55 0.08, 0.71
Working memory 0.10, 0.64 -0.40. 0.04 0.12, 0.57 -0.06, 0.79
Verbal learning -0.04, 0.85 -0.10, 0.61 0.06, 0.79 0.23, 0.25
Table 5.5 Correlations Between Cognitive Performance & FA in Four
Regions of Interest in First Episode Patients
SLF=superior longitudinal fasciculus, PTR=posterior thalamic radius
Correlation co-efficient and p-values are shown, df=24
SLF PTR
Cognitive variable Left Right Left Right
Premorbid IQ 0.33, 0.16 0.35, 0.14 0.04, 0.85 0.03, 0.89
Current IQ 0.07, 0.75 0.22, 0.35 -0.05, 0.84 0.02, 0.94
Processing speed -0.14, 0.55 -0.07, 0.75 0.20, 0.41 0.24, 0.31
Working memory -0.13, 0.60 -0.52, 0.02 0.11, 0.65 -0.06, 0.79
Verbal learning -0.03, 0.92 0.29, 0.21 0.07, 0.79 0.21, 0.37
Table 5.6 Correlations Between Cognitive Performance & FA in Four
Regions of Interest in Schizophrenia Patients
SLF=superior longitudinal fasciculus, PTR=posterior thalamic radius
Correlation co-efficient and p-values are shown, df=18
5.4 Discussion
Results of this study appear to support the hypothesis that FE patients have
reduced white matter FA compared to healthy controls. Mean FA values
(obtained as an average of all white matter tracts) were lower in both FE and
SZ patients compared to controls; however, regional FA comparison using
TBSS, identified bilateral areas of the PTR as having reduced FA in FE
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patients only but not in the SZ subgroup. This may have been due to the
smaller SZ patient group size having a weaker effect, therefore resulting in
loss of what was already a subtle group effect. Other studies using TBSS to
investigate FA in first episode schizophrenia have reported equivocal results.
Lee and colleagues reported neither mean nor regional FA differences in
patients compared to controls (Lee et al., 2012), while others have reported
regional but not mean FA reduction (Chan et al., 2010;Tang et al., 2010) in
FE patients.
The second hypothesis was partially supported by results of this study. As
predicted SZ patients performed worse than controls on cognitive measures
of current IQ, processing speed, working memory and verbal learning.
Premorbid IQ estimates were similar in both groups indicating that cognitive
decline had occurred following disease onset. Mean FA across all subjects
correlated with premorbid IQ but not with current IQ, working memory,
processing speed or verbal learning. When correlating regional FA
differences, a trend for association was seen between processing speed and
FA in FE patients. In SZ patients, FA in areas of the left SLF and right PTR
correlated with processing speed.
When comparing mean FA, both FE and SZ patients had lower FA than
healthy, matched controls. Using TBSS to investigate regional FA variation,
reduced FA in FE patients was identified in an area of the occipital lobe
where the PTR contributes most out of the multiple white matter tracts
(including the inferior longitudinal fasciculus, posterior thalamic tract, fronto-
occipital tract and optic radiations) that converge in this area.
In the post hoc analysis where FA values from 4 ROIs of SZ patients and
controls were compared, FA was similar in the right SLF and PTR bilaterally;
however FA values were higher in the left SLF of SZ patients than controls,
this was an unexpected finding. Although tissue damage typically results in
decreased FA, an apparent increase may occur where there is loss of tissue
in one of the tracts intersecting a junction (Pierpaoli et al., 2001).
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Paradoxically, increased FA is reflective of acute injury and is seen in axonal
cytotoxic oedema (Chu et al., 2010); at an early stage of disease such as first
episode schizophrenia, increased FA could indicate acute neuropathology.
Studies of cognitive function in schizophrenia tend to focus on fronto-
temporal specific tasks in domains such as working memory, executive
function and verbal fluency; however, no fronto-temporal areas of FA
variation were identified in this study. The functional significance of FA
measures have been demonstrated with verbal memory deficits in the
uncinate fasciculus and executive function in the cingulate (Nestor et al.,
2004), IQ, executive performance, verbal and visual memory (Kubicki et al.,
2002). Karlsgodt et al. (2008) identified that aberrant fronto-parietal
connectivity is implicated in first onset schizophrenia and worse verbal
working memory is reflected by reduced FA in the SLF. In the current study,
the SLF was also implicated but found to be associated with processing
speed rather than verbal learning. Some higher cognitive tasks are speed
dependent e.g. digit-symbol substitution task and multiple cognitive
operations may be employed in any one task alone. The digit-symbol
substitution task, (a measure of processing speed) is sensitive to various
neuropsychiatric conditions (including schizophrenia) and highly correlated to
overall cognitive performance (Dickinson et al., 2007); which may explain
why processing speed correlated with regional FA variation in this study.
Across both FE patients and controls, mean FA showed a positive correlation
with estimated premorbid IQ, so subjects with higher FA values had a higher
premorbid IQ. When the group was reduced to SZ patients only, no
correlation was identified, which suggests that the effect was too weak to be
observed in a smaller group with fewer subjects.
In summary, mean FA is reduced in FE patients compared to healthy
controls. Using TBSS to identify regional FA variation, a small area of the
PTR in FE patients showed a lower FA than controls. FE patients performed
worse than controls in cognitive tasks measuring current IQ, working
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memory, processing speed and verbal learning; however, only processing
speed and working memory correlated with FA. In controls and FE patients
there was a trend for correlation between processing speed and FA in a
small area of the left SLF. In controls and SZ patients, an association
between processing speed and FA was identified in the left SLF and right
PTR.
The current study provides evidence of disruption to white matter integrity in
FE psychosis. This would support a neurodevelopmental explanation for
schizophrenia and suggest problems with myelination are occurring early on
in the illness. DTI studies concentrating on patients with established
diagnoses of schizophrenia and schizoaffective disorder typically
demonstrate more widespread FA changes. Although this is suggestive of
progressive change in white matter microstructure, this can only be reliably
determined by longitudinally designed studies. Considering there was
evidence of early occipital lobe WM involvement, I decided to further
investigate the visual system in schizophrenia.
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6. A STUDY TO INVESTIGATE THE RETINAL NERVE FIBRE
LAYER IN SCHIZOPHRENIA
6.1 Introduction
Schizophrenia lacks a clearly defined diagnostic pattern of neuropathological
features, as discussed earlier (chapter 1). The best validated
neuropathological abnormalities include possible reductions of neuronal
density in the thalamus but not in the cerebral cortex or hippocampus;
although in these structures, pyramidal neurons may have smaller bodies
with reduced dendritic arborisation and spines (Harrison and Weinberger,
2005). Reductions in the number of some interneurons and in the number
and function of oligodendrocytes, relevant to myelination and neuronal and
synaptic integrity, complete the picture (Harrison and Weinberger, 2005). In
keeping with these findings, cross-sectional neuroimaging studies have
reported grey matter volume deficits in patients with chronic schizophrenia
(Ellison-Wright and Bullmore, 2010; Shenton et al., 2001a), in those at first
episode of psychosis (Bangalore et al., 2009), in prodromal illness (Pantelis
et al., 2003) and even in those at high genetic risk of schizophrenia (Witthaus
et al., 2009). Childhood onset schizophrenia also results in progressive grey
matter volume loss in the early years of illness (Sporn et al., 2003).
Compromised white matter integrity rather than white matter volume loss has
been reported in first episode schizophrenia (Price et al., 2007) and in
chronic schizophrenia (Kanaan et al., 2009a; Kubicki et al., 2002).
Longitudinal imaging studies (as discussed in chapter 3) have also
suggested that in at least some patients there may be an accelerated loss of
grey matter (GM) in comparison with healthy controls immediately after the
first episode of schizophrenia (Sun et al., 2009b). Similar results of reduced
GM volume have been documented in chronic schizophrenia (Brans et al.,
2008b) and in those at ultra-high risk, i.e. even before the first episode of
psychosis (Takahashi et al., 2010). The precise neuropathological changes
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that underlie these neuroimaging findings however, have yet to be
determined.
In-vivo visualization of the retinal nerve fibre layer (RNFL) can be achieved
by optical coherence tomography (OCT), a non-invasive imaging technique
originally developed to monitor retinal changes in glaucoma (Huang et al.,
1991). This imaging technique opens a “window” into the brain by allowing
measurement of RNFL thickness and macular volume (MV). The RNFL is
composed of unmyelinated axons that traverse the retina, with the highest
axonal density contained in the macula; these axons converge to form the
optic nerve which is part of the central nervous system. OCT has recently
been applied to the study of neurological conditions with diffuse and
progressive brain pathology. RNFL thinning has been described in patients
with mild cognitive impairment without dementia (Paquet et al., 2007) and is
inversely correlated with the severity of cognitive impairment in patients with
Alzheimer’s disease (Iseri et al., 2006). Even in the early stages of
Alzheimer’s disease, RNFL thinning has been reported (Berisha et al., 2007).
RFNL thickness is also reduced in patients with Parkinson’s disease in whom
loss of dopaminergic neurons is known to occur, not only in the cortex and
basal ganglia but also in the retinal ganglion cells (Altintas et al., 2007).
Following an episode of optic neuritis, which commonly heralds the onset of
multiple sclerosis (MS), OCT revealed a mean RNFL loss of 20% (Fisher et
al., 2006; Pro et al., 2006; Sepulcre et al., 2007; Trip et al., 2005). Reduced
RNFL thickness has also been described in MS patients without a history of
optic neuritis and appears to correlate with MRI measures of brain atrophy in
a condition which is characterized by inflammation, demyelination and axonal
loss (Gordon-Lipkin et al., 2007; Siger et al., 2008). RNFL thickness has also
been reported to be associated with cognitive performance of healthy
individuals, particularly in those below 40yrs of age (van Koolwijk et al.,
2009).
There is a growing body of evidence that early stage visual processing is
impaired in schizophrenia, with well documented abnormalities of perceptual
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organization (Butler and Javitt, 2005; Butler et al., 2006b; Butler and Javitt,
2005; Butler et al., 2006b) and visual evoked potentials (Mathalon et al.,
2000). Additionally, electroretinogram (ERG) abnormalities which may
represent a reduced number of rod photoreceptors or changes in inter-
neuronal retinal architecture (a possible marker of dysfunctional
neurodevelopment) have been described in unaffected offspring at genetic
risk of schizophrenia (Hébert et al., 2009), in those with schizophrenia
(Balogh et al., 2007; Warner et al., 1999) and in autism (Ritvo et al., 1988;
Warner et al., 1999). No published OCT studies have reported using this
technique to study the retina in patients with schizophrenia; although there is
evidence of widespread, subtle neuropathological and cognitive
abnormalities similar to those neurological diseases where OCT
abnormalities have been reported.
The study described in this chapter of my thesis presents data from an
investigation of RNFL thickness in patients with schizophrenia and
schizoaffective disorder and explores the potential of using OCT to measure
a possible disease biomarker.
6.2 Methods
6.2.1 Subjects
Patients recruited to this study were taken from the West London First
Episode Psychosis cohort and had a firmly established diagnosis of
schizophrenia or schizoaffective disorder. Full details of subject recruitment
are available in chapter 4.
Forty-nine patients (37 males, 16 females), mean age 29.9yrs (range 18 to
56) with diagnoses of schizophrenia (38), or schizoaffective disorder (11) and
median illness duration of 3.2 years (range 1.1 to 13.8) at the time of OCT
scanning were recruited to this study. Forty patients were prescribed
antipsychotics (39 atypical), 10 were prescribed antidepressants and 4
prescribed concurrent mood stabilising medication, 2 were prescribed mood
stabilisers only, 1 night sedation only and 5 were unmedicated. The Schedule
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for Assessment of Positive and Negative Symptoms (SAPS and SANS)
(Andreasen, 1981; Andreasen, 1983) scores were available for a subset of
32 patients. Severity of negative symptoms ranged from 0 to 16 (mean 3.7)
and positive symptoms ranged from 0 to 10 (mean 2).
Forty healthy, control subjects, matched for age (mean 29.5yrs, range 20 to
46) and gender (25 males, 15 females), were recruited to this study for OCT
imaging.
Exclusion criteria for all subjects were: a) concurrent or previous systemic
disease (e.g. diabetes or autoimmune disease) that could involve the eyes,
b) a neurological or ophthalmological condition (e.g. glaucoma) known to
affect the visual pathway, c) severe myopia (>6.0D) as this may cause
artefactual reduction in RNFL thickness (Kim et al., 2010) and difficulty in
fixation, d) previous head injury with loss of consciousness, e) drug or alcohol
dependence.
6.2.2 Optical Coherence Tomography
OCT produces a cross-sectional image of the retina by measuring the echo
time delay of back-scattered infra-red light after it has passed into the eye
and is bounced back using a low coherence light source and interferometer
(Schuman et al., 1995). OCT data gathered for this study was obtained by a
neurologist trained and experienced in using the Stratus 3 OCT device (fig
8.1) and software (Carl Zeiss Meditec Inc., California, USA) at UCL Institute
of Neurology, London. RNFL images were acquired for each eye by taking a
circumpapillary scan of 3.4mm diameter to effectively intercept all nerve
fibres converging toward the optic disc while avoiding inaccurate
measurements resulting from peripapillary atrophy (Schuman et al., 1996).
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Figure 6.1 The Stratus 3 Optical Coherence Tomography Device
S=superior quadrant
T=temporal quadrant
I=inferior quadrant
N=nasal quadrant
Figure 6.2 The OCT Scanning Circle is Seen Around the Optic Nerve
Head with a Cross-sectional View of the Retinal Nerve Fibre Layer
Below
(red = RNFL thickness less than 2 sd below normal population, green = normal RNFL
thickness)
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6.2.3 Retinal Nerve Fibre Layer and Macular Volume Measures
The thickness of the RNFL quadrants (temporal, superior, nasal and inferior),
were calculated by the OCT device software and represented by a graph
indicating RNFL thickness at any point of the scanning circle (fig 8.2). Using
the Fast RNFL protocol, the mean of three circular 3.4mm diameter scans,
centred on the optic disc was used to express RNFL thickness. MV was
measured in each eye by taking six consecutive radial linear scans centred
on the fovea, to provide six sets of equally spaced and intersecting scans to
obtain a single average value (using the fast macular thickness map
scanning protocol). The Stratus OCT3 device assigns a signal strength out of
10 to all OCT images. These were rejected if signal strength was less than 7
or when the difference in signal strength between images for the two eyes
was greater than 2 to ensure consistency in the quality of scans obtained.
The OCT scanning in this study was carried out by a neurologist trained and
experienced with carrying out the procedure on the Stratus OCT3.
6.2.4 Statistical analysis
Independent sample t-tests and chi-squared tests were used to compare age
(normally distributed in patients and controls) and gender between groups.
Relationships between patients and controls for whole retina and quadrant
RNFL thickness and macular volume (MV) were investigated using linear
regression with adjustment for age. In the patient group, linear regression
analyses were used to investigate relationships between severity of illness
duration, positive and negative symptoms with measures of RNFL thickness
and MV in both eyes, while controlling for age. A computer-based statistical
package (SPSS) was used throughout, with statistical significance reported
at p<0.05.
A generalized linear mixed model (GLMM) approach was used to compare
whole retina RNFL thickness, quadrant RNFL thickness and MV between the
three groups (healthy controls, schizophrenia patients and schizoaffective
disorder patients). Multilevel models were used to account for the fact that
observations within each patient (i.e. right and left eyes) were not
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independent, while also controlling for possible confounding effects of age,
gender and disease duration (Laird and Ware, 1982). Where association was
shown between eye and disease subtype, linear regression analysis was
used to investigate the effect of disease subtype on each eye independently.
In the patient group, multiple linear regression analysis was used to
investigate the relationship between severity of positive and negative
symptoms with measures of RNFL thickness and MV in both eyes, while
controlling for age and gender. Statistical significance was reported at
p<0.05.
6.2.5 Power calculation
A power calculation was based on studies reporting subtle changes in RFNL
thickness in the unaffected eyes of patients with MS due to subclinical axonal
damage (Fisher et al., 2006). In order to detect a mean difference in RNFL
thickness between groups of 9µm with standard deviation of +/-14µm and a
standardized difference of 0.64, an estimated sample size of 38 patients and
38 controls would be needed to achieve an 80% probability of detecting
differences between the two groups at a 5% significance level. Based on a
study by Henderson et al (2008), a mean difference in MV of 0.27mm³
between groups, would give a 70% probability of detecting a group difference
at the 5% level of significance with a sample size of 38 patients and 38
controls.
6.3 Results
Patients and controls were matched for age (t=0.27, df=85, p=0.79) and
gender (χ²=0.27, p=0.36). Across both patient and control groups combined, 
there was a weak negative correlation between age and RNFL thickness in
the right (r= -0.28, n=89, p=0.01) and left (r= -0.25, n=89, p=0.02) eyes but
not between age and MV, hence age was controlled for in all subsequent
analyses. No correlations were found between gender and RNFL thickness
or gender and MV.
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6.3.1 RNFL and MV
Data collected for this study including RNFL, MV and illness duration in
patients were confirmed as having a normal distribution according to
Kolmogorov-Smirnov tests. Using linear regression analyses, whole retina
and quadrant RNFL thickness, and MV were compared between patients and
controls, there were no significant differences between groups for either right
or left eyes (table 8.1). There were no significant differences between
schizophrenia or schizoaffective disorder patient subgroups compared to
controls for any of these measures.
6.3.2 Duration of illness
After adjusting for age, there was a significant correlation between longer
duration of illness and smaller MV of the right (r= -0.36, p=0.01) and left eyes
(r= -0.36, p=0.01). A correlation was also found between longer duration of
illness and thinner RNFL in the left eye (r= -0.28, p=0.05), with a trend in the
right (r= -0.27, p=0.06).
6.3.3 Symptom severity
There were no significant correlations between RNFL thickness and positive
or negative symptom severity, but there was a negative correlation between
severity of positive symptoms and right MV (r= -0.39, p=0.03) but not left MV
(r= -0.29, p=0.12). This correlation was no longer significant when patients
with (n=13) or without (n=15) positive symptoms were considered separately.
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Controls Patients
Regression coefficients
of retinal measures
adjusted for age (95%
CI)
Overall RNFL
thickness (µm)
Mean (sd) Mean (sd)
Right eye 100.71 (10.08) 100.07 (11.61) -0.64 (-5.28, 3.99) p=0.84
Left eye 101.24 (11.55) 98.80 (11.65) -2.45 (-7.36, 2.47) p=0.35
Macular volume
(mm³)
Right eye 6.81 (0.33) 6.86 (0.37) 0.05 (-0.19, 0.10) p=0.52
Left eye 6.91 (0.33) 6.92 (0.38) 0.01 (-0.16, 0.15) p=0.91
Temporal quadrant
RFNL (µm)
Right eye 70.63 (13.07) 67.00 (11.97) -3.63 (-8.91, 1.66) p=0.17
Left eye 64.50 (9.56) 67.06 (10.45) 2.56 (-1.70, 6.82) p=0.23
Superior quadrant
RNFL (µm)
Right eye 128.03 (15.10) 125.18 (18.97) -2.85 (-10.19, 4.50)
p=0.47
Left eye 127.70 (14.00) 127.67 (18.03) -0.03 (-6.95, 6.90) p=0.98
Nasal quadrant RNFL
(µm)
Right eye 81.53 (17.22) 84.47 (18.76) 2.94 (-4.72, 10.60)
p=0.41
Left eye 83.17 (18.93) 76.59 (18.43) -6.58 (-14.49, 1.32)
p=0.11
Inferior quadrant
RNFL (µm)
Right eye 121.53 (15.53) 124.31 (17.13) 2.78 (-4.18, 9.75) p=0.42
Left eye 124.28 (15.39) 123.24 (19.58) -1.03 (-8.58, 6.52) p=0.82
Table 6.1 Retinal Nerve Fibre Layer Thickness & Macular Volume
Measures
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Unadjusted analysis Adjusted analysis
Whole Retina
RNFL
Regression co-
efficient (95% CI)
P value Regression co-efficient
(95% CI)
P
value
Disease type:
Control
Schizophrenia
Schizoaffective
Ref
-0.97 (-5.79, 3.85)
-3.52 (-10.76, 3.73)
0.63
Ref
-0.78 (-5.58, 4.03)
-1.93 (-9.32, 5.47)
0.86
Eye: left vs. right -0.46 (-1.78, 0.86) 0.50 -0.46 (-1.78, 0.86) 0.50
Age: for each yr
older
-0.38 (-0.66, -0.10) 0.008 -0.38 (-0.67, -0.08) 0.01
Sex: male vs.
female
-2.72 (-7.54, 2.10) 0.27 -3.13 (-8.13, 1.87) 0.22
Disease duration:
for each yr longer
-1.01 (-1.85, -0.16) 0.02 - -
Temporal
Quadrant RNFL
Disease type:
Control
Schizophrenia
Schizoaffective
Ref
-0.62 (-4.91, 3.68)
-0.24 (-6.70, 6.21)
0.96
Ref
-1.33 (-5.76, 3.10)
0.68 (-6.14, 7.50)
0.79
Eye: left vs. right -2.72 (-5.28, -0.16) 0.04 -2.72 (-5.28, -0.16) 0.04*
Age: for each yr
older
-0.00 (-0.26, 0.26) 0.99 -0.01 (-0.29, 0.26) 0.92
Sex: male vs.
female
2.66 (-1.61, 6.93) 0.22 3.19 (-1.42, 7.80) 0.18
Disease duration:
for each yr longer
-0.65 (-1.37, 0.06) 0.07 - -
Superior quadrant
RNFL
Disease type:
Control
Schizophrenia
Schizoaffective
Ref
-1.09 (-8.02, 5.85)
-2.64 (-13.06, 7.79)
0.87
Ref
-2.10 (-9.22, 5.01)
0.36 (-10.58, 11.31)
0.83
Eye: left vs. right 1.22 (-1.48, 3.93) 0.37 1.22 (-1.48, 3.93) 0.38
Age: for each yr
older
-0.34 (-0.76, 0.07) 0.10 -0.36 (-0.81, 0.08) 0.11
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Sex: male vs.
female
2.09 (-4.86, 9.03) 0.56 2.52 (-4.89, 9.92) 0.51
Disease duration:
for each yr longer
-1.75 (-3.00, -0.49) 0.006 - -
Nasal quadrant
RNFL
Disease type:
Control
Schizophrenia
schizoaffective
Ref
0.07 (-6.91, 7.05)
-8.35 (-18.84, 2.14)
0.25
Ref
-0.40 (-7.61, 6.82)
-6.39 (-17.49, 4.72)
0.52
Eye: left vs. right -3.60 (-7.56, 0.37) 0.08 -3.60 (-7.56, 0.37) 0.08
Age: for each yr
older
-0.37 (-0.79, 0.05) 0.09 -0.29 (-0.74, 0.16) 0.21
Sex: male vs.
female
1.73 (-5.36, 8.83) 0.63 0.45 (-7.06, 7.96) 0.91
Disease duration:
for each yr longer
-1.19 (-2.36, -0.02) 0.05 - -
Inferior quadrant
RNFL
Disease type:
Control
Schizophrenia
schizoaffective
Ref
1.03 (-5.98, 8.05)
0.33 (-10.22,
10.87)
0.96
Ref
0.95 (-6.31, 8.20)
1.79 (-9.37, 12.94)
0.94
Eye: left vs. right 0.65 (-2.20, 3.51) 0.65 0.65 (-2.20, 3.51) 0.66
Age: for each yr
older
-0.26 (-0.68, 0.16) 0.22 -0.28 (-0.73, 0.17) 0.23
Sex: male vs.
female
-1.06 (-8.09, 5.97) 0.77 -1.24 (-8.79, 6.30) 0.75
Disease duration:
for each yr longer
-0.65 (-1.95, 0.66) 0.33 - -
Macular Volume
Disease type:
Control
Schizophrenia
schizoaffective
Ref
0.01 (-0.14, 0.16)
0.85
Ref
0.00 (-0.16, 0.16)
0.64
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0.07 (-0.16, 0.30) 0.11 (-0.13, 0.36)
Eye: left vs. right 0.08 (0.05, 0.11) <0.0001 0.08 (0.05, 0.11) <0.000
1**
Age: for each yr
older
-0.00 (-0.01, 0.01) 0.46 -0.00 (-0.01, 0.01) 0.34
Sex: male vs.
female
0.04 (-0.12, 0.19) 0.63 0.06 (-0.11, 0.22) 0.51
Disease duration:
for each yr longer
-0.04 (-0.07, -0.01) 0.005 - -
Table 6.2 Multi-level Analyses of Whole Retina and Quadrant RNFL and
Macular Volume
* Quadrant RNFL thinner in left than right eye
**MV smaller in left than right eye but no evidence for interaction between eye and disease type
(p=0.47).
6.4 Discussion
This study did not detect any statistically significant differences in the RNFL
thickness or macular volume between patients and healthy controls. These
negative findings suggest that in patients with schizophrenia or
schizoaffective disorder there is no detectable loss of unmyelinated axons in
the retina in the early years after disease onset. Based on average values
from both eyes for means and standard deviations of the RNFL thickness of
this study sample, a retrospective power calculation showed that at least 300
subjects would be required in each arm of the study to detect any significant
differences between groups (if they were present), with 80% power at a 5%
level of significance. It can therefore be concluded, that using the OCT
measurements described, RNFL variations are too subtle to be of value as a
clinically useful biological marker for schizophrenia.
Several factors (not mutually exclusive), may be contributing towards the
negative results seen in this study. The most obvious limitation is low
resolution, which may be inadequate to detect the subtle abnormalities that
may be present in the early years of schizophrenia. Transverse resolution
152
can reach a maximum of 10µm in tissue and 15µm in air using the Stratus 3
OCT device (Fujimoto et al., 2004), hence sensitivity is too low to visualize
individual axons typically 1 µm in diameter. This point has been made in a
recent study (Naismith et al., 2009) where OCT detected RNFL thinning in
optic neuritis in only 60% of cases and detection rates were lower in those
with mild onset and good recovery. Newer technology using spectral domain
OCT (e.g. the Cirrus HD-OCT device) can offer better axial resolution (5µm
compared to 10µm), in addition to macular thickness measurement and a
higher scanning speed (50x faster) than the Stratus 3 OCT device used in
this study.
Results of this study also suggest that axonal damage may be less important
than myelin abnormalities in explaining the frequently reported reductions in
brain volume in schizophrenia. There is growing evidence for disruption of
white matter integrity in the early stages of schizophrenia (Price et al., 2006;
Price et al., 2007; Pérez-Iglesias et al., 2010), which lends support to this
possibility. The negative findings are also in keeping with earlier studies
published on patient samples overlapping with the one described here, that
failed to demonstrate differences in cortical thickness between patients and
controls using surface-based morphometry (Gutiérrez-Galve et al., 2010) and
only fronto-temporal white matter volume loss in patients but no cortical
changes using magnetization transfer imaging or volumetric MRI (Price et al.,
2006).
Longer duration of illness was associated with decreased RNFL thickness
and smaller MV but the significance of these correlations, given the normal
range of RNFL thickness and MV, needs to be further investigated in a
longitudinal study to specifically determine the effects of illness chronicity and
identify the stage at which possible changes in RNFL and MV may occur.
While the RNFL measures reflect axons, MV measures are thought to reflect
neurons as the macula area of the retina contains the highest concentration
of retinal ganglion cells (Sakata et al., 2009). The tentative association
between severity of positive symptoms and MV also needs replicating in a
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larger sample, as it may represent state-dependent abnormalities similar to
that reported by a previous ERG study (Balogh et al., 2007) that described
transient retinal changes (i.e. decreased amplitude of the α-wave indicative 
of altered early visual information processing); which during acute relapses
correlated with the severity of positive symptoms and was attributed to state-
dependent alterations in phospholipid metabolism and/or impaired
dopaminergic transmission.
Finally, most of the patients (40 out of the 49) were prescribed atypical
antipsychotic medication at the time of OCT scanning and it is impossible to
exclude the potential neuroprotective effects of these drugs (Navari and
Dazzan, 2009), which could have obscured any minor differences in RNFL
between the groups. Despite the largely negative results of this exploratory
study using OCT scanning in schizophrenia, there is a need for further OCT
studies to replicate and further investigate our findings of RNFL thinning and
decreased MV in patients with longer illness duration. A longitudinal study
design would additionally be able to detect whether progressive retinal
changes occur and whether these measures could be utilized as a trait or
state marker for schizophrenia or schizoaffective disorder.
In this study, exploration of the beginning of the visual pathway
demonstrated no RNFL thinning in schizophrenia patients.
Neurodevelopmentally, both the RNFL and forebrain (which contain neurons
involved in higher cognitive processes) are derived from the same embryonic
origins of the prosencephalon. Any predisposing biological marker of
schizophrenia might therefore be expected to lie in the RNFL, especially
considering the many neuroimaging and cognitive studies that provide
evidence of fronto-temporal deficits in schizophrenia. The next chapter
describes a longitudinal imaging study designed to examine progressive
structural brain changes and explores correlations with cognitive function
occurring early in the course of illness.
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7. A LONGITUDINAL STUDY OF FIRST EPISODE PSYCHOSIS
USING MAGNETIC RESONANCE AND MAGNETISATION
TRANSFER IMAGING: STRUCTURAL BRAIN CHANGES AND
CORRELATIONS WITH COGNITIVE FUNCTION
7.1 Introduction
Different forms of magnetic resonance imaging (MRI) have been utilised to
measure brain volume changes over time in longitudinal studies of
schizophrenia (as discussed in chapter 3). There are fewer first episode
schizophrenia studies investigating brain changes early in the disease,
presumably because of difficulties with recruitment. One longitudinal study
following first episode schizophrenia patients over a 10 year period described
ventricular enlargement occurring at variable rates of progression, with some
patients exhibiting active structural changes only early in the illness or not at
all after first episode, while others exhibited continuous ventricular changes
spanning the decade (DeLisi and Hoff, 2004). Another longitudinal first
episode study reported that temporal lobe volume loss is not progressive
(DeLisi et al., 2005). Both these findings appear to be at odds with an earlier
review (Shenton et al., 2001) and meta-analysis (Wright et al., 2000); one
possible reason for this discrepancy would be the long follow-up duration with
data collected from an early stage of the illness.
During the course of schizophrenia, volume decrease in cortical grey matter
has been found to be particularly prominent in the prefrontal cortices and
medial temporal areas (Lawrie and Abukmeil, 1998). Such structural changes
may contribute to behaviours typically described as negative symptoms
(Andreasen et al., 1995) in addition to a distinctive profile of cognitive deficits
(Bilder et al., 1992). Early CT imaging studies by Johnstone and colleagues
showed enlargement of the lateral ventricles (Johnstone et al., 1976) this has
been a robust finding supported by both post-mortem neuropathology (Brown
et al., 1986) and in-vivo MRI studies (Shenton et al., 2001). Timing of the
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ventricular enlargement is unclear but may have relation to grey matter
abnormalities which have been described in the prodromal phase of illness
before first episode psychosis onset (Pantelis et al., 2005) and may also be
present to a lesser extent in unaffected first degree relatives (McIntosh et al.,
2004). There is also evidence that perinatal complications may contribute to
an increased risk of psychotic illness in later life, presumably due to neuronal
insult (Murray et al., 1992). In post-mortem neuropathology studies there is a
lack of neurodegenerative lesions and no evidence of post-maturational brain
injury (Arnold and Trojanowski, 1996). It therefore appears that aberrant
neurodevelopment in fronto-temporal regions give rise to schizophrenia.
White matter volume loss has been described in published literature but the
evidence is perhaps less convincing, a review of 193 studies by Wright and
colleagues (Wright et al., 2000) described 1% loss of whole brain white
matter but this magnitude of reported volumetric loss is close to the limit of
detection by MRI (Steen et al., 2006). Loss of fronto-temporal white matter
volume has been reported in first episode psychosis (Ho et al., 2003;
Whitford et al., 2007b) suggesting that changes may occur early on in the
disease. White matter volume loss has also been reported in patients with
schizophrenia and their unaffected first degree relatives (McIntosh et al.,
2005), indicative of a genetic trait. Others studies however, report no
evidence of white matter volume changes, even with increasing duration of
illness (Steen et al., 2006). A different hypothesis has proposed that it is the
integrity of white matter fibre bundles that are affected in schizophrenia rather
than a reduction of tissue volume (Friston and Frith, 1995). White matter
integrity is quantifiable and measured as fractional anisotropy (FA) using
diffusion tensor imaging (DTI) as discussed in chapter 2.
Magnetisation transfer imaging (MTI) is also believed to be able to identify
tissue integrity and has been described in chapter 2. A reduced
magnetisation transfer ratio (MTR) has been reported in the temporal lobe
WM of patients with chronic schizophrenia (Foong et al., 2000a); while in first
episode patients reduced MT in focal areas have been reported in the medial
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pre-frontal cortex, insula and uncinate fasciculus with no evidence of atrophy
(Bagary et al., 2003). A longitudinal MTI study of first episode patients (Price
et al., 2010) described reduced MT in patients for all areas where volumetric
differences between patient and control groups had been identified,
suggesting that volume and MT measures are related.
Cognitive deficits are a well-recognised feature of schizophrenia (Keefe and
Harvey, 2012) but fewer studies have investigated associations between
cognitive function and brain tissue volume changes. Guttierez and colleagues
described a significant association of premorbid IQ and IQ at disease onset
with area of frontotemporal cortex, while working memory was associated
with area of frontal cortex (Gutiérrez-Galve et al., 2010). Grey matter volume
loss in the left inferior parietal and right middle temporal cortex has also been
associated with deficits in attention (Wolf et al., 2008). A cross-sectional
study found that subjective reports of poor working memory were associated
with reduced frontal lobe volume (Garlinghouse et al., 2010).
The primary aim of this study was to investigate structural brain changes in
the period immediately following first episode psychosis in patients who
subsequently developed schizophrenia or schizoaffective disorder. A
longitudinal design was employed and the following were measured:
1) Whole brain, CSF, grey and white matter volumes.
2) Magnetisation transfer ratio (MTR) of grey and white matter.
A secondary objective was to investigate if any identified areas of structural
change were associated with cognitive performance.
7.2 Methods
Participants in this study were taken from the West London Longitudinal First
Episode Psychosis study cohort as described in chapter 4.
7.2.1 Subjects
Nineteen patients (12 males, 7 females), mean age 31.1yrs (range 21 to 52)
and 23 controls (13 males, 10 females), mean age 28.7yrs (range 18 to 46)
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underwent baseline and follow-up MRI scanning. Average duration of
treatment with medication at time of baseline imaging was 71 days (range 0 -
176). Fifteen patients had been prescribed an atypical antipsychotic (6 were
additionally prescribed antidepressants and 2 were additionally prescribed
benzodiazepines), 2 patients were prescribed typical antipsychotics while 2
were unmedicated. Diagnoses were confirmed by two consultant
psychiatrists through patient interview and clinical information obtained from
the medical notes. Twelve patients were diagnosed with schizophrenia and 7
with schizoaffective disorder.
All subjects returned for follow-up MRI scanning on the same 1.5T MRI
scanner, in the NMR Unit, UCL Institute of Neurology, London. The original
study protocol for a 3 year follow-up period had to be shortened due to
planned replacement of the departmental scanner. As a result, the scanning
interval was a mean of 1 year 8 months (sd 2 months) in controls and 1 year
10 months (sd 7 months) in patients.
7.2.2 Cognitive Assessment
Patients and controls underwent cognitive assessment (as described in
chapter 4) at time of baseline MRI scanning, the same test battery was
repeated at the time of follow-up MRI. Current IQ was measured using a
short form of the Wexler Adult Intelligence Scale (WAIS III) comprising of the
information, arithmetic, block design and digit symbol subtests (Wechsler,
1997). The digit symbol subtest scores were analyzed independently as a
measure of information processing speed. A measure of working memory
was obtained via the token search task using the computerized CANTAB
battery (Sahakian and Owen, 1992). The “between error score” was used as
an index of the ability to manipulate information in working memory. Verbal
memory was assessed using the Rey Auditory Verbal Learning (RAVLT)
(Lezak, 1995). Change in cognitive performance was obtained for each
subject on each of the four measures (IQ, processing speed, working
memory, verbal learning) by subtracting baseline scores from those obtained
at follow-up.
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Cognitive performance was compared between patient and control groups at
baseline and follow-up, with change in performance compared using
independent sample t-tests. At baseline, cognitive measures were available
from 19 patients and 22 controls with 18 patients and 16 controls completing
repeat cognitive testing at the time of their follow-up MRI and MTI.
7.2.3 Magnetic Resonance Imaging
MRI scans were obtained using a standard quadrature head coil on a GE
Signa 1.5 Tesla scanner (General Electric, Milwaukee, WI), which underwent
weekly quality-assessment checking. A preliminary sagittal localizing scan
was acquired and used to check head position for the follow-up scan. High-
resolution axial volumetric images were acquired using a 3-dimensional
inversion-recovery prepared T1-weighted spoiled gradient recalled (SPGR)
echo sequence generating 156 contiguous, 1.2mm axial slices (echo time
[TE] 5ms, repetition time [TR] 14 ms, inversion time [TI] 450 ms, field of view
[FOV] 31cm2, 256 × 256 matrix, flip angle 20°). The 1.2 × 1.2 × 1.2mm voxel
size at acquisition was determined by scan time constraints.
Axial magnetization transfer (MT) images were acquired using a 3D MT-
prepared SPGR dual spin-echo-based MT sequence (TE 5ms, TR 23ms, 28
contiguous 5mm axial slices, 256 × 256 pixel image matrix, 31cm2 FOV), two
volumes with and without a saturation pulse were generated. The
1.2 × 1.2 × 1.2mm voxel size was again determined by scan time constraints.
7.2.4 Processing of Magnetic Resonance Imaging for Brain volumes
MRI scans were processed on a Sun workstation (Sun Microsystems, Santa
Clara, CA). The FSL Brain extraction tool was used to remove voxels which
might include non-brain tissue from the periphery from each subject
(http://www.fmrib.ox.ac.uk/fsl/bet2/index.html). Image processing was
performed using Statistical Parametric Mapping (SPM5; Wellcome Dept of
Cognitive Neurology, Institute of Neurology, London, UK), running in Matlab
6.5 (The MathWorks, Inc., Natick, MA, USA). T1 weighted scans were
segmented in native space to determine grey matter, white matter and CSF
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voxels, http://www.fil.ion.ucl.ac.uk/spm/software/ was used to calculate the
volume (in cm³) of each tissue compartment, using the following command
line spm_volume –v SPM5 –f.
7.2.5 Processing of Magnetisation Transfer Imaging Data
The proton-density weighted scans (MTI data) from baseline and follow-up
were co-registered to the corresponding SPGR volume, with the SPGR at
follow-up co-registered to the SPGR at baseline. The transformation
determined was applied to the follow-up MTR so all volumes were in baseline
SPGR space. Methods for processing of MTR data were the same as those
described by Price et al. (2010).
MTR maps were created from the segmented MRI images and measures of
peak MTR height, peak MT location and mean MTR obtained. Whole brain
MTR maps were created pixel-by-pixel using the formula:
MTR = {[Mo − Ms]/Mo} × 100, where Ms was mean signal intensity with
saturation pulse and Mo was mean signal intensity without saturation pulse.
7.2.6 Volumetric and MTR group comparisons
The SPGR volumes and MTR images were then segmented into grey and
white matter masks and a “difference map” created for each subject in the
grey and white matter, reflecting changes in tissue density between the two
time points, calculated by subtracting the baseline from the follow-up image
for each tissue class. This difference map was normalised to the MNI52
template using the optimized VBM method (Good et al., 2001b), modulated
and smoothed with an 8mm FWHM Gaussian kernel to address residual
registration errors and inter-individual variability to ensure normality of
parametric statistics were met. As smoothing kernel size can affect results
(Jones et al., 2005), an 8mm kernel was selected as only small group
differences were expected.
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7.2.7 Statistical Analysis
Differences in age, gender and scanning interval between patient and control
groups were calculated.
Differences between patient and control groups were sought for grey matter,
white matter and CSF volumes at both baseline and follow-up. Changes in
each of the tissue compartments were calculated for patient and control
groups, differences between groups were sought using independent sample
t-tests.
Using SPM5 in the general linear framework, a multiple regression model
was used to investigate changes over time in grey matter, white matter and
CSF volumes across patient and control groups. Between group differences
with and without the effect of time were investigated while controlling for
confounding effects of age and gender.
Differences were sought between groups for change to grey and white matter
volumes and MTR measures using a multiple regression model containing
the following regressors: group, time to follow-up, gender, age and change in
cognitive performance; with IQ, working memory, processing speed and
verbal learning incorporated into separate design matrices. Results were
corrected for multiple comparisons using family-wise error correction at a
statistical significance of p<0.05 and statistical parametric maps depicting
regions of significant difference were compared. Only clusters greater than
10 voxels in size were reported.
7.3 Results
Patients and controls were matched for age (t= -1.26, df=40, p=0.21), gender
(χ²=0.19, p=0.66) and scanning interval (t= -1.66, df=40, p=0.1). 
7.3.1 Brain Volumes
There were no significant differences in grey or white matter volumes between
patient and control groups at baseline or follow-up but CSF volume was
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greater in patients than controls at both baseline (t= -3.1, df=40, p=0.003) and
follow-up (t= -2.9, df=40, p=0.006) as shown in table 7.1. Analysis of variance
identified a significant effect of age (p=0.01) on CSF volume across both
patients and controls. Across both groups, GM, WM and CSF volumes showed
no significant change between baseline and follow up. Patients showed no
significant change in GM, WM or CSF volumes between baseline and follow-
up. Controls showed no significant change in GM or CSF volumes but a WM
volume increase (t= -3.7, df=22, p=0.001) was identified over time.
Tissue Group Baseline Follow-up Change
Grey Matter Pt
Ctrl
705.60 (72.93)
694.08 (74.36)
701.51 (68.72)
695.16 (76.03)
-4.09 (15.75)
1.08 (11.22)
White Matter Pt
Ctrl
470.37 (46.28)
446.64 (53.19)
468.72 (44.20)
449.50 (54.03)
-1.65 (12.71)
2.86 (3.71)
CSF Pt
Ctrl
370.71 (88.93)
292.41 (72.60)
372.56 (98.00)
294.86 (74.30)
1.85 (36.28)
2.44 (16.95)
Table 7.1 Brain Tissue Volumes at Baseline, Follow-up & Change Over
Time to Follow-up
mean volume (sd) cm³
7.3.2 Volumetric group comparisons
VBM analysis showed that patients and controls had similar grey and white
matter volumes at both baseline and follow-up. There were no significant
changes in grey matter volume over time to follow-up, either between or across
both groups; however WM volume increase over time was identified in 3 small
areas across both groups (table 7.2, fig. 7.1).
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Cluster size
(voxels)
Max Talairach
Co-ordinates
(x, y, z)
Area
48 18, -22, 78 Right corticospinal tract
14 4, -8, 68 Right cerebral white matter
11 -22, 8, 68 Left cerebral white matter
Table 7.2 Cluster Sizes & Areas of White Matter Volume Increase in
Patients & Control
Figure 7.1 Position of Increased White Matter Areas in Patients and
Controls
7.3.3 MTR group comparisons
Both patients and controls had similar grey and white matter MTR at baseline
and follow-up time points. There were no changes in grey or white matter
MTR over time to follow-up either between or across both patient and control
groups.
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7.3.4 Cognitive Performance
Estimated premorbid IQ was similar between patients and controls. At
baseline, patients performed significantly worse than controls in measures of
IQ (t=2, df=30.8, p=0.05), processing speed (t=2.4, df=39, p=0.001) and
verbal learning (t=3, df=38, p< 0.001). At time of follow-up there were
significant differences between groups in IQ (t=2.4, df=32, p=0.02),
processing speed (t=5.3, df=32, p=0.001), and working memory (t= -2.1,
df=32, p=0.04). Changes between baseline and time to follow-up in patients
were a decrease in IQ and worse spatial working memory. Meanwhile,
controls showed an increase in IQ and processing speed and better working
memory (table 7.3). Differences between groups were statistically significant
for changes from baseline to follow-up in IQ (t=2.6, df=32, p=0.01) and
processing speed (t=3.6, df=32, p=0.001) but not spatial working memory or
verbal learning.
Pt
base-
line
Pt
follow-
up
Pt
change
Ctrl
base-
line
Ctrl
follow-
up
Ctrl
change
Premorbid IQ
(NART)
104.5
(12.0)
- - 109.0
(9.2)
- -
Current IQ
(WAIS)
103.3
(17.6)
101.2
(20.1)
-1.2
(19.5)
110.8
(11.8)
118.3
(17.6)
12.1
(12.2)
Processing
speed (WAIS digit
symbol)
7.5
(2.5)
7.5
(2.9)
0
(2.2)
10.3
(2.6)
13.0
(3.1)
2.7
(2.1)
Working memory
(Token search)
33.5
(5.7)
34.2
(7.5)
0.1
(5.3)
30.7
(5.3)
29.4
(5.4)
-1.1
(7.0)
Verbal learning
(REY AVLT)
11.2
(2.0)
12.6
(2.6)
1.2
(2.9)
13.4
(1.4)
13.9
(1.4)
0.3
(1.4)
Table 7.3 Cognitive Performance at Baseline and Follow-up, with
Change Over Time to Follow-up in Patients & Controls
results shown = mean (sd)
*higher score = worse performance in working memory, in all other cognitive
measures higher score = better performance
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7.3.5 Imaging and Cognitive Correlations
VBM analysis found no effect of cognitive performance (IQ, processing speed
or working memory) on GM or WM volumes either across patients and
controls considered as a single group or when investigating between group
differences. Across both groups there was an effect of time on white matter
volume increase in the right corticospinal tract, while controlling for effects of
age, gender and any of the three cognitive variables of IQ, processing speed
or working memory (table 7.4). No between group differences were identified
using this matrix.
Cognitive
variable
Cluster size
(voxels)
Max Talairach
Co-ordinates
(x, y, z)
Area
Current IQ 20 18, -22, 78 Right
corticospinal
tract
Processing
speed (WAIS
digit symbol)
23 18, -22, 78 Right
corticospinal
tract
Working
memory
(Token search)
23 18, -22, 78 Right
corticospinal
tract
Table 7.4 Cluster Sizes and Positions of White Matter Increase
Over Time Seen Across Both Groups
7.4 Discussion
Results from this VBM study did not identify any significant change in grey
matter volumes for patients or controls during a relatively short follow-up
period of under 2 years. Small areas of white matter volume increase were
observed across both groups over time in a distal region of the right
corticospinal tract and in right and left superior frontal lobes. Patients had
larger CSF volumes than controls at both baseline and follow-up time points.
The present study shows that patients at first episode of schizophrenia or
schizoaffective disorder already appear to have larger CSF volumes than
healthy controls. This finding lends support for the hypothesis that ventricular
165
dilatation is already present at first episode psychosis, as described by Vita
and colleagues (Vita et al., 2006). There was no significant change in CSF
volume over time but follow-up was fairly short in the current study. In a
meta-analysis of longitudinal studies of lateral ventricular volume,
progression of ventricular dilatation in first episode patients was similar to
that of chronic patients (Kempton et al., 2010).
Diffuse single voxels of grey matter volume loss were seen across all
subjects over time but there were no sizeable clusters of note were identified
in this study where a short follow-up duration was utilised. These results
appear to suggest that cortical grey matter volume may be changing very
slowly in this study cohort. Other studies with short follow-up duration have
reported grey matter volume reduction in first episode schizophrenia patients
(Cahn et al., 2002) and identified this occurring within the neocortical grey
matter of the fronto-temporal lobes (Nakamura et al., 2007). Meanwhile other
authors reported no change in grey matter volume over time (Lieberman et
al., 2001; Whitworth et al., 2005), with Whitworth and colleagues reporting
higher between-subject variability in schizophrenia patients, which may
represent morphologically visible disease progression in some patients but
not in others. Price and colleagues reported a simultaneous increase and
decrease of cortical grey matter in different areas with no overall volume
change (Price et al., 2010), a finding which could be explained by the
hypothesis that “some brain volume abnormalities may be reversible and
possibly associated with a better illness course” (Schaufelberger et al.,
2011). Patients in the current study were all well enough to be living in the
community at time of follow-up, which suggests a “better illness course” this
may explain why little overall change in cortical grey matter volume was
observed.
Regions where white matter increases were identified in the current study
appear to include the cortico-spinal tract and arcuate fibres. Although the
regions of interest are small and superficial, they are unlikely to be an
artefact due to stringent correction of scans during processing. In a large
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longitudinal study of 96 schizophrenia patients, change in white matter
volume during the scanning interval was reflected by an excessive WM
increase in patients between 18 and 32 years of age (van Haren et al.,
2008b). White matter maturation (myelination) continues into the third
decade of life and is the final stage of neurodevelopment (Lebel and
Beaulieu, 2011); therefore findings from the current study may have been
driven by larger numbers of younger subjects.
In the current study, no grey or white matter MTR differences between
patients and controls were found and there were no significant changes in
MTR over time to follow-up. MTR decreases typically occur in states of
pathological tissue damage and post-mortem studies suggest that MTR in
white matter depends on myelin integrity (Schmierer et al., 2007). A study
using MTI on a cohort of chronic schizophrenia patients reported MTR
reductions of left inferior frontal, right superior occipital and right inferior
temporal cortical regions and temporal lobe white matter (Foong et al.,
2001). In a cohort of first episode schizophrenia patients, small areas of MTR
reduction were reported in the prefrontal cortex, insular cortex, and uncinate
fasciculus in the absence of volumetric differences between patients and
controls (Bagary, 2003). In a first episode cohort study, Price et al. (2010)
reported MTR decreases in fronto-temporal grey and white matter regions
which were more extensive than the areas of volume reduction, concluding
that MTI suggests neuroaxonal and myelin changes may be more extensive
than what can be detected using conventional MRI. In a study comparing DTI
and MTI abnormalities in schizophrenia, different findings using both imaging
modalities were ascribed to different neuropathological processes of
abnormal coherence or organization of the fiber tracts and disruption of
myelin or axons (Kubicki et al., 2005a). The lack of MT findings in the current
study was unexpected considering that this method should be more sensitive
to detection of neuropathological changes than conventional MRI but our
study sample of just 19 patients was relatively small and it has already been
demonstrated that MTR and volumetric changes do not necessarily overlap
as they appear to indicate different pathological processes.
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In the current study, patients showed deficits in IQ, processing speed and
working memory at baseline and lower IQ and slower processing speed at
follow-up compared to controls. Cognitive performance was not associated
with brain tissue volume changes over time. In a longer follow-up study (2 to
3 years) of first episode patients (Zipparo et al., 2008), mild improvement in
IQ and visual memory were associated with progressive GM atrophy.
Cognitive performance may therefore vary, depending on follow-up duration.
The final number of subjects reported in this study was much lower than the
number originally recruited because of strict exclusion criteria and subjects
unable to tolerate the MRI scanning. Time to follow-up was shorter than
originally intended and perhaps not long enough for any significant
neuropathology to manifest itself; considering the subtle changes (if any)
reported in previous scanning studies.
This study demonstrates that structural brain changes such as ventricular
dilatation are already present at disease onset. Additional absence of MTR or
GM volume changes at this early stage of schizophrenia suggest that these
events occur at a stage beyond the first 18 months of illness eventually
resulting in cortical volume loss. The small increase in WM volume seen
across both groups supports the hypothesis of myelination continuing well
into adulthood but in schizophrenia this process could be aberrant at disease
onset and reflected in measures of WM integrity rather than volume. The
cognitive deficits demonstrated in schizophrenia do not appear to be related
to any structural imaging findings. Returning to the earlier theme of vision in
psychosis, the next study was designed to look at processes further along
the visual pathway and investigated hue discrimination.
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8. ABNORMAL HUE DISCRIMINATION IS RELATED TO
COGNITIVE DEFICITS IN SCHIZOPHRENIA SPECTRUM
DISORDERS
8.1 Introduction
Visual information is transmitted from the retinal nerve fibre layer (RNFL)
through the optic nerve. Most optic nerve axons terminate in the lateral
geniculate nucleus (LGN) of the thalamus, with the optic radiation continuing
in a posterolateral direction to the occipital cortex (Ellis, 1992). From the
LGN there are two main routes into the primary visual cortex (V1). The
magnocellular ‘M pathway’ carries information about luminance contrast and
movement discrimination to the visual cortex (Perry and Cowey, 1981), while
parvocellular ‘P pathway’ (Merigan and Maunsell, 1993) carries information
about chromatic (colour) vision, central acuity and fine stereopsis to the
visual cortex (Schiller et al., 1990). From the visual cortex the M pathway
continues in the dorsal stream projection to the parietal cortex and is involved
in attentional processes - the so-called ‘where pathway’. This is in contrast to
the P pathway which continues as the ventral stream to the temporal lobe
association cortex contributing to object and face recognition - the so-called
‘what pathway’. The M and P pathways also interact with each other; for
example the P pathway is under attentional control via inputs from the M
pathway as well as the frontal cortex (Butler et al., 2008).
In a study by Phillipson and Harris (1985), over 80% of patients with probable
schizophrenia reported visual distortions with subjective difficulty in
perceiving brightness, motion and/or colour compared to 27% of healthy
comparison subjects. These abnormalities appeared linked to the
development of visual hallucinations, with nearly half the patients reporting
improvement in visual distortions following treatment with antipsychotic
medication.
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Precise assessment of visual processing in schizophrenia has been mainly
investigated using “masking” paradigms where a target stimulus is quickly
followed (backward masking) or proceeded (forward masking) by another
stimulus or “mask” that overlaps or surrounds the target stimulus. Backward
masking paradigms in particular, have demonstrated larger and more
prolonged masking effects (i.e. greater difficulty in identifying the target
stimulus) in schizophrenia patients than controls (Green et al., 1999).
Backward masking effects correlate with poor premorbid social functioning
and negative symptoms of schizophrenia as described in a review by Green
et al. (2011) but not with severity of psychosis or positive symptoms
(Slaghuis and Bakker, 1995). Masking abnormalities have also been
observed in unmedicated patients (Butler et al., 1996) and in unaffected
siblings (Green et al., 2006), suggesting that they may be a marker of
vulnerability to schizophrenia.
Masking effects appear to originate at a stage of processing beyond basic
sensory input, and M pathway alterations are thought to explain these deficits
in schizophrenia (Schechter et al., 2003; Green et al., 2011). Using masks
that separately biased activation towards either the P (using colour contrast)
or M (using very low luminance) pathways, Schechter et al (2003) found
evidence of impaired M but not P pathways in schizophrenia. Furthermore,
as these deficits correlated with negative symptoms, they suggested that it is
impaired M pathway functioning that is related to poor outcome.
8.1.1 Colour vision in schizophrenia
Chromatic vision, a visual function mainly subserved by the P pathway has
received less attention in schizophrenia, despite deficits having been
reported several decades ago by Young (1974). The finding that retinal
dopamine is involved in a number of visual functions, including chromatic
vision, and that patients with reduced dopamine neurotransmission, as in
Parkinson’s disease, had deficits in colour discrimination in the blue-yellow
hue-specific axis (Desai et al., 1997; Haug et al., 1997), generated further
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interest, the hypothesis being that abnormal intrinsic or medication related
dopamine function may be detectable at the level of the retina.
Early studies failed to show that antipsychotic medication affected colour
vision (Gagrat, 1979; Haug, 1997). A later, more detailed study (Shuwairi et
al., 2002) which used 5 different measures of hue discrimination with variable
cognitive requirements reported that medicated, male schizophrenia patients
made more errors than controls across all colour hues. These deficits, which
were general and non-specific to the blue-yellow axis suggested that
abnormal hue discrimination in schizophrenia is unrelated to dopamine
function. It was concluded that these deficits were more likely to reflect poor
attention and fatigue in patients.
The current study had two aims: 1) to determine whether hue discrimination
is impaired in patients with schizophrenia spectrum disorder compared to
healthy controls with a larger sample sizes than previous studies; 2) to
investigate the relationship between hue discrimination and cognitive
performance.
8.2 Methods
8.2.1 Subjects
All subjects were part of The West London Longitudinal First Episode
Psychosis Study and had responded to a written invitation and follow-up
telephone call.
Exclusion criteria for all participants were: i) medical history of neurological
disease or systemic medical condition that might affect the eyes (e.g.
diabetes or hypertension), ii) previous head injury with loss of consciousness,
iii) a history of drug or alcohol dependence, iv) abnormal findings on
ophthalmological screening tests (Sloan Letter Chart assessment of visual
acuity, visual field assessment and visualisation of the retina), v) history of
achromatopsia.
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8.2.2 Patients
Forty-six schizophrenia spectrum disorder patients (34 males, 12 females),
mean age 30yrs (range 18 to 56) were included in this study. Thirty-six had a
diagnosis of schizophrenia and 10 of schizoaffective disorder; all patients
were analysed as a single group. At the time of this study, thirty-five patients
were prescribed atypical and two prescribed typical antipsychotic medication,
one was prescribed a mood-stabiliser plus an antidepressant; eight patients
were not taking medication.
Symptom type and severity were assessed in patients at the time of
recruitment to the present study using the Scales for the Assessment of
Positive Symptoms (Andreasen, 1983) and Negative Symptoms (Andreasen,
1981). Scores for the three syndromes of schizophrenia (Liddle & Barnes,
1990) were calculated and expressed as the ratio of the maximum possible
score. Symptoms scores were available for a subset of 33 patients: of these
15 patients had no symptoms, 14 had positive symptoms with a mean factor
score of 0.13 (range 0 to 0.6), 13 patients had negative symptoms (of whom
nine also had positive symptoms) with a mean factor score of 0.2 (range 0 to
0.8) and three had disorganisation symptoms (in addition to negative and/or
positive symptoms), mean factor score of 0.02 (range 0 to 0.3).
8.2.3 Controls
Thirty-nine healthy controls, mean age 29yrs (range 20 to 46), 24 males and
15 females were recruited. Controls were matched to patients for age
(t=0.09, df=83, p=0.93) and gender (χ²=0.22, p=0.25). 
8.2.4 Colour hue discrimination task
Hue discrimination was assessed in all subjects, using the Farnsworth-
Munsell 100-Hue Colour Test (FMHH) (Farnsworth, 1943). The FMHH is
recognized as the “gold standard” hue discrimination test and is widely used
in industrial and clinical settings. The test consists of 85 colour caps of
incremental hue variation split between four trays (fig. 8.1). Subjects were
instructed to line up the caps in a consistent colour continuum, always
seeking the hue closest to the one just matched. The two end points of each
tray were indicated by fixed
consecutive order.
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8.2.5 Cognitive Assessment
Thirty-one patients and 20 controls completed a cognitive battery measuring
estimated premorbid IQ (National Adult Reading Test) (Nelson, 2013),
current IQ (four subtests version of the Weschler Adult Intelligence Scale III)
(Blyler et al., 2000), spatial working memory (token search task from the
CANTAB battery) (Sahakian and Owen, 1992), verbal learning (Rey Auditory
Verbal Learning Test) (Rey, 1964) and processing speed (digit symbol test)
(Wechsler, 1981).
8.2.6 Statistical analysis
An independent samples t-test of √TES values was used to compare hue 
discrimination between patient and control groups. Linear regression was
used to examine effects of group, age and gender for each of the 4 trays.
As a surrogate marker of sustained attention, difference in scores for trays 1
and 4 were calculated for both eyes and differences between patient and
control groups sought using a paired t-test.
Correlations between hue discrimination and symptom severity as indicated
by three symptom clusters (positive, negative and disorganisation) were
investigated using linear regression.
Partial correlations were sought between hue discrimination and the cognitive
variables of premorbid IQ, current IQ, spatial working memory (total errors),
verbal learning (maximum number of words recalled over 5 attempts) and
information processing speed, while controlling for age and gender.
8.3 Results
8.3.1 Colour hue discrimination
Linear regression analyses showed no effect of age or gender on hue
discrimination. There was a significant effect of group across all colour hues
(table 8.1). Patients performed worse than controls on all four trays of the
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FMHH, indicating impaired hue discrimination across all colour spectra (table
8.2).
Group Age Gender
Tray 1 β=0.38, p<0.001 β=-0.10, p=0.32 β=0.01, p=0.96 
Tray 2 β=0.38, p<0.001 β=-0.10, p=0.31 β=0.07, p=0.52 
Tray 3 β=0.38, p<0.001 β=-0.08, p=0.42 β=0.15, p=0.13 
Tray 4 β=0.31, p=0.003 β=-0.19, p=0.08 β=0.11, p=0.30 
√TES β=0.45, p<0.001 β=-0.09, p=0.38 β=0.12, p=0.90 
Table 8.1 Results of linear regression showing a significant effect of
group on hue discrimination across all 4 trays
Patients
Mean (sd)
Controls
Mean (sd)
Significance
Tray 1 69.67 (22.02) 55.62 (9.92) t=3.89, df=64.74, p<0.001
Tray 2 85.13 (26.19) 67.51 (12.35) t=4.06, df=66.30, p<0.001
Tray 3 85.39 (27.16) 66.33 (14.22) t=4.14, df=70.13, p<0.001
Tray 4 76.30 (25.48) 62.13 (13.46) t=3.27, df=70.45, p=0.002
√TES 11.86 8.78 t=4.54, df=88.40, p<0.001
Table 8.2 Comparison of FMHH scores between patients and controls
Higher score indicates worse performance
8.3.2 Attention
Differences between patient and control groups were similar for hue
discrimination between trays 1 and 4, for both right (t=0.26, df=64.66,
p=0.80) and left (t= -0.33, df=83, p=0.74) eyes, suggesting that attention was
maintained throughout the testing.
8.3.3 Hue Discrimination and Symptom severity
The severity of positive, negative and disorganisation symptoms were
unrelated to hue discrimination ability in patients (table 8.3).
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Symptoms Mean (sd) Correlation
Positive 0.13 (0.18) β= 0.19, p= 0.46 
Negative 0.20 (0.30) β= -0.20, p= 0.44 
Disorganised 0.02 (0.08) β= 0.22, p= 0.27 
Table 8.3 Correlation of hue discrimination with symptom severity in
patients
8.3.4 Cognitive Performance
Estimated premorbid IQ (p=0.09) and spatial working memory scores
(p=0.44) were similar between patients and controls but patients performed
worse than controls in tests of current IQ (p=0.001) and verbal learning
(p<0.001). Speed of information processing (p=0.06) was slower in patients
at a trend level of significance (table 8.4).
Patients
mean (sd)
Controls
mean (sd)
Significance
Premorbid IQ 102.77 (11.35) 107.35 (7.37) t=1.75, df=49
p=0.09
Current IQ 98.48 (19.94) 118.20 (18.86) t=3.52, df=49
p=0.001
Working memorya 31.90 (8.96) 30.10 (6.46) t=-0.78, df=49
p=0.44
Verbal learning 11.32 (2.83) 13.85 (1.53) t=3.65, df=49
p=<0.001
Processing speed 9.26 (8.30) 13.55 (7.20) t=1.9, df=49
p=0.06
Table 8.4 Comparison of Cognitive Performance in Patient and Control
Groups
ahigher score = worse performance
Worse hue discrimination was associated with lower premorbid IQ in both
groups. There were no significant correlations between hue discrimination
and cognition in controls but in patients, worse hue discrimination was
associated with lower premorbid IQ, significantly worse spatial working
memory and verbal learning (table 8.5).
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All subjects Patients Controls
Premorbid IQ -0.51, p<0.001 -0.48, p=0.009 -0.46, p=0.05
Current IQ -0.42, p=0.003 -0.34, 0=0.07 -0.36, p=0.15
Spatial working
memorya
0.34, p=0.02 0.46, p=0.01 -0.17, p=0.50
Verbal learning -0.54, p<0.001 -0.51, p=0.004 -0.30, p=0.23
Processing
speed
-0.27, p=0.07 -0.30, p=0.11 0.15, p=0.56
Table 8.5 Correlations between hue discrimination and cognition in all
subjects, patients and control groups
ahigher score = worse performance
8.4 Discussion
The main finding from this study was that schizophrenia spectrum disorder
patients had worse hue discrimination ability than healthy controls across all
colour spectra. This replicates the findings of Shuwairi et al (2002) in a larger
group of patients who were earlier in their course of illness and suggests that
impaired hue perception is a trait present from the earliest stages of
schizophrenia. Shuwairi et al (2002) hypothesised that specific deficits in
colour vision would be seen in the blue-yellow hue axis due to dopamine
dysregulation, similar to that reported in Parkinson’s disease. When a more
generalised deficit was found, they suggested that this might be explained by
inattention or fatigue. In the current study there was no evidence to support
patients becoming more fatigued or less attentive during the FMHH task, as
performance in both eyes was equally stable in both groups across all four
colour trays which were presented sequentially. Furthermore, no association
was found between information processing speed and hue discrimination
ability.
On the other hand, worse auditory verbal learning, spatial working memory
and, to a lesser extent, current IQ were associated with worse hue
discrimination in patients but not in healthy controls. It has been
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demonstrated that from the onset of schizophrenia, patients display
persistent and widespread cognitive impairment, with verbal learning and
working memory being particularly compromised (Leeson et al., 2009b).
Cognitive impairment has also been demonstrated prior to onset of
psychosis, with deficits already seen in childhood suggesting that it is intrinsic
to the neurodevelopmental risk for schizophrenia (Khandaker et al., 2011).
The association between impaired hue discrimination and cognitive
impairment in the current study suggests that the underlying biological
mechanism of hue perception is abnormal in schizophrenia and that this is
also a facet of the neurodevelopmental abnormality.
An alternative explanation is that cognitive impairment caused a greater rate
of hue discrimination errors in the schizophrenia group but this is unlikely as
all subjects were given a practice trial of the task, to ensure they had
understood the instructions and the task was not timed. Medication could not
explain the difference between patients and controls as a post hoc analysis
comparing medicated and unmedicated patients found no difference between
groups on hue discrimination ability. This also supports the conclusions of
Shuwairi et al (2002) who failed to find a dose related performance response
on the same task.
Although age-related loss of hue discrimination has been reported (Jackson
and Owsley, 2003), this could not explain the results of this study as age did
not predict hue discrimination deficits. An earlier study of retinal nerve fibre
layer (RNFL) thickness (described in chapter 6) failed to show differences in
RNFL thickness between patients and controls (Chu et al., 2012). As those
subjects also formed the patient and control groups described in the current
study, hue discrimination deficits present in the same patients are unlikely to
be explained by structural retinal abnormalities.
The human visual area V4 is located in the lingual and fusiform gyri of the
occipital and occipto-temporal lobes and is the first area along the visual
pathway to contain cells specialised for colour perception and hue
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discrimination. Cells in this area project onward to the temporal cortex where
colour perception combines with object perception to enable object
recognition (Zeki et al., 1991). Results of the current study may therefore
reflect a dysfunction of this occipito-temporal cortical system or, more
broadly, of the P visual pathway.
The importance of our finding, and that of Shuwairi et al (2002), is that it
challenges previous work suggesting that the visual processing deficit in
schizophrenia is specific to the M pathway. Backward masking paradigms
biased towards either the M or P pathway have pointed to intact P pathway
and impaired M pathway function in schizophrenia (Schechter et al., 2003).
Similarly, studies measuring P1 and N1 evoked potentials thought to reflect
integrity of the M and P pathways respectively, have consistently reported
changes in the amplitude of the P1 but not the N1 potential (Koychev et al.,
2011). Conversely, a more recent psychophysiological study (Cadenhead et
al., 2013) using a visual contrast sensitivity paradigm able to detect near
threshold stimuli biased towards either M (luminance) or P (chromatic)
pathways found that patients with schizophrenia were impaired on both
conditions. These findings, along with results of the current study suggest
impairments in both M and P pathways or a more general impairment in
visual processing at a level where both pathways interact.
Studies implicating impaired M pathway function in schizophrenia have also
found an association with negative symptoms. Thus M pathway impairment
has been considered not only a marker of schizophrenia but also relevant for
clinical outcome (Schechter et al., 2003). No correlations were found
between hue discrimination and symptom severity in our patients, but given
that cognitive impairment at first episode of schizophrenia and schizoaffective
disorder is predictive of poor functional outcome later on in the disease
(Leeson et al., 2009a), the demonstrated association between cognitive and
hue discrimination impairments of the current study also implicates
dysfunction of the P pathway as being relevant for clinical outcome.
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This study is limited by the use of only one type of task to assess P pathway
function and the lack of a comparison M pathway task in the same
participants. Further work using different paradigms are required to clarify the
nature of visual processing abnormalities in schizophrenia and investigate if
there may be utility in such tests to help predict clinical outcomes for patients.
In conclusion, results of this study suggest a deficit in the visual pathway
lying somewhere along the occipito-temporal course of the P pathway. The
current study supports a neurodevelopmental explanation of schizophrenia
because hue discrimination deficits correlated with cognitive deficits, which
are already established early on in the illness. Continuing on the theme of
vision and combining this with structural imaging, the final study described in
the next chapter was designed to examine the relationship between
oculomotor function and grey matter volume.
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9. A STUDY OF OCULOMOTOR FUNCTION IN RELATION TO
GREY MATTER ABNORMALITIES IN FIRST EPISODE
PSYCHOSIS
9.1 Introduction
9.1.1 Oculomotor function in schizophrenia
Abnormalities in smooth pursuit (an eye movement which allows one to
follow a moving stimulus in a single direction) were ‘rediscovered’ in patients
with schizophrenia by Holzman (1974). This phenomenon was first described
in 1908 by Diefendorf and Dodge; using a modified photochronograph to
trace oculomotor movements onto a photographic plate they described
“abnormally rapid eye movements” in 10 patients with dementia praecox
(Diefendorf and Dodge, 1908). Other deficits of oculomotor function
associated with schizophrenia have since been established, including
delayed antisaccade latency (delay in making a saccadic movement towards
the mirror image location after presentation of a stimulus) and increased
antisaccade error rate (erroneous reflexive saccades made towards a
peripheral target when subjects are instructed to look at a mirror image
location) (Crawford et al., 1995; Katsanis et al., 1997; McDowell et al., 2002;
Sereno and Holzman, 1995).
Abnormal oculomotor function is now considered to be a phenotype for
schizophrenia, as this measurable characteristic is consistently observed, is
not explained by other disease-related factors and is not state related
(Thaker, 2000). Unaffected first degree relatives also demonstrate abnormal
antisaccade and smooth pursuit measures and are impaired to a degree
between that of healthy individuals and patients with schizophrenia,
suggesting that oculomotor function measures may be a marker of genetic
vulnerability for the disease (Clementz et al., 1994). This phenomenon is
unlikely to be a medication effect as abnormal smooth pursuit and increased
antisaccade error rates have also been reported in first episode psychosis
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patients who have received minimal medication (Hutton et al., 2004;
Lieberman et al., 1993).
Less attention has been given to measuring prosaccades (reflexive eye
movements towards a stimulus) although existing studies demonstrate no
difference in performance between patients with schizophrenia and healthy
controls (Fukushima et al., 1990; Barton et al., 2006; Hutton et al., 2002;
Reuter et al., 2006). This is perhaps surprising as motor reaction times are
generally slower in patients with schizophrenia (Birkett et al., 2007). As
prosaccade latency (the time delay to initiation of eye movement towards a
stimulus) is a measure of reflex action, this was further investigated in the
current study.
9.1.2 Oculomotor function and associated brain regions
The diagram and explanatory text in the paragraph below has been modified
from an article by Munoz and Everling (2004).
Figure 9.1 Neural Circuits Controlling Saccadic Eye Movements
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Visual inputs arise from the retino-geniculo-cortical pathway to the primary
visual cortex and from the retinotectal pathway to the superficial layers of the
superior colliculus (SC). The lateral interparietal (LIP) area in the posterior
parietal cortex is at the interface between sensory and motor processing and
projects to intermediate layers of the SC and fronto-cortical oculomotor
areas; which include frontal eye fields (FEF), supplementary eye fields (SEF)
and the dorsolateral prefrontal cortex (DLPFC). The FEF has a crucial role in
executing voluntary saccades, the SEF guides decision-making and
sequencing of saccades, while the DLPFC suppresses automatic reflexes. All
these frontal regions project to the SC, a vital node in the premotor circuit.
The FEF, SEF and SC project directly to the paramedian reticular formation
to provide the necessary input to the saccadic premotor circuit so that a
saccade is initiated or suppressed.
9.1.3 Neuroimaging of oculomotor function in schizophrenia
Neuroimaging studies, have allowed attempts to distinguish the neural
networks associated with oculomotor movements. fMRI findings have shown
varied results Fukumoto-Motoshita and colleagues (2009), described healthy
subjects showing greater dorsolateral prefrontal cortex and thalamus
activation in antisaccade than prosaccade tasks, while patients with
schizophrenia showed no difference in degree of activation between the two
tasks. Greater activation in the posterior hippocampi and right fusiform gyrus
have also been described in patients with schizophrenia during smooth
pursuit eye movements (Tregellas et al., 2004), while others have reported
decreased activation in the lateral frontal regions and hyperactivity in
temporal areas (Camchong et al., 2008). During antisaccades, fMRI showed
failure of activation in schizophrenia patients of the left inferior frontal gyrus,
thalami and lentiform nuclei bilaterally compared to healthy participants (Tu
et al., 2006), while another study also described lack of prefrontal cortex
activation (McDowell et al., 2002). In first-episode schizophrenia, it was found
that visual pursuit abnormalities correlated with reduced magnetisation
transfer ratio (MTR) in the right prefrontal cortex, while poorer performance
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on the antisaccade task was associated with reduced GM volume in the right
medial superior frontal cortex (Bagary et al., 2004).
The aim of the current study was to test the hypothesis that patients would
perform worse than controls in smooth pursuit, antisaccade and prosaccade
tasks and that these oculomotor function deficits would be associated with a
reduction in GM volume.
9.2 Methods
9.2.1 Subjects
All subjects were recruited from the West London First Episode Psychosis
study as described in chapter 4.
Eighteen first episode psychosis patients (12 males and 6 females) were
recruited to the study, 8 were diagnosed with schizophrenia, 8 schizoaffective
and 2 schizophreniform disorder. Seventeen patients were prescribed an
antipsychotic and 4 were prescribed one additional psychotropic medication.
A comparison group of twenty-two healthy controls (10 males and 12
females) were also recruited (Table 9.1).
Patients (n=18) Controls (n=22)
Mean age (sd) 22.6 (+/-5.7) yrs 30.1 (+/-6.7) yrs
Gender 12 male: 6 female 10 male: 12 female
Handedness 17 right: 1 left 17 right: 5 left
Diagnosis 8 schizophrenia
8 schizoaffective
2 schizophreniform
None
Antipsychotic
medication
12 olanzapine
4 risperidone
1 amisulpiride
1 unmedicated
None
Other medication 2 benzodiazepines
1 citalopram
1 orphenadrine
None
Table 9.1 Demographic Information
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9.2.2 Oculomotor Function Measures
All subjects had oculomotor function measurements performed in a quiet,
dimly lit room. Eye movements were recorded with an Eyelink I eye tracker
(SR-Research, Osgoode, Ontario), sampling the right eye at 250Hz by a
research psychologist who was trained and experienced in measuring
oculomotor function. Stimuli were presented on a 21" cathode ray tube (CRT)
display with the refresh rate set to 100Hz. For all tasks the stimulus consisted
of a red circle (luminance 15cd/m) presented on a black background, with the
circle subtending approximately 0.5 degrees of visual angle. Participants
were seated approximately 60cm from the display. Pupil position was
monitored via two miniature infrared charge-coupled device video cameras
mounted on an adjustable headband. A three-point horizontal calibration was
performed at the start of each test, followed by a three-point calibration
accuracy test. Calibration was repeated if the error at any point was more
than 1 º or if average error for all points was greater than 0.5 º.
The following three measures were recorded:
1. Smooth pursuit velocity gain
The pursuit stimulus appeared on the left of the display and, after a drift
correction procedure had been applied at that location, proceeded to move
horizontally +/- approximately 20º at a constant velocity. Three blocks of 6
cycles of pursuit were recorded, with the drift correct procedure being applied
before each block. The target moved at 0.125 Hz (5º per sec) in the first
block, 0.25 Hz (10º per sec) in the second block and 0.5 Hz (20º per sec) in
the third block. Participants were instructed to follow the target with their eyes
and to refrain from blinking whilst the target moved. Velocity gain, the ratio of
the eye velocity to the target velocity, was the measure used in subsequent
analyses.
2. Antisaccade error rate
The antisaccade task employed the same methods and parameters as the
prosaccade task, with the sole difference that participants were instructed
that when the peripheral target appeared they should not look at it, but
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should instead move their eyes as quickly and as accurately as possible to
the mirror image location (an equal distance from central fixation but in the
opposite direction). Participants performed 24 trials in total. Percentage error,
calculated as the number of trials in which the participant made a saccade in
the direction of the target as a function of the total number of successfully
recorded trials, was used for further analysis.
3. Prosaccade latency
Each trial began with a red circle presented in the centre of the screen.
Participants were instructed to look at the central stimulus, thus allowing a
pre-trial drift correction procedure to be applied. This procedure could vary in
length, taking longer if a participant blinked for example, but typically took no
longer than 2 sec. The drift correct procedure was followed by a brief delay
after which the central stimulus disappeared, and a target appeared
simultaneously in the periphery. The target could be presented at one of four
locations: +/-7.5 and 15 º from fixation. The target remained on screen for a
further 2 sec before the trial ended and the central fixation stimulus
reappeared signaling the onset of the next trial. Participants were instructed
to look at the peripheral target as quickly and as accurately as possible.
Participants performed 24 trials in total. Prosaccade latency, taken as the
time in ms between the target appearing in the periphery and gaze being
directed at the target in this new position, was the measure taken from this
task.
9.2.3 MRI Acquisition and Processing
All subjects who had oculomotor function measured also had MRI scanning
within a concurrent 2 week period. Brain MRI was performed on all subjects
using a GE Signa 1.5T scanner (Milwaukee, Wisconsin, USA). High
resolution T1 weighted images were acquired in the coronal plane with an
SPGR gradient echo pulse sequence.
MRI images were processed using statistical parametric mapping (SPM2)
software (http://www.fil.ion.ucl.ac.uk/spm) and the voxel based morphometry
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(VBM) method was carried out as described by Good et al. (2001a).
Segmented grey matter images were spatially smoothed with a 12mm
FWHM isoptropic Gaussian kernel. Statistical parametric maps were
calculated for the effects of interest within a general linear model.
Regions of significant effect were defined as having an extent of at least 100
contiguous voxels and reaching a threshold of significance at the cluster level
(p ≤0.05) following correction for multiple comparisons. Locations of local 
maxima were converted from MNI (Montreal Neurological Institute) to
Talairach co-ordinates and referenced against the Jürgen-Mai brain atlas
(Mai et al., 2004) http://imaging.mrc-cbu.cam.ac.uk/imaging/MniTalairach.
9.2.4 Data Analysis
Statistical differences were sought between patient and control groups for
age, gender and oculomotor function measures.
A preliminary analysis was used to compare GM volume of patient and
control groups. Total brain volume was calculated directly from segmented
grey and white matter images (by taking the sum of the voxel intensity in the
grey or white matter probability images, and multiplying by the voxel volume)
and retained as a confounding variable in all subsequent analyses. Using a
general linear model (GLM), each of the three different measures of
oculomotor function were added in turn to the preliminary analysis model and
their association with GM volume investigated across both patient and control
groups, between groups and within groups. Regions where local maxima
reached significance were then corrected for multiple comparisons using a
family-wise error (FWE) correction.
9.3 Results
9.3.1 Demographics
Patients had a mean age of 22.6 years (sd=5.7) and were significantly
younger (t= -3.8, df=38, p=0.001) than controls (mean age 30.1 years,
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sd=6.7); age was therefore retained as a covariate in all subsequent
analyses. Groups were similar for gender (χ²=1.8, df=1, p=0.18) and 
handedness (χ²=2.29, df=1, p=0.13). Average treatment duration with 
antipsychotics prior to MRI was 11 weeks (range 2-23 wks).
9.3.2 Oculomotor function
Results of oculomotor function measures are summarized in Table 9.2.
Patients had slower smooth pursuit velocity gain than controls at 5°/sec (t= -
2.639, df=38, p=0.012) and at 10°/sec (t= -2.059, df=38, p=0.046). As these
measures were strongly correlated (Pearson’s rho = 0.74), mean value for
results at 5 and 10°/sec were used. Although recordings were obtained from
both groups at 20°/sec these results were excluded from analysis as one
patient outlier was >3sd below the mean, which severely skewed the data.
Patients had slower smooth pursuit velocity gain than controls (t= -2.587,
df=38, p=0.015).
Patients made more antisaccade errors than controls but this no longer
reached statistical significance (t=3.178, df=37, p=0.339) after excluding one
patient outlier who was performing at worse than chance level, with a 100%
antisaccade error rate.
There was no difference in prosaccade latency (t=0.608, df= 38, p=0.547)
between patients and controls.
Oculomotor Function Patient
Mean (sd)
Control
Mean (sd)
Sig
(p value)
Smooth pursuit (ratio) 0.96 (0.04) 0.98 (0.04) 0.01
Antisaccade error rate (%) 56.82 (26.85) 48.41 (26.93) 0.34
Prosaccade latency (ms) 183.93(68.01) 174.66 (20.31) 0.55
Table 9.2 Oculomotor Function Measures
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9.3.3 Grey matter volume
Preliminary analysis found GM volume in first episode patients was similar to
that of healthy controls (matched for handedness and gender). Any apparent
differences in GM volume were explained by total brain volume and age;
confounding variables of total brain volume, age and gender were therefore
controlled for in all subsequent analyses.
9.3.4 Grey matter volume and smooth pursuit velocity gain
Smooth pursuit velocity gain was entered as the factor of interest on the GLM
model across both groups, but this failed to explain variation in GM volume.
In the patient group, an association was found between smooth pursuit
velocity gain and GM volume (p<0.0003), with local maxima in the striate
area of the right occipital lobe, although the cluster also included bilateral
cerebellar components (Figure 9.2). This suggests that the greater the
smooth pursuit velocity gain, the greater the GM volume of these brain
regions in patients. When patient and control groups were compared, the
strength of association between smooth pursuit velocity gain and GM volume
was greater in patients than controls (p=0.024) in bilateral cerebellar regions.
Across all subjects, an inverse association was found between smooth
pursuit velocity gain and GM volume, with local maxima in the anterior
cingulate (p=0.006) extending into the prefrontal cortex (Figure 9.3). This
suggests slower smooth pursuit velocity gain was associated with greater
GM volume in this region.
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Figure 9.2 Right Striate & Bilateral Cerebellar Areas Where Grey Matter
Volume is Associated with Smooth Pursuit in Patients
Figure 9.3 Anterior Cingulate Areas Where Grey Matter Volume is
Inversely Associated with Smooth Pursuit in Patients & Controls
9.3.5 Grey matter volume and antisaccade error rate:
When antisaccade error rate was entered as the factor of interest on the
GLM model, no regions of association between antisaccade error rate and
GM volume were found either across or between both groups, or within either
patient or control group alone.
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9.3.6 Grey matter volume and prosaccade latency:
Prosaccade latency was entered as the factor of interest on the GLM model
across both groups, but this failed to explain variation in GM volume beyond
that of the nuisance variables (age and gender).
In the patient group, an inverse association was found between prosaccade
latency and GM volume in the bilateral prefrontal cortices (Figure 9.4),
suggesting that as prosaccade latency increases, GM volume decreases in
these areas. Local maxima were found in the left (p=0.027) and right anterior
frontal cortices (p=0.042). In the control group, there was no association
between prosaccade latency and GM volume.
When patient and control groups were compared, association between
prosaccade latency and GM volume was greater in patients than controls
(Figure 9.5) in the right posterior inferior temporal region (p=0.015).
Figure 9.4 Bilateral Frontal Lobe Areas Where Grey Matter Volume
Displays Inverse Association with Prosaccade Latency in Patients
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Figure 9.5 Right Inferior Temporal Lobe Areas Where Grey Matter
Volume is Associated with Prosaccade Latency in Patients More than
Controls
N.B. Only right hemisphere regions reached statistical significance
Number
of voxels
in
cluster
Max
Talaraich
coordinates
(x, y, z)
Area Association
with GM
volume and
group
Smooth
pursuit
23243 (11, -93, -11) Right striate &
bilateral
cerebellar areas
Positive
association
in patients
only
Smooth
pursuit
6727 (34, -8, -49) Anterior cingulate Positive
association
across both
groups
Prosaccade
latency
6727 (34, -9, -41) Right inferior
temporal gyrus
Positive
association
greater in
patients than
controls
Prosaccade
Latency
3718
3085
2730
(-18, 46, 34)
(-10, 35, 26)
(28,59,23)
Bilateral
prefrontal
cortices
Inverse
association
in patients
only
Table 9.3 Cluster Sizes & Talaraich Co-ordinates Where Grey Matter
Volume Showed Associations with Oculomotor Function Measures
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9.4 Discussion
Smooth pursuit task performance was worse in patients than controls in this
study. In the patient group, poor performance was associated with decreased
GM volume in the striate area of the right occipital lobe and cerebellum. The
striate region plays a crucial role in visual processing because most visual
information is funneled through this area before reaching the rest of the
visual cortex (Felleman and Van Essen, 1991). When patients and controls
were compared, this association remained stronger in the posterior
cerebellum of patients. Regions of the oculomotor vermis (lobuli vi-vii) in the
posterior cerebellum are known to control ocular movements (Thier et al.,
2002) and activation of this region using transcranial magnetic stimulation
(TMS) has been demonstrated to correlate with increased visual pursuit
velocity in “normal” subjects (Ohtsuka and Enoki, 1998).
Across patient and control groups combined, decreased GM volume in the
anterior cingulate cortex (ACC) was associated with better performance on
the smooth pursuit task in this study. This finding seems plausible
considering the ACC directs spatial attention (Mesulam, 1981) and eye gaze,
with the posterior dorsal ACC being specifically involved with volitional
saccadic control (Gaymard et al., 1998). White matter (WM) underlying the
ACC may be relevant in schizophrenia as reduced WM integrity of the
cingulate in the right hemisphere has been described in chronic
schizophrenia (Manoach et al., 2007b). If the WM tract underlying the ACC
has reduced in volume, existing GM may spread to occupy the available
space. Alternatively, although disruption of WM tract integrity may not affect
volume; resulting MRI signal intensity may be reduced and come closer to
that of GM, leading to misclassification of brain tissue by the segmentation
algorithm.
Although studies consistently show that schizophrenia patients display an
increased proportion of antisaccade errors compared to healthy controls
(Turetsky et al., 2006) patients and controls recruited to the current study had
a similar rate of antisaccade errors, which was unexpected. Antisaccade
193
impairment is known to be associated with genetic loading for schizophrenia
(Petrovsky et al., 2009), considering diagnoses of patients in this study
included schizoaffective and schizophreniform disorder, genetic loading for
antisaccade impairment in our patient group may have been reduced.
Small sample sizes are a possible limitation of this study, although unlikely to
explain the findings as other studies using small numbers of subjects
reported that schizophrenia patients performed significantly worse than
controls in an antisaccades task (McDowell et al., 2002). In the early stages
of schizophrenia, GM volume changes may still be in a process of evolving
(Szeszko et al., 2003), which may explain the lack of association between
antisaccade errors and GM volume at first-episode psychosis.
Poorer performance on the prosaccade task was associated with reduced
frontal cortex GM volume and increased right temporal GM volume, an effect
of greater significance in patients than controls. This finding appears to lend
support for the hypothesis of abnormal fronto-temporal connectivity in
schizophrenia (Fletcher et al., 1999). It is the right hemisphere which plays a
dominant role in spatial attention (Heilman and Valenstein, 1979) and eye
gaze (De Renzi et al., 1982). One fMRI study reported hyperactive temporal
regions and hypoactive frontal regions during visual pursuit tasks in
schizophrenia patients (Tregellas et al., 2004). Increased regional cortical
blood flow to the temporal region may be associated with increased local GM
volume; furthermore the right temporal lobe is associated with visuo-spatial
function of which prosaccadic tasks are a subset. Considering that both
patients and controls performed at a similar level in the prosaccade task, this
oculomotor function was unlikely to be associated with the GM volume
differences seen in this study.
Most patients were taking atypical antipsychotics but medication effects are
unlikely to affect smooth pursuit (Flechtner et al., 2002) or antisaccade task
performance (Calkins et al., 2003). Although atypical antipsychotics are
reported to affect brain structure, with reports of increased thalamic volume
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(Dazzan et al., 2005) and increased cortical grey matter volume (Scherk and
Falkai, 2006); this is unlikely to have affected our patient sample, as they had
been prescribed medication for only a short period of time and all patients
were in their first episode of psychosis.
This study is perhaps limited by the varied diagnostic distribution of our
patient group as less than half were first episode schizophrenia. Inclusion of
patients with schizoaffective and schizophreniform disorder may have diluted
any findings of significance. A larger patient cohort would have allowed
further subdivision of the schizophrenia spectrum disorders to examine
whether oculomotor function varies according to diagnosis and whether there
were any GM volume differences between healthy controls and patients with
different diagnoses. Looking at patient and control groups separately, the
sample size may be too small to pick up areas of true GM volume association
if the effect size is only small and it is difficult to determine if associations
found in only one of the two groups is truly due to a disease effect. If patients
had reduced GM volume in addition to worse oculomotor function compared
to controls, there would be an increased likelihood that this was due to a
disease effect rather than simply the spread of results within a normal
distribution.
With an increasing drive to reclassify illnesses within the schizophrenia
spectrum into more meaningful endophenotypes as proposed in 2007 by the
American Psychiatric Association and the Consortium on the Genetics of
Schizophrenia; abnormalities of oculomotor function are once again under
scrutiny as a potential biomarker for schizophrenia. Future studies coupling
oculomotor function with neuroimaging may yield data of greater scientific
value in the field of schizophrenia research.
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10. SUMMARY AND CONCLUSIONS
The contents of this thesis have described a series of investigations to try
and improve our understanding of the neurobiology of schizophrenia. By
using a variety of brain imaging techniques the structural manifestation of
schizophrenia was investigated and by examining ocular movement, visual
function and retinal structure the eyes (which form a direct extension of the
brain) were also investigated.
10.1 Summary of Findings
Chapter 5
A study of white matter FA using DTI techniques compared first episode
psychosis patients with healthy controls using TBSS to measure average FA
from the core of all white matter tracts. Patients performed worse than
controls in cognitive measures of current IQ, working memory, processing
speed and verbal learning. Reduced FA indicative of disrupted white matter
integrity affecting the myelin sheath was found in the posterior thalamic
radiations at first episode psychosis. Slower processing speed was
associated with decreased FA in the left superior longitudinal fasciculus
(SLF) and right posterior thalamic radius (PTR) in patients. This suggests
that white matter changes start at the back of the brain and are only subtle at
first episode of illness.
Chapter 6
The main focus of the projects in this thesis were based on experimental
imaging techniques, hence a novel method of looking directly at an
unmyelinated portion of the brain was investigated. Using the eyes as a
“window into the brain” OCT enabled measurement of RNFL thickness and
macular volume in patients with schizophrenia. No RNFL thinning was
identified in the patients, suggesting that unmyelinated axons are unaffected
by schizophrenia at least in the early years following illness onset. The
neuropathology is therefore more likely to involve myelin early on and
predominantly appears to affect white matter integrity. Visual pathways may
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be affected further downstream in schizophrenia rather than at the start in the
retina.
Chapter 7
The longitudinal follow-up study of first episode patients and healthy controls
found a small increase in white matter volume for both groups over a short
follow-up period of around 18 months but no change in grey matter volume.
Patients had significantly larger ventricular volumes at both time points,
demonstrating that increased CSF and ventricular dilatation is already
present from early on in the course of illness. Grey and white matter MTR
showed no significant changes in either group over time; although this
negative finding was unexpected it appears to suggest an absence of
structural change in grey or white matter early on in the course of illness.
Cognitive deficits were present in patients at both time points with a further
decline in performance over time in IQ and processing speed but this did not
correlate with any structural brain changes. Ventricular dilatation and
cognitive deficits appear to be the first markers of change and are present by
the first onset of schizophrenia.
Chapter 8
Further investigation of the visual pathway using hue discrimination found
that patients with schizophrenia had impaired colour hue discrimination
across all colour spectra compared to healthy controls. In patients, hue
discrimination correlated with premorbid IQ, verbal learning and working
memory. In controls, hue discrimination did not correlate with any of the
cognitive variables measured. Impaired hue discrimination in patients could
not be explained by a deficit in attention but correlated with poor cognitive
function. This suggests that visual pathway deficits may be present in the
occipito-temporal P pathway in schizophrenia thus giving rise to deficits in
both hue discrimination ability and cognition.
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Chapter 9
This study combined structural brain imaging to examine associations
between grey matter volume and oculomotor function. First episode
psychosis patients performed worse than healthy controls in oculomotor
function measurements of smooth pursuit while prosaccade latency and
antisaccade error rates were similar in both groups. An association was
found between better smooth pursuit performance and increased right striate
and bilateral cerebellar areas in patients. An association was demonstrated
between reduced prefrontal cortex grey matter and worse prosaccadic
performance, an effect more marked in patients than controls. Conversely,
increased grey matter in the right infero-posterior temporal lobe was
associated with worse prosaccadic performance. This study demonstrates
that oculomotor function deficits are already present by the first episode of
schizophrenia and these appear to be related to grey matter volume.
10.2 Conclusions
Findings from the experiments described in my thesis suggest that the
neuropathology of schizophrenia may manifest itself in a number of ways and
at different time points. The limited neuroimaging findings from the first
episode patients suggest that the neuropathology of schizophrenia arises
from a combination of factors that cause “neurotoxicity” therefore these are
not as evident early on in the course of illness.
The MRI scanning studies that were carried out and described in my thesis
appear to demonstrate that in first episode psychosis, there is only a small
degree of change in brain white matter affecting tract integrity in posterior
brain regions. In at least the first 18 months following clinical diagnosis of a
schizophrenic illness, there were no structural changes affecting grey matter
volume although small areas of white matter volume increase were found.
There was no loss of unmyelinated axons in the retinal nerve fibre layer
observed, suggesting that the neuropathology of schizophrenia manifests
itself first and foremost in the myelin sheath of white matter in the early years
of illness. Hue discrimination ability was adversely affected by schizophrenia
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and associated with impaired cognitive performance, indicative of occipito-
temporal deficits. Cognitive deficits, increased CSF volume and impaired
oculomotor smooth pursuit were present at first episode of psychosis in the
cohort of patients used in my study, which replicates well-known findings
from schizophrenia research.
10.3 Future Research
Although schizophrenia is typically thought of as being a disorder of fronto-
temporal connectivity and much research has been concentrated specifically
on these regions, the visual system runs a long and convoluted course as an
extension from the retina at the front of the brain through the optic nerve to
the occipital lobes at the back of the brain. Little is known about how the
ocular system is affected by schizophrenia, yet abnormal oculomotor function
and impaired hue discrimination are clearly present in this patient population.
Important information about schizophrenia may perhaps be revealed by
studying other visual function domains.
Suggestions for further work and possible research questions include:
1. Examining whether variation in density of DA receptors on the retina
correlates with performance in colour hue discrimination.
2. A longitudinal MRI scanning study of longer duration e.g. introducing a
third scan to track changes over different follow-up time points and
using higher resolution, 3T MRI scanning.
3. Looking at long term functional outcome and seeing if this can be
predicted by matching with earlier MTR measures.
4. DTI studies using tractography to look at the integrity of white matter
tracts implicated in visual processing pathways.
5. A longitudinal OCT study to track whether there is any progressive
RNFL thinning following repeated episodes of psychosis.
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10.4 General Criticisms
One criticism of this series of studies was the high rate of attrition in patient
data either through excessive movement artefacts or patients unable to
tolerate the scanning process. In order for results to be more widely
generalised and more meaningful, it would be necessary to scan a much
larger number of patients. To do this effectively, a multi-centre trial would
need to be set up in order to generate such large quantities of data but there
are inherent complications with MRI scanner compatibility and the costs that
such a study would incur.
With an increasing emphasis towards early intervention in the treatment of
psychosis, it is becoming increasingly difficult to recruit medication naïve
patients to studies. The precise cellular effects of antipsychotic medication
are unclear and may; at least to some extent, be responsible for the large
variation in results obtained by different MRI study groups. Efforts are
therefore turning towards patients who are at “ultra high risk” or in the
prodromal phase of a psychotic illness.
A further point for consideration is the age of subjects being recruited to
studies. In the normal neurodevelopmental process a period of cortical
pruning occurs during adolescence while white matter maturation continues
well into adulthood in the third decade, so the age range of the subjects may
have affected findings in the imaging studies.
Above all else, we should remember that patients who chose to engage in
this set of research studies participated voluntarily and are therefore a self-
selecting group of participants. A further feature of the first episode patients
recruited to the studies described in my thesis is that they were all well
enough to be living in the community (either independently within their own
home or with family members) and were not severely ill. By accessing a
community rather than a hospitalized sample of patients, any possible
confounding effects of institutionalisation and environmental changes have
been minimised. Because such patients are less unwell, this could explain
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why any neuropathological features of disease in this group would be subtle.
If a patient sample with a well-established, chronic course of disease had
been selected to participate, abnormalities on imaging may have been much
more pronounced and more readily observed.
10.5 Clinical and Research Implications
From a clinical perspective, one major difficulty facing clinicians is the
classification of psychotic illness and this may have had implications on the
validity of the studies I carried out. At the recruitment stage of the study,
patients were experiencing their first clinical episode of psychosis but this
could have arisen from a range of different psychiatric diagnoses. In view of
this “first episode psychosis” was the term used to describe patients in
chapters 5, 7 and 9 which encompassed those at first episode of
schizophrenia, schizoaffective and schizophreniform disorder. With the
absence of biological disease markers, current diagnostic criteria and
boundaries which are based on clinical observations may not be entirely
accurate. Caution is therefore required when interpreting findings from these
studies as they may not be generalised to a broader range of patients with
psychotic illness arising from different disorders.
The studies incorporated into my thesis (Table 10.1) appeared to provide
some support for the neurodevelopmental hypothesis of schizophrenia. In
foetal development both the retinal nerve fibre layer (RNFL) and neurons
used in higher cognitive functions arise from the same embryonic origins of
the prosencephalon. Although there was no RNFL thinning, cognitive deficits
were already present in patients at first episode of psychosis and remained a
feature in patients with established diagnoses of schizophrenia or
schizoaffective disorder so this may be attributable to a neurodevelopmental
abnormality.
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Study Hypotheses
Tested
Findings Conclusion
Comparison of FA
between FE pts
and controls
Pts have lower FA
than controls.
Pts perform worse
on cognitive
measures and this
correlates with
reduced FA.
Pts have lower FA
in the posterior
thalamic radius.
Evidence of
disrupted WM
integrity in occipital
lobe tracts early in
the illness course.
No evidence of
neurodegeneration
Findings support the
neurodevelopmental
theory or may be
evidence of
neurotoxicity.
Comparison of
RNFL thickness
between sz/sa
patients and
controls
Pts have thinner
RNFL than
controls.
No difference in
RNFL thickness
between groups.
Sz does not appear
to affect
unmyelinated
axons.
No evidence to
support
neurodegeneration.
Longitudinal
imaging study of
FE pts
Pts have reduced
brain tissue
volumes compared
to healthy controls.
No grey or white
matter volume loss
seen in patients.
No correlations
between brain
tissue volumes
and cognition.
No evidence to
support
neurodegeneration.
Cognitive deficits
already present at
disease onset
supports the
neurodevelopmental
theory.
Hue discrimination
ability and
cognitive function
in sz spectrum
patients
Pts perform worse
in hue
discrimination than
controls.
Pts have worse
hue discrimination
ability than
controls across all
colour spectra,
which correlates
with cognitive
performance.
No evidence to
support or refute
neurodegeneration
.
Oculomotor
function and
correlations with
grey matter
volume in FE pts
FE pts have worse
oculomotor
function than ctrls.
Performance is
correlated with
grey matter
volume.
FE pts have
slower smooth
pursuit than ctrls.
No difference in
GM volume
between groups.
Oculomotor
impairments may be
evidence of
neurotoxicity.
No evidence of
neurodegeneration
at FE schizophrenia
Table 10.1 Summary and Conclusions
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There was unequivocal support for the neurodegenerative hypothesis of
schizophrenia provided by the studies in my thesis. Although there was
evidence of disruption to white matter integrity at first episode of psychosis,
only small areas on two white matter tracts were affected and reduced FA
may indicate neurotoxicity rather than neurodegeneration and cell death. This
may have been the beginning of a more extensive neuropathological process
but this could not be ascertained as only cross-sectional DTI scanning was
carried out in this study cohort. As the longitudinal study showed no evidence
of grey or white matter volume loss, neurodegeneration may occur at a later
stage in the course of illness but not in the first 18 months following first
episode psychosis. The small increase in white matter volume seen over time
was possibly reflective of white matter maturation. A cross-sectional study
correlating oculomotor function with GM volume failed to demonstrate
differences in GM volume between FE patients and controls, again refuting
the hypothesis of neurodegeneration at disease onset. However the
presence of oculomotor function deficits may have arisen from neurotoxicity.
The rationale for using optical coherence tomography (OCT) was to
investigate if this device might prove useful in helping with the diagnosis and
clinical tracking of schizophrenia by measuring RNFL thickness as a
biological disease marker. The negative RNFL finding provided evidence that
unmyelinated axons are not affected by schizophrenia (or at least not in the
optic nerve) and therefore the clinical utility of this instrument is limited. The
absence of axonal loss that would result in RNFL thinning also refutes the
neurodegenerative hypothesis of schizophrenia.
Colour hue discrimination in schizophrenia deserves further investigation.
Although the exact mechanism for this deficit remains unclear it was
associated with cognitive impairment in patients and may have clinical utility
as a diagnostic tool and for tracking disease progression.
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